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Abstract 
Gastro-oesophageal reflux disease (GORD) is one of the commonest chronic conditions in 
the western world with a reported prevalence of 10-20% in Europe and the USA.  The 
disease involves an interplay between factors promoting reflux of gastric juice and failure 
of defensive forces designed to neutralise the resulting acidity.  Transient lower 
oesophageal relaxations, the acid pocket and the presence of a hiatus hernia are important 
factors.  Acid reflux can cause benign oesophageal injury, including oesophagitis, 
oesophageal ulceration and peptic structuring, as well as malignant complications like 
Barrett’s oesophagus and oesophageal adenocarcinoma (OAC).  GORD, Barrett’s and 
OAC rates have been rising over the last few decades in the Western World and the 
reasons for this are unclear. 
Helicobacter pylori (H. pylori) is a common bacterial infection of the stomach present in 
the majority of the world’s human population.  It is known to cause chronic gastritis, and 
can be complicated by the development of peptic ulcer disease, gastric adenocarcinoma 
and gastric MALT lymphoma. An unexplained observation regarding H. pylori infection is 
its negative association with gastro-oesophageal reflux disease and its malignant 
complications.   
The prevalence of H. pylori infection appears to be falling, especially within the Western 
World.  It is possible that H. pylori infection is protecting against the development of 
oesophageal disease from acid reflux and one possible explanation is the infection causing 
a reduction in gastric acid secretory function.  For this to be true, the protective effect from 
H. pylori must be apparent in the majority of those infected.  There is little available data 
on the effect of H. pylori infection within the general population. The few previous studies 
assessing gastric acid secretion have used H. pylori infected healthy volunteers, rather than 
subjects representative of the general population.    
The incidence of central obesity is rising in both children and adults across the world. 
Obesity is strongly associated with gastro-oesophageal reflux and its complications of 
Barrett’s oesophagus and OAC.  Central adiposity seems to be of particular importance.  
The nature of this association is incompletely understood and both mechanical and 
humoral effects of central obesity may be important.   
In the first study we investigated whether the incidences of OAC and gastric 
adenocarcinoma, as well as their time trends, may be inversely related pointing to a 
common environmental factor exerting opposite effects on these cancers.  We used cross-
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sectional data from “Cancer Incidence in Five Continents” (CI5) Volume X and 
GLOBOCAN 2012.  Relevant ICD-10 codes were used to locate oesophageal and gastric 
cancers anatomically, and ICD-O codes for the histological diagnosis of OAC. For 
longitudinal analyses, age standardized rates (ASRs) of OAC and total gastric cancer 
(TGC) were extracted from CI5C-Plus.   Estimated (2012) ASRs were available for 51 
countries and these showed signiﬁcant negative correlations between OAC and both TGC 
(males: correlation coefﬁcient (CC) = −0.38, P =0.006, females: CC= −0.41, P =0.003) and 
non-cardia gastric cancer rates (males: CC= −0.41, P =0.003 and females: CC= −0.43, P 
=0.005). Annual incidence trends were analysed for 38 populations through 1989–2007 
and showed signiﬁcant decreases for TGC in 89% and increases for OAC in 66% of these, 
with no population showing a fall in the latter. Signiﬁcant negative correlation between the 
incidence trends of the two cancers was observed in 27 of the 38 populations over the 19–
50 years of available paired data. Super-imposition of the longitudinal and cross-sectional 
data indicated that populations with a current high incidence of OAC and low incidence of 
gastric cancer had previously resembled countries with a high incidence of gastric cancer 
and low incidence of OAC.  The negative association between gastric cancer and OAC in 
both current incidences and time trends is consistent with a common environmental factor 
predisposing to one and protecting from the other. 
In our second study we assessed the gastric acid secretory capacity in different anatomical 
regions in H. pylori positive and negative volunteers in a Western population. We studied 
31 H. pylori positive and 28 H. pylori negative volunteers, matched for age, gender and 
body mass index. Jumbo biopsies were taken at 11 predetermined locations from the 
gastro-oesophageal junction and stomach. Combined high-resolution pHmetry (12 sensors) 
and manometry (36 sensors) was performed for 20 min fasted and 90 min postprandially. 
The squamocolumnar junction was marked with radio-opaque clips and visualised 
radiologically. Biopsies were scored for inflammation and density of parietal, chief and G 
cells immunohistochemically. 
 
Under fasting conditions, the H. pylori positives had less intragastric acidity compared 
with negatives at all sensors >1.1 cm distal to the peak lower oesophageal sphincter (LOS) 
pressure (p<0.01). Postprandially, intragastric acidity was less in H. pylori positives at 
sensors 2.2, 3.3 and 4.4 cm distal to the peak LOS pressure (p<0.05), but there were no 
significant differences in more distal sensors. The postprandial acid pocket was thus 
attenuated in H. pylori positives. The H. pylori positives had a lower density of parietal and 
chief cells compared with H. pylori negatives in 10 of the 11 gastric locations (p<0.05). 
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17/31 of the H. pylori positives were CagA-seropositive and showed a more marked 
reduction in intragastric acidity and increased mucosal inflammation.  In conclusion, H. 
pylori positives have reduced intragastric acidity which most markedly affects the 
postprandial acid pocket. 
 
In the third and final study we investigated the effect of increasing abdominal pressure by 
waist belt on reflux in patients with reflux disease. We performed a prospective study of 
patients with oesophagitis (n = 8) or Barrett's oesophagus (n = 6); median age was 56 years 
and median body mass index was 26.8. Proton pump inhibitors were stopped at least 7 
days before the study and H2 receptor antagonists were stopped for at least 24 hours before. 
The severity of upper GI symptoms was assessed, and measurements of height, weight, and 
waist and hip circumference taken. Combined high-resolution pH measurements and 
manometry were performed in fasted state for 20 minutes and for 90 minutes following a 
standardized meal. The squamocolumnar junction was marked by endoscopically placed 
radio-opaque clips. The procedures were performed with and without a waist belt (a 
weight-lifter belt applied tightly and inflated to a constant cuff pressure of 50 mmHg). 
Without the belt, intragastric pressure correlated with waist circumference (r = 0.682; P = 
.008), with the range in pressure between smallest and largest waist circumference being 
15 mmHg. The belt increased intragastric pressure by a median of 6.9 mmHg during 
fasting (P = .002) and by 9.0 mmHg after the meal (P = .001). Gastro-oesophageal acid 
reflux at each of the pH sensors extending 5.5 cm proximal to the peak lower oesophageal 
sphincter pressure point was increased by approximately 8-fold by the belt (all P < .05). 
Following the meal, the mean number of reflux events with the belt was 4, vs 2 without 
(P = .008). Transient lower oesophageal sphincter relaxations were not increased by the 
belt, but those associated with reflux were increased (2 vs 3.5; P = .04). The most marked 
effect of the belt was impaired oesophageal clearance of refluxed acid (median values of 
23.0 seconds without belt vs 81.1 seconds with belt) (P = .008). The pattern of impaired 
clearance was that of rapid re-reflux after peristaltic clearance.  In conclusion we found 
belt compression increased acid reflux following a meal. The intragastric pressure rise 
inducing this effect is well within the range associated with differing waist circumference 
and likely to be relevant to the association between obesity and reflux disease. 
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CHAPTER 1 
 
Rising Incidence of  
Gastro-oesophageal Reflux 
Disease and its Complications  
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1.1 Introduction 
Gastro-oesophageal reflux disease (GORD) is one of the commonest chronic conditions in 
the western world with a reported prevalence of 10-20% in Europe and the USA.(1) A 
common definition is “a condition which develops when the reflux of stomach contents 
causes troublesome symptoms and/or complications.”(2)  The classical symptoms of 
GORD are heartburn and acid regurgitation, and the condition can be diagnosed based on 
the occurrence of these symptoms at least twice per week.  Other less common symptoms 
include dysphagia, odynophagia, nausea and extra-oesophageal symptoms such as chronic 
cough, hoarseness and asthma. Complications of GORD include Barrett’s oesophagus and 
oesophageal adenocarcinoma.  Epidemiological data shows a rising incidence of GORD 
and these malignant complications. 
 
1.2 Pathophysiology 
1.2.1 Anatomy of the gastro-oesophageal junction 
The understanding of the pathophysiology of GORD has constantly evolved, and it is now 
accepted that the condition involves an interplay between factors promoting reflux of 
gastric juice and failure of defensive forces designed to neutralise the resulting acidity.  
The gastro-oesophageal junction functions as a barrier to prevent acid reflux and is 
anatomically complex.  It is composed of an intrinsic and extrinsic sphincter.  The intrinsic 
sphincter is made up of a ring of smooth muscle approximately 3cm in length.  The muscle 
fibres split at the distal end to from short transverse clasps around the lesser curve of the 
stomach and long muscle loops around the greater curve, known as the gastric sling.(3) 
The external sphincter is provided by contraction of the diaphragmatic crura during normal 
respiration.  
The distal end of the oesophagus is attached to the diaphragm by the phrenoesophageal 
membrane.  This membrane inserts circumferentially into the oesophageal musculature 
very close to the squamocolumnar junction (SCJ).(4)  There is a 3-4cm portion of the distal 
oesophagus which lies below the diaphragm within the abdominal cavity.  
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1.2.2 Role of Transient Lower Oesophageal Sphincter Relaxations   
Transient lower oesophageal sphincter relaxations (TLOSRs) are the most common events 
which allow the defences of the gastro-oesophageal junction (GOJ) to be breached.  These 
TLOSRs are defined as lower oesophageal sphincter (LOS) relaxations not induced by 
swallowing.(5)  They play an important physiological role by allowing venting of gas from 
the stomach following a meal when intragastric pressure is increased.(6)  Complete 
relaxation of the LOS and proximal movement of the GOJ above the crural diaphragm 
occur simultaneously to facilitate the release of gas (7) and this provides an ideal time for 
acid reflux to occur.  It has been shown in healthy volunteers that 80-100% of acid reflux 
events are associated with TLOSRs.(8)  In GORD patients, the overall number of TLOSRs 
is not increased compared to controls, however the number of TLOSRs associated with 
reflux events is increased.(9)  A positive pressure gradient between the stomach and the 
GOJ lumen is required for acid reflux to occur during TLOSRs and this can be provided by 
abdominal straining or the inspiratory phase of respiration.(10) 
Whilst TLOSRs explain why acid reflux is more frequent in the period following a meal, it 
does not explain why the refluxate is acidic.  This paradox of acid reflux occurring at a 
time when the intragastric environment is least acidic due to the buffering effect of the 
meal was explained by the discovery of the acid pocket. This was first described in 2001 
when Fletcher et al discovered an area of low pH immediately distal to the cardia using 
dual pH electrode pull-through studies 15 minutes after a meal.(11)  The authors 
hypothesised that there was a local pocket of acid close to the gastro-oesophageal junction 
which escaped the buffering effect of the meal.  It was proposed that this pocket is the 
source of acid in postprandial refluxate.  The finding of regional differences of acidity in 
the stomach in the postprandial period has been confirmed in several subsequent 
studies.(12, 13) 
 
1.2.3 Role of hiatus hernia 
A hiatus hernia is a condition in which elements of the abdominal cavity herniate through 
the oesophageal hiatus into the mediastinum.(14)  This usually involves the stomach and 
can be a sliding hernia or para-oesophageal hernia.  Sliding hernia are more common, and 
result from disruption of the GOJ due to dilatation of the diaphragmatic hiatus and 
circumferential laxity of the phrenoesophageal ligament. This leads to dysfunction of the 
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GOJ, which can allow acidic gastric juice leading to reflux.  There is no link between the 
less common para-oesophageal hernias and GORD. 
A sliding hiatal hernia can be diagnosed by upper GI endoscopy when the SCJ is 
positioned greater than 2cm proximal to the diaphragmatic hiatus.  It can also be diagnosed 
by barium studies, or by high resolution manometry where a double pressure peak is seen, 
with the proximal peak representing the internal sphincter and the distal peak caused by the 
diaphragmatic crura.  
The correlation between reflux disease and hiatus hernia is well established.  GORD 
patients with oesophagitis are more likely to have a hiatus hernia than those without 
oesophagitis.(15)  An increasing hiatus hernia size correlates with an increased 
oesophageal acid exposure time, an increased number of long reflux events and a 
prolonged acid clearance time.(16)   Increasing hiatal hernia size is the main predictor of 
reflux oesophagitis and severity of gastro-oesophageal reflux.(17)   
The presence of a hiatus hernia is thought to disrupt several of the normal anti-reflux 
mechanisms. A study from the 1960s using simultaneous barium and manometry 
techniques showed early retrograde flow of previously swallowed barium situated within 
the hiatus hernia during a subsequent swallow.  This can happen as the internal sphincter 
relaxes immediately after the swallow. The barium will flow along the pressure gradient 
from the hiatus hernia, through the relaxed sphincter, and into the distal oesophagus.  In 
addition, as the intrinsic sphincter has moved above the diaphragm, it no longer benefits 
from the compressive effect of intra-abdominal pressure.(18)  The extrinsic sphincter 
provided by the diaphragmatic crura remains closed preventing the acid from leaving the 
hiatal sac distally into the stomach.  It has been shown that the more distal extrinsic 
sphincter remains intact during swallow-associated LOS relaxations, but completely 
relaxes during TLOSRs.(19)      
This demonstrated re-reflux of barium from the hiatal sac was also shown to occur with 
gastric acid in a subsequent study.  Mittal et al in 1987 observed that in hiatus hernia 
patients, a small amount of acid became trapped in the hiatal hernia sac and this acid 
refluxed back into the oesophagus during subsequent swallow induced relaxations of the 
LOS.  This repeated re-reflux contributed to impaired oesophageal clearance.(20)  This is 
another important mechanism linked to GORD and Jones et al found that impaired 
oesophageal clearance strongly correlated with oesophagitis and hiatus hernia.(16)   
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Sloan et al introduced the concept of early and late retrograde flow.   They found late 
retrograde flow of barium 5-10 seconds after a swallow occurred in control subjects 
without hiatus hernia and subjects with a reducing hiatus hernia.  However, subjects with a 
non-reducing hernia had early retrograde flow.  They suggested that in the subjects without 
a hernia or with a hernia which had reduced into its original position, the distal portion of 
the oesophagus remained below the diaphragm and therefore benefited from intra-
abdominal pressure helping to maintain a closed sphincter and prevent reflux until the 
sphincter was opened by the food bolus.  However, in subjects with a non-reducing hernia, 
early retrograde flow occurred as the intrinsic sphincter was intra-thoracic and therefore 
intra-gastric pressure easily exceeded intra-sphincteric pressure.  In this study the non-
reducing hernia group had significantly greater acid clearance times than controls.(21)  
In addition to the effect on oesophageal acid clearance, a hiatus hernia can also alter the 
length and position of the acid pocket.  Beaumont et al found patients with a large hiatus 
hernia had a longer acid pocket and it was situated above the diaphragm for a longer period 
compared to those with a small hiatus hernia.  As a result, the proximal border of the acid 
pocket was situated above the SCJ for 50% of the time in large hiatus hernia patients 
compared to 16% in patients with a small hiatus hernia.(13)   
Whilst acid reflux is most common after a meal, it can occur at other times, and this must 
involve mechanisms other than TLOSRs. Van Herwaarden et al described other 
mechanisms which disrupt the GOJ in patients with hiatus hernia include lower resting 
LOS pressure, swallow-associated normal LOS relaxations, deep inspiration and 
straining.(22)  Subjects with hiatus hernia have a lower maximal pressure within the high 
pressure zone of the GOJ.(23)   
 
1.3 Complications of gastro-oesophageal reflux disease 
Acid reflux can cause a spectrum of oesophageal injury, from oesophagitis, oesophageal 
ulceration, peptic structuring, Barrett’s oesophagus and oesophageal adenocarcinoma 
(OAC).  
Erosive oesophagitis is diagnosed at upper gastrointestinal (GI) endoscopy.  The most 
validated classification system is the Los Angeles classification of oesophagitis.(24)  It 
includes four grades (A-D) based on the length and circumferential extent of mucosal 
breaks. In severe oesophagitis ulceration can be present.  A benign peptic stricture can 
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develop within the distal oesophagus due to chronic oesophageal injury and can present as 
dysphagia requiring endoscopic dilatation. 
Barrett’s oesophagus is a condition in which metaplastic columnar epithelium with goblet 
cells replaces the stratified squamous epithelium which normally lines the distal 
oesophagus.  It occurs as a consequence of chronic inflammation due to reflux disease and 
is a predisposing factor for the development of oesophageal adenocarcinoma.  
The earliest estimation of Barrett’s oesophagus prevalence was an autopsy study from 
1986-1987 which found an estimated prevalence of 376 cases per 100,000 population.  
This was much higher than the population based study they performed in parallel to the 
autopsy study which found a prevalence rate of 22.6 cases per 100 000 population.(25)  
The authors suggested that only a small proportion of this disease is actually diagnosed.  
Further studies, both population-based and endoscopic studies, would suggest that the 
prevalence of Barrett’s oesophagus is between 0.5-2.0% of unselected individuals, and 5-
15% of individuals with GORD.(26)  An Italian study of 1533 adults from the general 
population who underwent upper GI endoscopy found a prevalence rate of 1.3%.  Of the 
subjects with Barrett’s oesophagus, 46.2% did not report reflux symptoms.(27) 
It is estimated that Barrett’s oesophagus increases the risk of oesophageal adenocarcinoma 
by approximately 30-125 fold compared to the general population.(28, 29)  Non-dysplastic 
Barrett’s mucosa can progress to low-grade and high-grade dysplasia before 
adenocarcinoma develops.  The annual incidence of OAC in Barrett’s patients varies from 
0.3% to 0.6%.  The combined incidence of high grade dysplasia and OAC is 0.9 to 
1.0%.(30, 31) 
Oesophageal adenocarcinoma is the main histological type of oesophageal cancer in the 
Western World.  In 2012 there were an estimated 52,000 oesophageal adenocarcinomas 
diagnosed worldwide and the vast majority of these were in Northern and Western Europe, 
North America and Australia.(32) This is in contrast to squamous cell cancers which are by 
far the commonest type of oesophageal cancer worldwide.   
Oesophageal adenocarcinomas are predominantly found in the distal third of the 
oesophagus and the main risk factors for developing this cancer are GORD, obesity and 
cigarette smoking whilst oesophageal squamous cell cancers develop more proximally 
within the oesophagus, and alcohol, diet and smoking are more significant risk factors.   
The UK has the highest reported incidence rate of oesophageal adenocarcinoma at 7.2 per 
100 000 person-years in men and 2.5 per 100 000 person-years in women.  There is an 
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obvious male predominance in oesophageal cancer incidence, stronger than any other non-
sex specific cancer. In North America the incidence in men is more than eight times greater 
than women.(32)    White men have the highest risk of developing oesophageal 
adenocarcinoma.  Another North American study found the cancer was three times more 
common in white men than black men, and 7.6 times more common in white men 
compared to white women.(33) 
There is a strong association between symptoms of GORD (heartburn and acid 
regurgitation) and risk of oesophageal adenocarcinoma.  A pooled analysis of 5 case-
control studies found individuals with symptoms for at least 30 years had a 6.2-fold higher 
risk for developing oesophageal adenocarcinoma.(34)  Approximately 40% of patients who 
develop oesophageal adenocarcinoma are not known to have GORD prior to diagnosis.(35) 
 
1.4 Rising incidence of gastro-oesophageal reflux disease 
Evidence to support the rising incidence of GORD exists, although it has not been 
extensively documented.  The HUNT study was a Norwegian population-based cohort 
study which showed that patient-reported symptoms of reflux disease increased from 
31.4% between 1995-1997 to 40.9% between 2006-2009.(36)  A systematic review 
comparing GORD prevalence in population-based studies conducted before and after 1995 
found a statistically significant increase.  This was true using studies from North America, 
Europe and East Asia.(37) 
However, there is more convincing data for the increasing incidence of the malignant 
complications of GORD.  Prach et al found an increase in incidence of Barrett’s 
oesophagus from 1.4 new cases per 1000 upper gastrointestinal endoscopies in 1980–1981 
to 42.7 new cases per 1000 upper gastrointestinal endoscopies in 1992–1993 in 
Scotland.(38)  Conio et al also observed a strong increase in the incidence of BO from 0.37 
to 10.5 cases per 100 000 person years in Minnesota but the authors suggested that the 
similar 22 fold increase in number of endoscopies performed may explain the increase.(39) 
A Dutch cohort study of 386,002 patients showed the incidence of Barrett’s oesophagus 
increased from 14.3 per 100,000 person years in 1997 to 23.1 per 100,000 person years in 
2002.(40)  When controlled for the change in endoscopy numbers of the same time period, 
the increase was even more significant.   
Oesophageal adenocarcinoma has been one of the fastest increasing malignancies in many 
countries and is the fastest rising solid cancer in the western world.(41) This increase 
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appears to have begun in the 1970s in Europe, North America and Australia.(42)  It has 
now overtaken squamous cell carcinoma as the commonest oesophageal cancer in many 
countries within the Western World.(32)  One of the first studies to highlight this rise was 
a North American study which found incidence rates of oesophageal adenocarcinoma rose 
by 100% from 1976 to 1987.  The average annual increase in white men in this study was 
9.4%, and a similar rise of 9.8% was calculated for black men.(33) Using the same North 
American database, another study discovered a six-fold increase in oesophageal 
adenocarcinoma incidence from 1975 to 2001.(43) 
A large epidemiological study of cancer registries from eight Western countries found the 
average annual increase ranged from 3.5% per year in Scotland to 8.1% per year in Hawaii 
between 1960 and 1990.(42)   Increases in incidence of the cancer in females has mirrored 
the rise in males, however it remains 3 to 9 times lower than male cancer incidence.    
The previously discussed Dutch cohort study that showed a rise in Barrett’s oesophagus 
also found an increased incidence of oesophageal adenocarcinoma.  The cancer incidence 
rose from 1.7 per 100,000 person years in 1997 to 6.0 per 100,000 person years in 
2012.(40) 
A North American study using data from the Surveillance, Epidemiology and End Results 
(SEER) program found an increase in oesophageal adenocarcinoma from 1.01 per 100,000 
person-years in 1975-79 to 5.69 per 100,000 person-years in 2000-2004 in white men, a 
463% increase.  A similar rise of 335% was seen in white women.  This study did not 
analyse data among blacks and other races due to a lack of oesophageal adenocarcinoma 
diagnoses within this population.(41)  
 
1.5 Conclusion 
GORD is a common chronic condition which occurs due to failure of the barrier function 
of the GOJ.  Understanding of the mechanisms leading to this failure are improving.  
TLOSRs play a key role, as does the presence of a sliding hiatus hernia. A reduced LOS 
resting pressure, impairment of oesophageal clearance, oesophageal hypersensitivity and 
the acid pocket are also involved.  Whilst GORD itself is a benign condition, it can lead to 
the malignant complications of Barrett’s oesophagus and oesophageal adenocarcinoma.  
GORD, Barrett’s and oesophageal adenocarcinoma rates have been rising over the last few 
decades in the Western World and the reasons for this are unclear. 
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2.1 Introduction  
Helicobacter pylori (H. pylori) is a common bacterial infection of the stomach present in 
the majority of the world’s human population.  It is known to cause chronic gastritis and 
can be complicated by the development of peptic ulcer disease, gastric adenocarcinoma 
and gastric MALT lymphoma. An unexplained observation regarding H. pylori infection is 
its negative association with gastro-oesophageal reflux disease and its complications of 
Barrett’s oesophagus and oesophageal adenocarcinoma.  This chapter will look at our 
current knowledge of the effect of H. pylori infection on gastric acid secretion in the 
general population and discuss potential mechanisms for this negative association. 
 
2.2 Helicobacter pylori infection 
H. pylori was first discovered in 1984 by Australian scientists, Robert Warren and Barry 
Marshall.  They announced their discovery in the paper titled “Unidentified Curved Bacilli 
in the Stomach of Patients with Gastritis and Peptic Ulceration” which was published in 
the Lancet.(44)  They described the bacteria as S-shaped or curved gram-negative rods, 3 
µm x 0.5 µm in size.  They noted it’s similarity to Campylobacter and suggested the name 
Campylobacter pyloridis initially.   They found a close correlation between antral gastritis 
and the presence of the bacteria, linking this as a causal factor for the first time.  Finally 
they hypothesised that peptic ulceration may be due to this bacteria, at a time when the 
aetiology of peptic ulceration was unknown.(44) In 2005 they jointly received the Nobel 
Prize in Physiology/Medicine for the discovery of “the bacterium Helicobacter pylori and 
its role in gastritis and peptic ulcer disease”. 
H. pylori infection is primarily acquired during childhood and the transmission occurs 
through an oral-oral or fecal-oral route primarily within families and particularly in the 
setting of poor sanitation and hygiene.(45)  H. pylori has evolved to thrive in the harsh 
environment of the human stomach.  It secretes urease, an enzyme that converts urea into 
bicarbonate and ammonia, which neutralises the gastric acid.  In the majority of cases, 
colonized H. pylori persists in the stomach over the lifetime of the individual host unless 
eradicated with antibiotics.(46)  
 
 
 
11 
 
2.2.1 Epidemiology  
H. pylori is estimated to infect more than half of the entire human population. A recent 
systematic review of studies of H. pylori prevalence from 62 countries found the highest 
rates of H. pylori are in Africa, with a pooled prevalence rate of 70.1%.(47)  The lowest 
rates are found in Australia with a prevalence rate of 24.6% in the general population, 
however 76% of the indigenous community were infected.  The regions with the highest 
prevalence of H. pylori infection are West Asia, South America and Africa, whilst Western 
Europe, North America and Oceania all have rates lower than 40%.(47) 
The prevalence of H. pylori infection appears to be decreasing in many parts of the world.  
The same recent systematic review looked at two time periods (1970-1999 and 2000-2016) 
and found that H. pylori prevalence was lower after the year 2000 in Europe, North 
America and Oceana. The greatest change was in North America which saw H. pylori 
prevalence drop from 42.7% before 2000 to 26.6% after.(47)   
A study from Finland looked at prevalence rates of gastritis, as a surrogate marker for H. 
pylori infection, in patients undergoing diagnostic upper GI endoscopy within a single 
hospital in 1977, 1985 and 1992.  They found an 18% fall in prevalence of gastritis 
between 1977 and 1992.  The greatest reduction was in the 20-49 age group where there 
was a decrease in prevalence of 38%.(48)   
A large retrospective study from Belgium looked at rates of H. pylori infection from more 
than 22,000 patients from 1998 to 2007.(49)  They found the overall proportion of infected 
patients fell from 43% in 1988 to 29% in 2007.  They also grouped patients by their ethnic 
origin and found those from Western Europe had the lowest rate of infection (31.2%) and 
patients originally from Turkey and North Africa had the highest rates of infection (71.1% 
and 68.5% respectively).   
Even in Eastern countries with higher H. pylori prevalence there is evidence of falling rates 
of the infection.  A South Korean study of over 15,000 subjects found a fall in H. pylori 
prevalence from 66.9% in 1998 to 59.6% in 2005.  The highest rates remained in the low 
income group and in subjects from the provinces.(50)  In the Guangzhou province in 
China, a study found that the overall H. pylori seroprevalence rate had decreased from 
62.5% in 1993 to 47% in 2003.(51) 
The falling prevalence of H. pylori infection in Western countries is likely to reflect 
reduced overcrowding, improved sanitation, improved access to clean water and improved 
socioeconomic status.   
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2.2.2 Histopathology 
The primary histological feature of H. pylori infection is infiltration of the lamina propria 
by plasma cells, lymphocytes and occasional eosinophils.  Active chronic superficial 
gastritis indicates the presence of neutrophils within the lamina propria in addition to these 
chronic inflammatory cells.  Degenerative changes in gastric surface epithelial cells can 
occur, including cellular oedema, apical mucin loss and microerosions.(52)  Lymphoid 
aggregates are commonly found and are located close to the muscularis mucosa.(53) 
The H. pylori organisms can often be easily recognised as curved or S-shaped bacilli on 
routine haematoxylin and eosin (H&E) staining within the surface mucus layer.  They are 
most often seen within the gastric pits.  Special stains can be used to make recognition of 
the infection easier, including the modified Giemsa stain.  The organisms are usually most 
numerous in the gastric antral mucosa with a resulting higher intensity of associated 
gastritis in this area.    
Chronic gastritis is known to progress in a proportion of patients to atrophic gastritis. 
Atrophic gastritis refers to loss of parietal and chief cells in the gastric body mucosa.  This 
leads to increased space between the glands which become occupied by inflammatory cells 
or loose connective tissue.  The degree of glandular loss can be graded as mild, moderate 
or severe as described in the Sydney system for the classification of chronic gastritis.(54) 
Atrophy of the antral mucosa can be more difficult to recognise as the mucosa is composed 
of mucus glands and often contains a more intense inflammatory cell infiltrate.  The 
grading of the degrees of gastric atrophy shows considerable interobserver variation, 
especially antral mucosa.(55)  Atrophic gastritis can be patchy and multifocal in the early 
stages.  The lesser curvature tends to be affected first with subsequent spread and 
coalescence of atrophic areas from the antrum up towards the incisura angularis and 
beyond.  This spread is known as the atrophic front.(56)    
There is a subgroup of H. pylori infected patients in whom bacterial colonisation and 
gastritis primarily affects the gastric body, with the antrum being relatively spared.  This is 
accompanied by hypochlorhydria and increased atrophic gastritis in the stomach body.(57)   
Intestinal metaplasia commonly accompanies H. pylori associated atrophic gastritis.   H. 
pylori organisms are rarely found in areas of intestinal metaplasia in the stomach, and in 
patients with severely atrophic gastritis and extensive intestinal metaplasia, the organism 
can disappear.   
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2.2.3 CagA 
The CagA gene, which encodes the CagA (Cytotoxin-associated gene A) protein, is found 
within a specific chromosomal region called the cag pathogenicity island (PAI) in some H. 
pylori strains.  It is thought that this is involved in the translocation of CagA into the 
cytoplasm of gastric epithelial cells.  Approximately 30–40% of H. pylori strains isolated 
in Western countries do not carry the cag PAI and thus are cagA-negative, whereas almost 
all the H. pylori isolates from East Asian countries contain the cag PAI and are thus cagA-
positive.(58) It has been found that cagA-PAI positive strains of H. Pylori cause peptic 
ulceration and gastric cancer more frequently that cagA-PAI negative strains.(59)    
 
2.2.4 Complications of H. pylori infection 
2.2.4.1 Peptic ulcer disease 
H. pylori infection is a common cause of both gastric and duodenal ulceration.  Up to 10% 
of patients infected with H. pylori may develop peptic ulcers.(60) Gastric ulcers are 
thought to occur due the direct effect of the organism on the gastric mucosa. The infection 
causes mucus depletion and microerosions of the gastric surface epithelial cells which may 
permit acid, pepsin, bacterial antigens and toxins into the underlying mucosa, leading to 
the formation of a gastric ulcer.(52)  In subjects with duodenal ulcers, the infection 
produces a predominantly antral gastritis which stimulates gastrin production, causing 
increased amounts of acid to be produced by the well-maintained and non-inflamed gastric 
secretory cell mass of the oxyntic mucosa.  The gastrin-mediated negative feedback control 
of acid secretion is lost(61) and the increased acid load passes into the duodenum, 
damaging the mucosa, causing duodenal ulceration and gastric metaplasia.  H. pylori may 
colonise this gastric metaplasia and the consequent inflammation may contribute to the 
ulceration. 
 
2.2.4.2 Gastric cancer 
H. Pylori was classed as a type 1 carcinogen in 1994 by the International Agency for 
Research in Cancer after large epidemiological studies suggested a strong association with 
non-cardia gastric cancers.(62)  Patients with a corpus predominant gastritis or pan-
gastritis with patchy but widespread atrophy and intestinal metaplasia seem to be at 
particular risk of gastric carcinoma.(63)  Approximately 89% of all gastric cancers can be 
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attributable to H. pylori infection.(47)  Cag-A positive strains of the infection have been 
associated with an increased risk of gastric cancer.(59)    There is increasing evidence that 
eradication of H. pylori infection reduces the risk of gastric cancer.(64) 
 
2.2.4.3 Gastric MALT lymphoma 
Epidemiologic studies have shown strong associations between H. pylori infection and the 
presence of gastric MALT lymphomas.(65) Furthermore, eradication of the infection 
causes regression of most localized gastric MALT lymphomas.(66) 
 
 
2.3 Negative association between H. pylori and GORD 
An unexplained observation regarding H. pylori infection is its negative association with 
gastro-oesophageal reflux disease and its complications of Barrett’s oesophagus and 
oesophageal adenocarcinoma.  A systematic review published in the BMJ in 2003 
examined the prevalence of H. pylori infection in patients with GORD.  The pooled 
estimate of the odds ratio from the 20 studies included in the review was 0.60 (95% CI, 
0.47-0.78), indicating a lower prevalence of the infection in GORD patients.(67)  
Substantial heterogeneity was found between the studies, with location being an important 
factor in this. Further analysis of the studies based on location found studies from the Far 
East and North America had stronger odds ratios, with studies from Western Europe being 
equivocal for this association.(67)   
A Korean case-control study of 5615 subjects undergoing endoscopy showed the 
prevalence of H. pylori infection was lower in cases of erosive reflux oesophagitis than in 
controls (38.5% vs 58.2%, p<0.001).(68)  A large Japanese cross-sectional study of over 
10,000 subjects found a negative correlation between H. pylori and erosive reflux 
oesophagitis, but not with non-erosive reflux disease.(69)   They also found a negative 
association between erosive reflux oesophagitis and the pepsinogen I/II ratio, a serological 
marker for gastric fundic gland atrophy, supporting a protective effect of atrophic gastritis 
in GORD.   
There is more epidemiological data on the inverse association between H. pylori infection 
and the malignant complications of GORD.  A North American case-control study of 533 
men recruited from the colorectal cancer screening programme and 80 men diagnosed with 
Barrett’s oesophagus found H. pylori infection was inversely associated with Barrett’s 
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oesophagus (OR 0.53; 95% CI, 0.29-0.97).  The association was stronger with the CagA 
positive strain (OR 0.36; 95% CI, 0.14-0.90).(70)  An Irish case-control study published in 
Gut in 2007 found H. pylori seropositivity was associated with a greater than 50% 
reduction in risk of reflux oesophagitis, Barrett’s oesophagus and oesophageal 
adenocarcinoma.(71)  A meta-analysis of 49 studies examining the effect of H. pylori 
infection on Barrett’s oesophagus, found a protective effect despite obvious heterogeneity.  
Four studies were identified that did not have obvious selection and information bias, and 
these showed a protective effect with a relative risk of 0.46 (95% CI, 0.35-0.60).(72)  In 
addition, seven studies examined the effect of CagA positivity which found an even greater 
protective effect with a relative risk of 0.38 (95% CI, 0.19-0.78).(72)  An earlier meta-
analysis found similar results with a pooled odds ratio of 0.64 (95% CI, 0.43-0.94) for the 
relationship between Barrett’s oesophagus and H. pylori prevalence, and 0.39 (95% CI, 
0.21-0.76) for the relationship with CagA positive strains.(73)  This meta-analysis also 
included ten studies examining the association between H. pylori infection and 
oesophageal adenocarcinoma and found a negative association with an odds ratio of 0.51 
(95% CI, 0.31-0.82).(73)   
 
 
2.4 Potential mechanisms to explain negative association 
It has been postulated that the negative association between H. pylori infection and GORD, 
Barrett’s and oesophageal adenocarcinoma may represent the gastric infection protecting 
against these oesophageal disorders. If so, the falling incidence of the infection in the 
general population might explain the rising incidence of the oesophageal disorders.  One 
mechanism by which the infection might protect against oesophageal disease is by 
reducing the ability of the gastric mucosa to secrete acid and pepsin which are the 
constituents of gastric juice which can induce oesophageal damage.  Relatively little is 
currently known about the effect of chronic H. pylori infection on gastric secretory 
function in the 90% of infected patients who do not develop gastric or duodenal 
complications.  If the degree of reduction in oesophageal disease in the H. pylori infected 
population is due to the infection reducing gastric acid secretion, then this suppression of 
acid secretion would need to be apparent in the majority of infected subjects.   
There is also uncertainty over the mechanism of H. pylori infection reducing acid 
secretion.  Potential mechanisms include loss of glands due to gastric atrophy and a 
reduction in acid output from the glands due to mucosal inflammation.  It is known that the 
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pattern of inflammation and atrophy in H. pylori infection does not occur uniformly 
throughout the stomach and is more marked at the junction between oxyntic mucosa of the 
stomach body and antral mucosa. This is potentially relevant as differences in secretory 
function at the proximal border between oxyntic mucosa and cardiac mucosa could 
contribute to a protective effect from GORD.    
 
2.5 Measurement of gastric acid secretion 
Gastric acid secretion has been measured using many different methods.  One of the first 
validated methods was to perform nasogastric aspiration of gastric juice.  The position of 
the nasogastric tube within the stomach was determined either by fluoroscopy or by the 
water recovery test.(74)  The latter method ensured the tube was in the most dependent part 
of the stomach corpus, allowing the maximum volume of gastric juice to be aspirated and 
therefore minimise losses by gastric emptying.  It also obviated the requirement for X-ray 
exposure.  The potential mesurements of gastric secretion that can be made by nasogastric 
aspiration  include basal acid output (BAO), maximal acid output (MAO) and peak acid 
output (PAO).  BAO is generally a small volume which can fluctuate throughout the 
course of the day, making it of limited value.  MAO and PAO are measured by stimulating 
gastric acid secretion, and are better measures of parietal cell mass.  Histamine (75, 76), 
pentagastrin, tetragastrin, gastrin-17, gastrin-releasing peptide, bombesin and meal 
stimulation have all been used for this purpose.  The samples, which are usually collected 
over 15 minute periods, are titrated to a pH of 7 using an alkaline solution to determine the 
hydrogen ion concentration.  The acid output is calculated by multiplying the hydrogen ion 
concentration by the volume of gastric aspirate.  MAO is the acid output obtained over a 
period of one hour following stimulation, whilst PAO uses the highest measurements 
obtained within that hour.   
The Endoscopic Gastrin Test (EGT) is a newer method for measuring gastric acid secretion 
developed in Japan.(77)  It involves subjects being given an injection of tetragastrin or 
pentagastrin prior to the endoscopy.  At endoscopy any pooled gastric acid on initial 
intubation is aspirated and discarded.  The gastric acid produced between 20 and 30 
minutes after injection is then aspirated and collected in a bottle placed between the 
endoscope and the aspirator.  Titration is performed to determine the hydrogen ion 
concentration.  The acid output is calculated by multiplying this with the volume of gastric 
aspirate, and it is expressed as H+mEq/10 min. 
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Nasogastric placement of pH-measuring electrodes can be used as a measure of gastric 
acidity. They are usually antimony electrodes which are smaller and cheaper than glass 
electrodes.  Most studies have been performed using either one or two sensors.  Studies 
using two sensors usually have one in the oesophagus to measure reflux, and one in the 
stomach.  The gastric electrode can be positioned either using fluoroscopy or by concurrent 
manometry analysis of the LOS.  It has been shown that by advancing the pH probe 
beyond the LOS the distal end usually ends up in the gastric fundus. 24 hour pH results 
have been found to be highly reproducible at this site.(78)  The main disadvantage to this 
method is that there is no measurement of the actual volume of acid produced.  The 
measured pH is that of gastric juice which, in addition to hydrochloric acid, is made up of 
other substances like pepsin and mucous, and can be affected by saliva and bicarbonate 
secretions.   
 
2.6 Gastric acid secretion in the healthy population 
2.6.1 Effect of H. pylori infection  
There are few studies of gastric acid secretion specifically looking at the healthy 
population.  Peterson et al studied 63 H. Pylori positive healthy volunteers and 73 H. 
pylori negative healthy volunteers.(79)  The acid secretory studies were carried out over a 
15 year period, from 1974 to 1989; therefore pentagastrin, histamine and human gastrin 
heptadecapeptide were all used at various times on different subjects for gastric acid 
stimulation.  The main finding was that BAO in H. pylori positive healthy volunteers was 
2.8 mmol/h compared to 4.4 mmol/h in H. pylori negative healthy volunteers, which was a 
statistically significant finding.  The study did not find any difference in PAO or meal-
stimulated acid output.   
One of the largest prospective studies was performed in Japan by Iijima et al and involved 
157 Japanese subjects who had previously had a normal upper GI endoscopy.(80)  The 
majority were completely asymptomatic, whilst 20 subjects had symptoms thought to be 
unrelated to the upper GI tract, mainly lower abdominal pain and change in bowel habit.  
They also included 36 healthy volunteers between the ages of 20 and 39 due to the small 
number of young subjects in the initial study group.  They used the Endoscopic Gastrin 
Test to measure gastric acid secretion.  They found the mean EGT value in H. pylori 
positive males was 1.6 mEq/10min, compared to 3.9 mEq/10min in H. pylori negative 
males.  In women the difference was less prominent but still statistically significant.   
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Tarnasky et al measured acid secretion by NG tube aspiration under basal conditions and 
in response to peptone meal stimulation and pentagastrin.(81)  The study started with 30 
healthy males, however only 22 managed to complete the acid secretion tests.  It was not 
stated the reasons for failure to complete the study.  Two subjects were also excluded due 
to conflicting results from the H. pylori breath tests and serology.  Therefore data from 
twenty subjects, 50% of which were H. pylori positive, were available for analysis.  They 
found the BAO in H. pylori negative subjects was 5.7 mmol/h compares to 3.3 mmol/h in 
H. pylori positives, although this was statistically non-significant.  There was no difference 
in pentagastrin stimulated PAO.   
Smith et al looked at retrospective data from 95 healthy males who had undergone a 24-
hour study of pH measurements from hourly intragastric acid aspiration.  All tests were 
performed at the Royal Free Hospital in London; however, it was not clear over what 
period these tests had been performed.  All the subjects were young, with an age range of 
19 to 26.   Only eight were H. pylori positive.  They found no difference in the 24 hour 
intragastric acidity between the two groups of patients.(82)   
Gillen et al compared H. pylori infected and uninfected healthy volunteers, as well as H. 
pylori positive duodenal ulcer patients.(83)  They measured BAO, MAO to increasing doses 
of G-17 and MAO to increasing doses of CCK-8, by nasogastric aspiration.  They found no 
significant differences in these between 20 infected and 35 uninfected healthy volunteers.    
They found that the 15 duodenal ulcer patients had significantly higher acid secretion, both 
under basal conditions and in response to G-17 and CCK-8 stimulation.  They also 
investigated the concentration of gastrin needed to achieve 50% of the maximal acid 
response, termed C50.  Interestingly this showed H. pylori positive healthy volunteers 
required 164.5 ng/l gastrin, compared to 82.2 ng/l in H. pylori negative subjects and 
69.5ng/l in duodenal ulcer patients.  This gives evidence of a decreased sensitivity to 
gastrin stimulation in H. pylori infected healthy volunteers compared to duodenal ulcer 
patients as the reason for increased acid secretion and subsequent pathology in the latter 
group.  Despite the lack of difference found between the two groups of healthy volunteers 
in this study, the reduced acid secretion found in the previously mentioned studies could be 
explained by H. pylori associated chronic active superficial gastritis affecting the stomach 
body, leading to reduced sensitivity to gastrin stimulation. 
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2.6.2 Effect of H. pylori eradication 
Four studies have measured gastric acid secretion in healthy volunteers before and after H. 
pylori eradication.    Feldman et al looked at 24 healthy volunteers aged between 28 and 54 
who were all found to be H. pylori positive.(84)  They underwent NG tube aspiration under 
basal conditions, as well as meal stimulation with a liquidised steak meal infused through 
the NG tube, and intragastric titration to a pH of 3.  Subjects also had gastric biopsies 
performed through the NG tube under fluoroscopic guidance. The volunteers then had H. 
pylori eradication with lansoprazole, amoxicillin and clarithromycin for 2 weeks and acid 
secretion tests were repeated 4 weeks later.  67% were found to have successfully 
eradicated H. pylori.  It was found that the basal acidity was 20 mmol/l higher after 
successful eradication, and that there was no change in acidity if eradication failed.  There 
was no change seen for meal stimulated gastric acid secretion.  All the subjects had a pan-
gastritis based on the biopsy results, with resolution of the gastritis in subjects in whom H. 
pylori was successfully eradicated. 
Gutierrez published a similar study in the Scandinavian Journal of Gastroenterology in 
1997.(85)  There were 11 H. pylori positive healthy subjects included, aged from 21 to 49.  
The study took place in Columbia.  Gastric acid secretion was measured by NG aspiration, 
and this was carried out before and then 5 to 15 weeks after H. pylori eradication.  The 
PAO increased from 14.6 mmol/h to 29.0 mmol/h after eradication, and this was a 
statistically significant finding.  BAO increased from 3.4 mmol/h to 5.4 mmol/h, however 
the p value was 0.07.   
Verdu et al measured 24 hour intragastric pH in 18 H. pylori positive healthy 
individuals.(86)  The pH electrode was placed 5cm distal to the cardia, determined by 
fluoroscopy.  Recordings were carried out on four occasions, before and after H. pylori 
eradication, and on and off omeprazole.  They found no difference in the mean 24-hour pH 
value before (pH 1.2) and after (pH 1.3) eradication, whilst off omeprazole.  They did, 
however, find that nocturnal pH fell from 1.6 whilst infected with H. pylori to a pH of 1.2 
post-eradication (p = 0.005). 
The fourth study was an American study published in 1991.(87)  Five H. pylori positive 
healthy subjects from Houston had their acid secretion measured by aspirating 10ml 
aliquots every hour nasogastrically and measuring the pH.  These were all young subjects 
between the ages of 21 and 25.  This was repeated after H. pylori eradication.  The study 
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found that the integrated intragastric acidity before and after eradication of H. pylori did 
not change. 
 
2.6.3 Effect of aging  
The remaining studies measuring gastric acid secretion looked at the effect of aging.  The 
largest of these studies was published in Gastroenterology in 1996.(88) 206 volunteers 
underwent a gastric secretory study which involved an NG tube placed in the antrum.  
BAO and PAO were measured, and pentagastrin was used as the stimulant.  The volunteers 
were split up into 3 groups, young (18-34), middle-aged (35-64) and elderly (>65).  H. 
pylori infection rates differed between the three groups, with 81.8% of volunteers in the 
elderly group infected, 58.2% in the middle-aged group and 45.2% in the young group.  
Despite this there was no difference in BAO between the three groups.  However, there 
was a difference in PAO between the elderly group and the other two groups.  The PAO 
was 19 mmol/h in the elderly compared to 29.9 mmol/h in middle-aged group (p=0.002) 
and 29.3 mmol/h in young group (p=0.004).  This paper also looked at gastric histology, by 
passing biopsy forceps through the NG tube under fluoroscopic guidance and taking one 
biopsy from the upper body.  This showed that 7 subjects with H. pylori associated chronic 
atrophic gastritis (CAG) had a greatly reduced BAO and PAO of 1.0 and 6.8 mmol/h 
respectively.  78 subjects had chronic active superficial gastritis (CASG), and they had a 
slightly reduced PAO compared to subjects with normal histology (p<0.05) but no 
difference in BAO.  This paper also commented on smoking habit and found that current 
smokers had a significantly higher BAO and PAO compared to non-smokers.  Multiple 
regression analysis suggested that age has no effect on gastric acid output, and the 
reduction in PAO in the elderly was due to the higher prevalence of H. pylori associated 
CASG and CAG, as well as lower prevalence of smoking.  It is worth noting that only 22 
out of 206 volunteers were in the elderly group. 
A Japanese study of 110 healthy volunteers was published in Gut one year later.(89)  Gastric 
acid secretion was measured by NG tube aspiration and pentagastrin stimulation was used.  
The volunteers were comprised of those who had previously had gastric acid studies in the 
early 1970s and those who were investigated in the early 1990s.  They were then divided 
into eight groups depending on H. pylori status and age.  This study found that gastric acid 
secretion was lower in elderly subjects, both in the 1970s and 1990s. H. pylori infection 
was shown to decrease BAO and MAO, especially in the elderly population.  It also 
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showed that acid secretion had increased in both elderly and non-elderly subjects over the 
20-year period, and suggested that this was not only due to reduced H. pylori prevalence.  
The final two studies were small studies.  One showed no difference between young and 
old subjects, unless they had evidence of atrophy.(90)  The other found elderly patients had 
an increased MAO to Gastrin-17 and meal-stimulated gastric acid secretion.(91) 
 
 
2.7 Role of the acid pocket 
It is thought that refluxed acid in the postprandial period originates from gastric contents 
close to the gastro-oesophageal junction, and this area has been termed the acid pocket.  
The acid pocket was first described in 2001 when Fletcher et al discovered an area of low 
pH immediately distal to the cardia using dual pH electrode pull-through studies 15 
minutes after a meal.  The pH at this point was 1.6, lower than the more expected buffered 
intra-gastric pH of 4.4.(11) (Figure 2.1) The authors hypothesised that there was a local 
pocket of acid close to the gastro-oesophageal junction which escaped the buffering effect 
of the meal.  It was proposed that this pocket is the source of acid in postprandial refluxate.  
The finding of regional differences of acidity in the stomach in the postprandial period has 
been confirmed in a number of subsequent studies.(12, 13)  In actual fact the acid pocket 
was first described over a century ago in the context of the study of peptic ulcers.  An 
American paper by Cannon published in 1898 states:  “In the fundus food near the 
periphery was acid; food 2cm from the gastric wall showed the original alkalinity.”(92)  A 
British paper by Hurst published in 1911 observes “As no peristalsis and consequently no 
churning of the contents occurs high in the fundus, the outer layer of chyme remains 
constantly very acidic. A cardiac ulcer is therefore bathed in acid gastric juice at a very 
early stage in digestion.”(93)  
The acid pocket forms due to the buffering effect of food within the stomach.  The acidity 
falls within the main stomach body where mixing of food and gastric juice is at its greatest.  
The proximal stomach relaxes following a meal and acts as a reservoir for food. (16)  Acid 
in this area will therefore escape the buffering effect of the meal.  The lack of mixing will 
also allow gastric juice to pool and form a layer of acid on top of the gastric contents.  In-
vitro experiments have been performed to mimic the movement of food within these two 
areas of the stomach.  When a blended meal and acid is allowed to settle, acid was shown 
to form a separate layer floating on top.  Gentle agitation caused this acid layer to 
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disappear and measurement of the pH through the mixture proved that mixing had started 
to occur.(11) 
 
FIGURE 2.1 Example of a pH tracing recorded during the catheter pull-through technique 
in 1 subject while fasting and again after a meal. The postprandial recording shows a 
region of high acidity corresponding to the location of the pH step-up point observed under 
fasting conditions.  
 
 
 
The acid pocket was first detected by stationary pull-through pHmetry, however this 
simply gives us a one-dimensional understanding of the acid pocket.  Interestingly, in 
many studies of the acid pocket, another area of similar acidity is commonly detected by a 
more distal pH sensor. (94, 95) It is thought that this distal sensor will be pressed up 
against the gastric mucosa of the greater curvature.(78)  The ‘acid coat’ theory has been 
proposed as an explanation for this.  As acid is secreted from the gastric mucosa in 
response to a meal, the periphery of the gastric lumen will be most acidic due to its 
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proximity to the acid source.  The acidity will progressively decrease towards the centre of 
the lumen within the intragastric contents due to a buffering effect.  (Figure 2.2)   
 
FIGURE 2.2 A schematic of the “acid coat” forming in the postprandial period. The “acid 
coat” (dark grey area) forms nearest the gastric mucosa and surrounds the buffered 
intragastric contents (light grey area). 
 
 
 
 
Two factors will play a role in the evolution of this acid coat.  Continuing gastric acid 
secretion will maintain the acidity around the periphery of the gastric lumen, and may start 
to overcome the buffering effect more centrally.  In addition, gastric emptying means the 
volume of the intragastric content continues to fall.  Complete gastric emptying can take up 
to two hours in healthy people(96) and as this process continues the buffering capacity will 
be reduced.   Eventually the intragastric environment will return to the fully acidic state 
seen in the fasting period.    
An ‘acid film’ has been proposed to exist by Pandolfino et al who showed the pH 
transition point moves proximally into the high-pressure zone of the LOS, even extending 
across the SCJ after a meal in GORD patients.  Manometry confirmed that although the 
LOS pressure was lower in GORD patients, the fact that the LOS still had a pressure 
associated with it showed that it remained closed.  The authors argued that a volume of 
fluid would not be able to cross the LOS, suggesting instead that only a film of acid could 
extend through this.(12) 
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2.7.1 Effect of H. pylori infection on the acid pocket 
If the acid pocket forms due to secretion of acid from the gastric mucosa of the proximal 
stomach, then any factors which reduce gastric secretion, either locally or throughout the 
stomach, may affect the development of the acid pocket.  H. pylori infection is the major 
cause of gastric mucosal atrophy and reduced acid secretion.  Loss of gastric secretary cells 
does not occur uniformly throughout the stomach but may be more marked at the periphery 
of the acid-secreting mucosa.(97)  The term “atrophic front” describes atrophic gastritis 
initially seen at the border between the antrum and the oxyntic mucosa of the gastric body 
and moving proximally with time.  It is thought to advance quicker up the lesser curve.(56)  
Mucosal atrophy and intestinal metaplasia have been shown to occur more frequently on 
the lesser curvature compared to the greater curvature.(98) The overall reduction in gastric 
acid secretion throughout the oxyntic mucosa could result in reduced acidity of the acid 
pocket.  It is also plausible that H. pylori infection could cause a similar process starting at 
the cardia and extending distally, which would potentially have a more direct effect on the 
acid pocket.  However, this effect in the proximal stomach has not been studied previously.  
The falling prevalence of H. pylori infection in many countries (48, 99) might therefore be 
contributing to the rising incidence of GORD and its complications.   
 
2.8 Conclusion 
There is a negative association between H. pylori infection and GORD.  The infection also 
has an inverse association with Barrett’s oesophagus and oesophageal adenocarcinoma, the 
complications of chronic GORD.  Greater than 50% of the world’s population is infected 
with H pylori.  The prevalence of H. pylori infection appears to be falling, especially 
within the Western World.  It is possible that H. pylori infection is protecting against the 
development of oesophageal disease from acid reflux and one possible explanation is the 
infection causing a reduction in gastric acid secretory function.  For this to be true, the 
protective effect from H. pylori must be apparent in the majority of those infected.  There 
is little available data on the effect of H. pylori infection within the general population. The 
few previous studies assessing gastric acid secretion have used H. pylori infected healthy 
volunteers, rather than subjects representative of the general population.    
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CHAPTER 3 
 
Obesity and gastro-oesophageal 
reflux disease 
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3.1 Introduction 
 
In this chapter I will discuss the evidence for the rising incidence of obesity over the last 
three decades and how this is a global phenomenon.  I will then review the evidence for the 
association between obesity and gastro-oesophageal reflux disease, Barrett’s oesophagus 
and oesophageal adenocarcinoma.  Finally, I will review the potential mechanisms behind 
the association, acknowledging that there are both mechanical and humeral mechanisms. 
 
 
3.1 Obesity and its rising incidence 
 
Obesity is generally defined as excess bodyweight.  The body mass index (BMI) is used to 
express weight adjusted for height and is calculated as weight in kilograms divided by 
height in metres squared. The World Health Organisation (WHO) classification defines 
being overweight as having a BMI greater than 25 and obesity as a BMI greater than 30.    
Over the last three decades there has been a dramatic increase in rates of obesity in the 
Western World.   
 
In the United Kingdom comprehensive data from health surveys shows the prevalence of 
obesity in adults in 1980 was 6% for men and 8% for women.  The proportion of the 
population defined as obese trebled by 2002, with 23% of men and 25% of women 
affected.(100)  The largest increases were in the younger age groups, with a doubling of 
obesity prevalence seen in both men and women in the age range 25-34 years.   
 
In the United States, the prevalence of obesity in adults increased from 15% in 1980 to 
33% in 2004.(101)  In addition, the prevalence of overweight children increased from 6% 
to 19%.(102)  The National Health and Nutrition Examination Survey (NHANES) carried 
out by the Centers for Disease Control and Prevention (CDC) in the US shows the 
prevalence of obesity in the 1960s was 11% for men and 16% among women.  There was 
little change up to 1980, until the survey between 1988 and 1994 showed prevalence had 
risen to 21% in men and 26% in women.  A further increase was found in 2003-2004 with 
the prevalence rising to 32% in men and 34% in women.(103)   
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The increase in obesity has also been documented in children.  Padez et al looked at 
obesity trends in Portuguese children aged 7-9 years from 1970 up to 2002.  The study 
found an increase in BMI over this period, with the greatest increase in the period 1992-
2002.  The prevalence of obesity in 2002 was 11.3%.(104)  Luo et al looked at data from 
the China Health and Nutrition Survey from 1989 to 1997.  They found the overall 
prevalence of obesity in pre-school children aged 2-6 years increased from 4.2% in 1989 to 
6.4% in 1997.  The greatest increase was in children living in urban areas, where the 
prevalence increased from 1.5% in 1989 to 12.6% in 1997.(105) 
   
 
3.2 Association between obesity and gastro-oesophageal reflux 
disease 
 
In addition to the known associations with type 2 diabetes mellitus, cardiovascular disease 
and non-alcoholic fatty liver disease, obesity is also strongly associated with gastro-
oesophageal reflux disease and its’ complications.  A meta-analysis by Hampel et al found 
nine studies which examined the relationship of BMI with GORD symptoms, and six of 
the studies showed statistically significant associations.(106)  Obese subjects were found to 
have a 2.0-fold increased risk of GORD symptoms, and 2.8-fold increased risk of 
oesophageal adenocarcinoma.  No studies were found which examined the relationship 
between obesity and Barrett’s oesophagus.  A more recent met-analysis by Corley et al 
identified 20 studies consisting of 18,346 patients.(107)  The pooled estimates for an 
association between GORD and increased BMI were heterogeneous.  When stratified by 
country of origin, seven studies from the United States demonstrated an association 
between BMI and GORD with an odds ratio of 1.57 for the overweight category and 2.15 
for the obese category. The results from European studies were heterogeneous with some 
individual studies showing an association and some showing no association.(107)  
 
El-Serag et al performed a cross-sectional study of 206 consecutive patients undergoing 
24-hour pH measurements.  They found a BMI in the obese range was associated with a 
significant increase in the percentage of time oesophageal pH<4, number of acid reflux 
episodes and number of reflux episodes lasting longer than 5 minutes.(108)   
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A North American cross-sectional study posted a validated self-reported questionnaire to a 
random sample of the general population of Olmsted County, Minnesota.  1524 subjects 
(72%) responded, with 69% of the subjects with a BMI greater than 30 reporting 
symptoms compatible with GORD.  The study demonstrated that obese subjects had an 
odds ratio of 2.8 for experiencing at least weekly reflux symptoms. Obesity was the 
strongest risk factor which the study assessed, surpassing family history, smoking, and 
alcohol intake.(109)     
 
Ruhl et al used NHANES data to follow up 12,349 subjects for a median of 18.5 years and 
performed a multivariate survival analysis.  Reflux disease was recorded as patients 
requiring hospital admission with a diagnosis of oesophagitis or uncomplicated hiatus 
hernia.  They found for every increase in BMI of 5kg/m2 the hazard ratio for developing 
GORD was 1.22.(110)   
 
Nandurkar et al used data from validated questionnaires on GORD, energy expenditure, 
dietary intake, and measures of personality and life event stress completed by 211 
community subjects.  They used logistic regression analysis to analyse potential risk 
factors for GORD and found BMI was associated with GORD independently of lifestyle 
factors known to  induce acid reflux, such as a high fat diet or exercise.(111) 
 
It has been suggested that central abdominal fat deposition leading to an increase in intra-
abdominal pressure is more important in causing GORD, Barrett’s oesophagus and 
oesophageal adenocarcinoma than simple obesity.  This could help explain the increased 
incidence of these diseases in men as excess abdominal fat is characteristic of male-pattern 
obesity.  A systematic review and meta-analysis of the relationship between central 
adiposity and erosive oesophagitis by Singh et al included studies if they reported on 
visceral adipose tissue area, waist-hip ratio or waist circumference.  19 studies were 
identified which reported on the association between central obesity and erosive 
oesophagitis.  The pooled odds ratio was 1.87 (95% CI, 1.51-2.31) indicating a 
significantly higher risk of erosive oesophagitis with increased central adiposity.(112)  The 
association between central adiposity persisted after adjusting for BMI in an analysis 
restricted to 8 studies.(112) 
 
The same meta-analysis also looked at the association between central adiposity and the 
complications of GORD, namely Barrett’s oesophagus and oesophageal adenocarcinoma.  
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15 studies examined the association between central adiposity and Barrett’s oesophagus 
and found a significantly higher risk with central adiposity with a pooled odds ratio of 1.98 
(95% CI, 1.52-2.57).(112)  Five of the studies adjusted for BMI, and the pooled odds ratio 
remained significant with a pooled odds ratio of 1.88 (95% CI, 1.20-2.95).  The 
relationship was stronger for long-segment Barrett’s oesophagus as compared with short 
segment.  There was also a significantly higher risk of oesophageal adenocarcinoma with 
central adiposity.  From 6 relevant studies, meta-analysis found a pooled odds ratio of 2.51 
(95% CI, 1.56-4.04) for the risk of developing oesophageal adenocarcinoma with central 
adiposity.  There was insufficient data to assess the BMI-independent effect.(112) 
 
A case-control study conducted in California with 320 cases of Barrett’s oesophagus, 316 
patients with GORD and 317 controls found a positive association between Barrett’s 
oesophagus and an abdominal circumference greater than 80cm, independent of BMI, 
compared with population controls (odds ratio 2.24, 95% CI, 1.21-4.15). (113)  Another 
North American case-control study including 193 patients with Barrett’s oesophagus and 
211 matched population controls found all measures of central adiposity were strongly 
related to Barrett’s.  A high waist/hip ratio (Greater than 0.9 in males and greater than 0.85 
in females) had an adjusted odd ratio of 2.4 (95% CI, 1.4-3.9) for Barrett’s with an even 
stronger odds ratio of 4.3 (95% CI, 1.9-9.9) for long-segment Barrett’s oesophagus.  
Waist/thigh ratio and waist circumference also had statistically significant associations 
with Barrett’s whilst BMI had an odds ratio of 2.0 for long segment Barrett’s and a non-
significant association with visible Barrett’s cases.(114)   
 
A more recent meta-analysis analysing the effect of BMI on oesophageal and gastric cardia 
adenocarcinoma identified 22 case-control and cohort studies which included almost 8000 
cancer cases.  The overall relative risk was 2.34 (95% CI, 1.95-2.81), with a stronger 
association with oesophageal adenocarcinoma which had a relative risk of 2.73 (95% CI, 
2.16-3.46).(115) 
 
 
3.4 Potential mechanisms of association between obesity and 
GORD 
 
The reason for the increased incidence of GORD in obese patients is likely to be 
multifactorial, and both mechanical and humoral effects may be involved. The presence of 
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a hiatus hernia is an independent risk factor for the development of GORD.  There is 
evidence that hiatus hernia is more common with increasing BMI.(116) In a retrospective 
study of 181 patients undergoing workup for bariatric surgery, 37.0% had evidence of a 
hiatus hernia on an upper GI contrast study.(117)  In a prospective study of 1224 patients 
undergoing upper GI endoscopy, the BMI was significantly higher in the 20% of patients 
found to have a hiatus hernia.(118)  The increased prevalence of hiatus hernia in obese 
subjects is likely to contribute to the increased incidence of GORD in these subjects.  
Pandolfino et al used high-resolution manometry to show that obesity was significantly 
associated with separation of the manometric LOS component and crural diaphragm 
component of the gastro-oesophageal junction.(10) 
 
In addition, central obesity has been shown to increase intra-abdominal pressure(119) and 
intragastric pressure. A prospective cross-sectional study of 322 patients found a 10% 
increase in intragastric pressure for each unit increase in BMI.(120)  This is likely due to 
mechanical pressure on the stomach from the increased mass of abdominal fat.  A similar 
increase in intragastric pressure has been observed in pregnant women and in patients with 
ascites.(121, 122)  This increase in intragastric pressure is generally greater than the 
increase in intra-oesophageal pressure, leading to an increased gastro-oesophageal pressure 
gradient (GOPG).(10)  The increase in GOPG in obese subjects compared to lean subjects 
may overcome the lower oesophageal sphincter (LOS) pressure.  It has been shown that the 
LOS pressure is not increased in obese subjects.(123, 124)  
 
Transient lower oesophageal sphincter relaxations (TLOSRs) are the predominant event 
leading to gastro-oesophageal reflux and are triggered by gastric distension.  Wu et al 
recruited 28 asymptomatic obese patients referred for weight-loss surgery and compared 
them with age and sex matched overweight subjects (BMI 25-30) and normal weight 
subjects (BMI 20-25).  Two-hour postprandial oesophageal manometry and pH monitoring 
revealed the obese and overweight groups had an increased rate of TLOSRs.  The obese 
group had 7.3 in 2 hours compared with 3.8 in the overweight group and 2.1 in the normal 
weight group (p<0.001).   All three groups had comparable LOS pressure, LOS length, and 
peristaltic function.(125)  A smaller study comparing 7 health controls with 7 morbidly 
obese patients using 24 hour ambulatory oesophageal manometry and pH monitoring 
found a substantial increase in the number of TLOSRs in the obese group compared to the 
controls in the postprandial period.(126)  
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A study of gastric emptying of a mixed solid/liquid meal using a double-isotope technique 
in 31 obese patients and 31 controls found significantly reduced gastric emptying of both 
the solid and liquid component of the meal.  There was a significant correlation between 
BMI and gastric emptying (r = 0.44, p<0.01).(127)  This potentially means acidic gastric 
contents are present within the stomach for a greater length of time and therefore available 
to reflux for a greater length of time.  
 
Other potential mechanisms thought to play a role in GORD including a lower oesophageal 
sphincter pressure, gastric volume and content, and crural diaphragm function have also 
been studied in obese patients and have not been shown to differ from controls.(124, 128, 
129)   
Humoral changes in obesity may also be involved.  One study of gastric acid secretion 
comparing 13 grossly obese patients with 16 age-matched controls of normal body weight 
found obese patients had a higher maximal gastric acid response to graded pentagastrin 
(36.6 +/- 2.9 mmol/hr, compared to 27.1 +/- 2.4 mmol/hr in controls; p<0.05), and required 
a lower dose of pentagastrin to reach maximal acid output.(130) 
In another functional study, obese patients had higher outputs of bile and pancreatic 
enzymes, as well as higher plasma levels of pancreatic polypeptide, in the resting state 
compared to healthy controls.(128)  Therefore the content of the gastric juice in obese 
patients may be altered such that it is more damaging to oesophageal mucosa in the event 
of gastro-oesophageal reflux. 
There is also evidence of altered vagal function in obese patients.  Vagal stimulation by 
modified sham feeding led to reduced gastric acid secretion in obese patients compared to 
subjects with normal body weight and a similar parietal cell mass.(130) Obese patients also 
had a 50% reduction in pancreatic enzyme secretion, bile acid emptying and gastrin 
release.(128)   
Nilsson et al found a strong association between BMI and endoscopically-proven reflux 
oesophagitis in women, but not in men.  In addition they found this association was even 
stronger in females using oestrogen replacement.(131)  A population-based case-control 
study by the same group using results of public health surveys from 65,363 adults found 
the risk of reflux among severely obese men was 3.3-fold higher compared to those with 
normal body weight, and 6.3-fold higher in severely obese women.(132)  They found this 
association was strongest in pre-menopausal women, and the use of oestrogen replacement 
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strengthened the association in post-menopausal women.  The authors argued that 
oestrogen may play an important role in GORD. 
Visceral fat is known to produce hormones known as adipocytokines, including 
adiponectin, leptin, IL-6, and TNF-a.  Obesity causes changes in the circulating levels of 
these enzymes.  Leptin is a peptide hormone secreted by adipocytes and circulating levels 
of leptin are directly proportional to body mass fat.(133)  Leptin has been observed to 
enhance the anti-apoptotic and growth-promoting effects of acid in oesophageal 
adenocarcinoma cells in culture.(134)  A case-control trial showed that Barrett’s 
oesophagus is associated with an increase in proinflammatory cytokines and leptin.(135)  
The work in this area supports a role for inflammation in the development of Barrett’s and 
oesophageal adenocarcinoma, however more work is required.   
 
3.5 Conclusion 
 
The incidence of central obesity is rising in both children and adults across the world. 
Obesity is strongly associated with gastro-oesophageal reflux and its complications of 
Barrett’s oesophagus and oesophageal adenocarcinoma.  Central adiposity seems to be of 
particular importance.  The nature of this association is incompletely understood and both 
mechanical and humoral effects of central obesity may be important.   
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CHAPTER 4 
 
Study of the inverse association 
between gastric cancer and 
oesophageal adenocarcinoma 
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4.1 Introduction 
Over the past three decades, oesophageal adenocarcinoma (OAC) has been one of the fastest 
increasing malignancies in many countries.(33)  The cancer is thought to be the result of 
gastro-oesophageal reflux damaging the distal oesophagus and causing columnar metaplasia 
often with intestinal phenotype.  This Barrett’s mucosa has an increased risk of progressing 
to dysplasia and adenocarcinoma. 
The environmental factors causing the recent marked increase in incidence of OAC are 
unclear.  Central obesity is associated with both reflux and OAC but a study indicates that 
this can only explain 6.5% of the rise in incidence of OAC.(136)  In addition, obesity does 
not explain some of the geographical variations in the rising incidence of the cancer.(137)    
Smoking is another well-established risk factor for oesophageal adenocarcinoma.(138)  
However, the prevalence of smoking in the Western world has decreased over the past few 
decades and thus this cannot account for the rise in incidence of oesophageal 
adenocarcinoma.  Another possible explanation is that H. pylori infection has been 
protecting against acid reflux, and thus OAC, and this is being lost by the falling incidence 
of the infection.(139)  There is a well-established negative association between H. pylori 
infection and both gastro-oesophageal reflux and OAC.(71, 140)  The negative association 
between H. pylori and OAC is independent of the other risk factors of OAC including 
smoking and BMI.(141)  A proposed mechanism for the protective effect of H. pylori is that 
the gastritis induced by it may cause atrophy and reduced acid secretory capacity of the 
gastric mucosa.  As the acidity of the gastric juice is its main damaging component, reduction 
of this by H. pylori would protect against reflux-induced oesophageal damage and associated 
adenocarcinoma.(142)   
H. pylori infection may produce different patterns of gastritis which are associated with 
different disease outcomes.  When the H. pylori gastritis spares the acid secreting body 
region of the stomach, it results in increased gastrin release and accompanying increased 
acid secretion which is the key condition leading to duodenal ulceration.(143)  When the 
H. pylori gastritis involves the entire stomach and causes atrophy and reduced acid 
secretion, there is a markedly increased incidence of gastric adenocarcinoma for all regions 
of the stomach except the cardia adjoining the gastro-oesophageal junction.(144)  There is 
little information on the pattern of H. pylori gastritis and gastric secretory status in the 90% 
of H.pylori-positive subjects who do not develop either ulcer disease or gastric cancer.    
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If H. pylori infection does protect against OAC by reducing gastric acid secretion, there 
should be a negative association between non-cardia gastric cancer (NCGC) and OAC at a 
population level as the gastric mucosal changes predisposing to gastric cancer would be the 
same as those protecting from OAC. 
 
4.2 Aims    
 This study examined the relationship between the current incidences of the two cancers in 
different geographical regions of the world.  In addition, we studied the relation between 
changes in incidence of the two cancers over time.   
 
4.3 Materials & Methods 
 
4.3.1 Cross-Sectional Studies    
Based on data from Cancer Incidence in Five Continents Vol. X (CI5X) and GLOBOCAN 
2012, age-specific and age-standardized (world population) incidence rates (WASR) were 
estimated for OAC and gastric cancer by topographical subsite (cardia and non-cardia) in 
2012. This method has been described in more detail by Arnold et al.(32) and Colquhoun et 
al.(145)  In brief, sex- and age-specific (<65; ≥65 years) proportions of OAC were computed 
for all countries included in CI5X except for those with no cases of OAC in one of four 
substrata (male, female; <65, ≥65 years) (N=51). Similarly, the proportions of cardia cancer 
(C16.0) and NCGC (C16.1-6) cases out of all gastric cancers with known topography 
(C16.0-6) were calculated for each country included in CI5X and stratified by sex and the 
same broad age groups, provided there were two or more cases of cardia cancer (CGC) and 
NCGC within each sex and age group stratification. Where there were multiple datasets 
(from different regional cancer registries within a country), cases and populations were 
pooled to obtain estimated national proportions. The histological types of oesophageal 
cancer and the topographical classification of gastric cancers were defined according to the 
third edition of the International Classification of Diseases for Oncology (ICD-O-3) which 
was presented in Cancer Incidence in Five Continents Vol. IX (CI5IX). For this analysis, the 
national or regional proportions of CGC/NCGC and OAC cases determined in the previous 
steps were applied to the 2012 gastric and OAC incidence estimates in GLOBOCAN 2012. 
Age-standardized incidence rates were computed using the world standard population. 
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4.3.2 Longitudinal Studies 
For the longitudinal study, WASR of OAC and total gastric cancer (TGC) were extracted 
from Cancer Incidence in Five Continents-Plus (CI5-plus).  Cardia and non-cardia subsite 
data were not used because there were few longitudinal data for the specific subsite and 
because there have been continuous changes in the subsite assignation practices for gastric 
cancer in histopathology laboratories.  A total of 38 populations around the world were 
selected for this study based on a) availability of data of oesophageal cancer recorded by 
histology, b) a time period of at least 19 years ending in 2007, c) if separate datasets were 
available for ethnic groups, at least one dataset per ethnic group was selected.  
 
4.3.3 Statistical Analyses 
For the cross-sectional study, Spearman’s rho correlations were used to explore the 
relationship between WASR of the two cancers. In the longitudinal study, in addition to 
Spearman’s rho correlations for pairwise correlation of OAC and TGC, time trends for 
individual registries, regression modelling was used to estimate the degree of incidence 
changes over time as described by Kim et al.(146)  Briefly, using Joinpoint Programme 
version 4.1.0 (National Cancer Institute, USA) we analysed the time trend data for each 
cancer, in each registry, in men and women individually (38 x2 x2= 152 datasets). The 
programme fitted the simplest Joinpoint model that the data allowed. The models used the 
log of the WASR for calculating the average annual percent change (AAPC) in rates and 
their corresponding 95% confidence intervals.  When any comparisons were made between 
different populations, the AAPC was always limited to the same 19-year period (1989-2007).  
When correlations were made between the change of cancer incidence between the two 
cancers within the same population, we present this in two different forms, firstly for the full 
length of available longitudinal data for each population and secondly, limiting it to the same 
common observation period (1989-2007).   
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4.4 Results 
4.4.1 Cross-sectional Study of National data     
Incidence rate estimates were available for 51 countries. (Table 4.1) There was a wide range 
in the rates of both gastric cancer and OAC across these different countries.  The incidence 
of OAC varied from 0.23 per 100,000 person-years to 7.24.  The incidence of TGC varied 
from 2.84 to 62.26 and that of NCGC from 1.75 to 58.64. In general terms, gastric cancer 
was highest in East Asia and lowest in Western Europe and North America whereas OAC 
showed the opposite trend.  In all 51 countries except the UK, OAC incidence rates were 
lower than the TGC rates and in 43 of 51 countries also lower than the NCGC incidence rate.   
Statistically significant negative correlations between the incidence rates of OAC and both 
TGC (CC= -0.38, p=0.006) and NCGC incidence (CC= -0.41, p=0.003) were observed.  The 
wide range in incidence of both OAC and TGC together with their inverse correlation 
resulted in a more than 200-fold range in the ratios of TGC to OAC across the different 
countries (more than 200:1 for the Republic of Korea to less than 1:1 for the UK)   
Despite the strong negative correlation between the incidence rates of the two cancers, 
inspection of the data points indicated that in two respects the correlation was not linear 
(Figure 4.1).  Firstly, the incidence of OAC seemed to be at a similar low level for all 
countries with moderate or high gastric cancer incidence and with a progressive rise in 
incidence at lower gastric cancer levels.  The incidence of TGC below which the rise in OAC 
was apparent was approximately 15 per 100,000p/y in men (Figure 4.1) and 7.5 per 
100,000p/y in women (Figure 4.2).  Secondly, when the incidence of TGC was low, the level 
of OAC incidence varied considerably between countries with some showing marked 
elevation, some moderate and some no elevation. The equivalent figures for women showed 
a similar pattern though this was less clear due to much lower incidence rates (Figure 4.2).   
In order to investigate further the geographical distribution of the countries according to their 
TGC and OAC incidence rates, we sub-divided them into 4 groups (Figure 4.1b).  In men, 
the first 3 groups consisted of countries with low TGC incidence (<15 per 100,000 p/y) and 
OAC incidence high (>5) - Group A, medium (1.5-5) - Group B, and low (<1.5) – Group C.  
The fourth group (D) consisted of countries with high rates of gastric cancer (>15) and low 
OAC (<1.5).  
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Table 4.1: Age-standardised incidence rate (world) of gastric cancer and oesophageal 
adenocarcinoma in different countries in cross-sectional study 
 Men  Women 
Country TGC Cardia NCGC OAC  TGC Cardia NCGC OAC 
UK 6.44 3.89 2.55 7.24  3.15 1.46 1.69 1.36 
Netherlands 7.61 3.39 4.22 7.05  3.9 1.03 1.69 1.36 
Ireland 8.83 3.64 5.19 5.36  4.42 1.42 3.0 1.01 
New Zealand 6.69 3.27 3.42 3.96  3.83 0.88 2.94 0.56 
USA 5.33 2.6 2.73 3.62  2.7 0.66 2.04 0.42 
Belgium 8.04 4.96 3.08 3.53  3.83 1.36 2.48 0.57 
Australia 6.72 3.44 3.27 3.41  3.14 0.99 2.15 0.49 
Denmark 8.32 5.79 2.53 3.07  3.05 1.27 1.78 0.76 
Canada 6.95 3.26 3.69 2.99  3.12 0.83 2.29 0.42 
Switzerland 5.01 2.21 2.8 2.59  3.58 0.89 2.69 0.49 
Norway 5.61 2.41 3.2 2.32  3.82 0.91 2.91 0.43 
Malta 11.08 6.1 4.98 2.3  5.53 1.2 4.33 0.11 
Germany 10.66 3.84 6.82 2.16  5.44 1.01 4.43 0.28 
Czech Rep 10.21 2.81 7.41 2.16  5.27 0.75 4.52 0.29 
Uruguay 14.36 7.61 6.75 2.07  6.7 2.06 4.64 0.61 
Argentina 9.87 2.79 7.08 1.98  4.19 0.71 3.48 0.44 
Austria 9.2 4.89 4.31 1.97  4.83 1.42 3.41 0.23 
Brazil 13.08 4.26 8.82 1.96  5.96 1.16 4.8 0.59 
Finland 6.72 4.86 1.86 1.8  3.94 2.06 1.88 0.3 
France 6.97 3.03 3.94 1.56  2.8 0.48 2.32 0.33 
Spain 10.97 2.91 8.05 1.27  5.11 0.66 4.45 0.18 
Columbia 18.89 6.93 11.95 1.11  8.97 2.18 6.8 0.21 
Lithuania 22.73 2.99 19.75 1.09  8.02 0.61 7.41 0.15 
Turkey 17.92 4.49 13.43 1.09  10.93 2.34 8.59 0.21 
Israel 9.71 4.03 5.68 0.94  4.9 1.45 3.45 0.2 
Puerto Rico 5.28 1.37 3.91 0.94  3.11 0.48 2.64 0.26 
Ukraine 22.39 4.36 18.03 0.9  9.14 1.29 7.85 0.16 
Latvia 23.05 4.97 18.08 0.86  8.68 0.93 7.74 0.18 
Bulgaria 14.51 2.71 11.8 0.86  6.99 0.88 6.12 0.12 
Croatia 14.47 7.5 6.97 0.85  6.27 2.39 3.88 0.12 
Iran 20.6 13.37 7.22 0.85  9.72 5.4 4.32 0.85 
Belarus 29.14 3.37 25.77 0.84  12.22 0.95 11.27 0.1 
China 32.77 11.97 20.8 0.83  13.1 3.37 9.73 0.26 
Russia 24.45 4.74 19.71 0.79  10.8 1.58 9.21 0.13 
Slovakia 13.95 3.43 10.52 0.79  6.58 0.92 5.66 0.15 
Costa Rica 21.43 4.65 16.78 0.75  13.66 1.48 12.18 0.15 
Chile 23.29 7.35 15.94 0.74  9.19 1.99 7.2 0.26 
Slovenia 15.37 5.01 10.36 0.65  6.42 1.02 5.4 0.1 
Italy 10.89 2.43 8.46 0.61  5.92 0.63 5.29 0.09 
Serbia 11.94 6.69 5.25 0.59  5.68 2.94 2.75 0.14 
Philippines 4.81 2.03 2.78 0.56  2.88 0.89 1.99 0.14 
Egypt 2.84 1.09 1.75 0.52  2.27 0.55 1.72 0.28 
Poland 13.19 7.87 5.32 0.50  4.95 2.08 2.86 0.09 
Estonia 19.5 2.96 16.54 0.44  10.31 1.03 9.28 0.07 
India 8.56 3.26 5.3 0.43  3.68 1.41 2.27 0.13 
Japan 45.75 4.73 41.01 0.42  16.46 1.25 15.21 0.07 
Saudi Arabia 3.84 1.36 2.48 0.42  2.41 0.72 1.69 0.15 
Singapore 10.85 3.18 7.67 0.34  5.83 1.31 4.52 0.07 
Ecuador 20.69 3.5 17.19 0.33  13.43 0.95 12.48 0.21 
Thailand 3.77 1.36 2.14 0.27  2.49 0.80 1.68 0.08 
Rep of Korea 62.26 3.62 58.64 0.23  24.67 1.07 23.60 0.04 
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Figure 4.1: Correlations between incidence rates (WASR) of OAC and gastric cancer in 
cross-sectional study in men. 1a: OAC versus total gastric cancer, 1b: visual clustering of 
countries divided into groups A-D. Note: Each dot represents a dataset from a country. 
 
 
 
Figure 4.2: Correlations between incidence rates (WASR) of OAC and gastric cancer in 
cross-sectional study in women. 1a: OAC versus total gastric cancer, 1b: visual clustering 
of countries divided into groups A-D. Note: Each dot represents a dataset from a country. 
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In men, incidence rate in the different groups showed distinct geographical patterns (Figure 
4.3).  Group A with the highest rate of OAC and low (<15) TGC was limited to the UK, the 
Netherlands and Ireland.  Group B with moderate OAC and low TGC (<15) comprised 
Northern America, Australia, New Zealand, Germany, Belgium, Denmark, Finland, 
Norway, France, Brazil and Uruguay.  Area C with low OAC and low TGC (<15) was a very 
heterogeneous group from around the world (Thailand, Philippines, India, Bulgaria, Croatia, 
Egypt, Israel, Italy, Spain, Poland, Serbia, Slovakia, Singapore); Group D with low OAC 
and moderate to high TGC includes South American countries, Eastern Europe, Korea, 
China, Japan, Russia, Iran and Turkey.  
In women, sub-dividing all countries into groups based on their rates of oesophageal and 
gastric cancer incidence demonstrated similar geographical patterns (Figure 4.4) 
 
 
Figure 4.3: Maps of countries colour-coded with visual clustering of populations with 
different combinations of OAC and gastric cancer in cross-sectional study in men.  
Note: The colour coding is based on groups A-D. Group A: (red) TGC<15 & OAC≥5, 
Group B (yellow): TGC<15 & 1.5≤OAC<5, Group C (green): TGC<15 & OAC<1.5,   
Group D (blue): TGC≥15 & OAC<1.5. The grey code indicates no data available. 
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Figure 4.4: Maps of countries colour-coded with visual clustering of populations with 
different combinations of OAC and gastric cancer in cross-sectional study in women.  
Note: The colour coding is based on groups A-D. Group A: (red) TGC<15 & OAC≥5, 
Group B (yellow): TGC<15 & 1.5≤OAC<5, Group C (green): TGC<15 & OAC<1.5,   
Group D (blue): TGC≥15 & OAC<1.5. The grey code indicates no data available. 
 
 
4.4.2 Longitudinal Study 
4.4.2.1 Changes in incidence of oesophageal adenocarcinoma and gastric 
cancer 
The incidence (WASR) of OAC and TGC at the start year (different for each registry), year 
1989 (earliest time common for all populations) and year 2007 (end year) were reported in 
Table 4.2, for men and women separately. 
To explore the rate of change in incidence of OAC and TGC during the period of 1989- 2007 
in males, we calculated average annual percentage change (AAPC) for each of the 38 
populations individually, and presented these in Figure 4.5, ordered by the most recent 
incidence of OAC. During this time period, most populations (34/38, 89%) had experienced 
a significant decrease in the incidence of TGC, with these 34 showing a range of AAPC from 
-1.4% (95% CI: -2.1, -0.6 in Japan, Miyagi) to -5.1% (95% CI: -5.8, -4.3) in Austria, Tyrol.    
Twenty-five of 38 (66%) populations showed a significant increase in incidence of OAC 
during the period of observation and no population showed a significant fall in incidence 
(Figure 4.5).  Annual increases in OAC incidence ranged from 1.5% (95% CI: 0.8, 2.3 in 
Victoria, Australia) to 11.7% (95% CI: 3.7, 20.2 in Estonia).  
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Table 4.2: List of recruited registries in longitudinal study, and incidence rates (WASR) of total gastric cancer and oesophageal adenocarcinoma at the start, year 1989, and end 
of period. 
Study Population 
 
Full-range 
Period (yrs) 
Men  Women 
OAC 
(start) 
OAC 
(1989) 
OAC 
(2007) 
TGC 
(start) 
TGC 
(1989) 
TGC 
(2007) 
 OAC 
(start) 
OAC 
(1989) 
OAC 
(2007) 
TGC 
(start) 
TGC 
(1989) 
TGC 
(2007) 
Scotland, all 1975 -2007  (33) 2.36 3.42 7.47 21.17 18.56 9.72  0.83 1.05 1.49 10.64 7.90 4.57 
England, North West 1979 -2007  (29) 1.58 3.70 7.07 22.32 17.76 10.12  0.46 0.86 1.34 10.01 7.74 4.08 
England, South & West 1979 -2007  (29) 1.40 3.46 5.84 17.21 14.79 7.02  0.30 0.48 1.11 6.99 3.77 2.72 
Netherlands, all 1989 -2007  (19) 2.26 2.26 5.42 15.68 15.68 8.88  0.58 0.58 0.93 6.11 6.11 3.98 
USA, Michigan, Detroit, Whites 1973 -2007  (35) 0.67 1.74 4.39 10.13 9.56 6.42  0.10 0.22 0.64 4.49 3.76 2.93 
USA, SEER (9 Regs), Whites 1975 -2007  (33) 0.61 1.83 3.74 9.31 8.04 5.55  0.22 0.27 0.60 7.02 5.09 3.35 
Switzerland, St Gall-Appenzell 1983 -2007  (25) 0.93 0.76 3.22 12.09 12.23 6.41  0.32 0.35 0.53 6.14 5.32 3.92 
USA, Calif, Los Angel, Non-His Whites 1973 -2007  (35) 0.35 1.61 2.77 9.92 7.99 5.52  0.10 0.22 0.51 4.03 3.19 2.43 
Australia, New South Wales 1983 -2007  (25) 0.71 1.54 2.67 12.36 10.82 7.54  0.00 0.26 0.50 8.03 6.46 3.68 
Australia. Victoria 1983 -2007  (25) 1.23 1.74 2.64 14.84 12.33 7.97  0.12 0.20 0.45 5.27 4.40 3.47 
Canada, Manitoba 1958 -2007  (50) 0.08 1.28 2.64 25.6 12.60 8.33  0.05 0.26 0.42 4.45 3.28 2.26 
Denmark, all 1978 -2007  (30) 0.81 1.76 2.54 15.05 10.29 7.68  0.19 0.19 0.40 3.88 3.88 3.86 
Switzerland, Vaud 1988 -2007  (20) 1.48 1.48 2.47 10.63 10.63 7.22  0.13 0.13 0.36 11.3 4.88 3.22 
France, Bas-Rhin 1975 -2007  (33) 0.88 0.83 2.12 17.58 12.78 8.42  0.00 0.11 0.35 8.14 7.27 4.33 
Canada, Sascatchhevan 1968 -2007  (40) 0.13 1.20 1.99 14.2 8.51 5.93  0.00 0.00 0.31 18.15 19.07 13.53 
France, Isere 1979 -2007  (29) 0.33 1.98 1.51 13.26 14.81 7.36  0.04 0.05 0.28 6.81 3.54 3.01 
USA, Calif, Los Angel, His Whites 1973 -2007  (35) 0.04 1.47 1.47 14.98 13.43 9.53  0.09 0.14 0.27 7.68 5.77 5.62 
Spain, Murcia 1983 -2007  (25) 0.74 1.21 1.44 17.88 15.67 10.46  0.09 0.02 0.24 5.96 5.02 3.31 
Spain, Granada 1985 -2007  (23) 0.58 0.39 1.16 17.77 14.92 10.02  0.03 0.03 0.22 16.40 16.40 6.93 
USA, Michigan, Detroit, Blacks   1973 -2007  (35) 0.30 0.48 1.03 16.24 16.10 12.08  0.04 0.05 0.19 14.78 6.19 5.20 
Colombia, Cali 1983 -2007  (25) 0.19 0.68 0.87 32.46 33.40 25.82  0.00 0.07 0.18 7.82 6.31 4.81 
Israel, Jews 1963 -2007  (45) 0.06 0.08 0.86 24.84 13.26 9.58  0.00 0.05 0.17 8.63 7.96 7.01 
Italy, Torino 1985 -2007  (23) 0.41 0.55 0.82 20.25 19.18 10.65  0.00 0.00 0.16 8.94 9.15 5.40 
Austria, Tyrol                1988 -2007  (20) 0.42 0.42 0.79 28.24 28.24 11.24  0.04 0.09 0.16 6.69 6.22 4.78 
Slovakia, all                   1973 -2007  (35) 0.15 0.35 0.78 42.30 25.06 16.43  0.00 0.04 0.15 8.29 5.40 3.80 
USA, SEER (9 Regs), Blacks       1975 -2007  (33) 0.17 0.46 0.74 15.30 15.04 10.43  0.00 0.00 0.14 23.97 23.97 10.48 
Japan, Miyagi 1978 -2007  (30) 0.68 0.43 0.69 82.51 84.41 65.72  0.05 0.19 0.10 8.44 7.09 5.20 
Croatia, all 1988 -2007  (20) 0.26 0.26 0.63 28.98 28.98 17.36  0.02 0.04 0.09 19.41 10.89 7.19 
Costa Rica, all 1980 -2007  (28) 0.55 0.52 0.63 48.40 39.53 24.65  0.08 0.08 0.08 11.87 11.87 7.22 
USA, Calif, Los Angel, Blacks    1973 -2007  (35) 0.37 0.68 0.59 15.53 13.76 8.66  0.00 0.05 0.08 26.73 16.45 11.43 
Estonia, all 1968 -2007  (40) 0.04 0.09 0.56 57.27 35.25 23.29  0.16 0.03 0.06 8.62 6.67 4.30 
Brazil, Goiania 1988 -2007  (20) 0.45 0.45 0.51 25.46 25.46 25.86  0.01 0.06 0.06 52.05 30.70 17.26 
Philippines, Manila      1983 -2007  (25) 0.32 0.34 0.45 14.16 11.72 6.91  0.00 0.02 0.04 17.21 15.12 7.86 
Italy, Romagna 1988 -2007  (20) 0.44 0.44 0.45 41.78 41.78 20.34  0.23 0.05 0.03 38.26 34.52 22.21 
Japan, Osaka 1963 -2007  (45) 0.00 0.22 0.41 107.06 70.42 44.19  0.15 0.25 0.03 23.39 17.19 14.11 
Singapore, Chinese 1968 -2007  (40) 0.00 0.28 0.38 45.07 33.48 14.90  0.00 0.00 0.03 4.48 4.79 4.17 
Thailand, Chiang Mai    1983 -2007  (25) 0.00 0.06 0.11 8.25 8.09 6.84  0.08 0.05 0.02 5.10 4.08 2.58 
India, Mumbai               1978 -2007  (30) 0.29 0.04 0.08 7.11 6.68 4.46  0.11 0.11 0.00 12.46 12.46 12.27 
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Figure 4.5: Average Annual Percentage Changes (AAPC) of OAC versus TGC in men 
during short common period (1989-2007) of registration in populations. 
 
 
We investigated any differences between the 13 populations showing no significant rise in 
OAC and the 25 populations showing a rise.  The populations which showed no significant 
change in OAC showed a rate of decrease in TGC (AAPC range -4.9% to 0.7%) similar to 
those that showed increase in OAC (AAPC range = -5.1% to -1.4%), (p=0.504).  Likewise, 
the registries showing no rise in OAC did not differ from those showing an increase in that 
the two groups had a similar most recent (2007) TGC incidence (9.5 vs 9.6/1000,000py; 
p=0.584).   
 
4.4.2.2 Correlation of Incidence trends of oesophageal adenocarcinoma and 
gastric cancer 
We looked for any correlation between the incidence trends for both cancers for those 38 
populations with sufficient longitudinal data and included the full observation period of 
paired data (i.e. not limited to 1989-2007) (Table 4.3).  In men, significant negative 
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correlations between incidence rate trends of OAC and TGC over time were present in 28 of 
the 38 populations when compared over preceding 19-50 years and evaluated in pairs. 
Positive correlations were not observed for any population. 
When the calculation of correlations between OAC and TGC incidence trends was limited 
to the common but shorter observation period (last 19 years of 1989-2007), the magnitude 
of correlations was weaker in some of the populations.  Only 19 of 38 populations showed 
significant negative correlations for men and 7 of 38 for women (Table 4.4).   
 
Table 4.3: Correlations between incidence (WASR) trends of oesophageal 
adenocarcinoma and total gastric cancer in two time periods of full range and 1989-
2007 in men 
Study Population 
 
Population Full Range  1989 - 2007 
(2007) Period (yrs) CC P value  CC P value 
Scotland, all 2485606 1975 -2007  (33) -0.961 0.000  -0.913 0.000 
England, North West 3223560 1979 -2007  (29) -0.926 0.000  -0.800 0.000 
England, South & West 3442830 1979 -2007  (29) -0.924 0.000  -0.774 0.000 
Netherlands, all 8100293 1989 -2007  (19) -0.961 0.000  -0.971 0.000 
USA, Michigan, Detroit, Whites 1390555 1973 -2007  (35) -0.921 0.000  -0.821 0.000 
USA, SEER (9 Regs), Whites 10682176 1975 -2007  (33) -0.972 0.000  -0.834 0.000 
Switzerland, St Gall-Appenzell 263298 1983 -2007  (25) -0.590 0.002  -0.519 0.023 
USA, Calif, Los Angel, Non-His 
Whites 
1446148 1973 -2007  (35) 
-0.843 0.000 
 -0.520 0.023 
Australia, New South Wales 3420484 1983 -2007  (25) -0.888 0.000  -0.810 0.000 
Australia. Victoria 2574901 1983 -2007  (25) -0.810 0.000  -0.593 0.007 
Canada, Manitoba 588875 1958 -2007  (50) -0.777 0.000  -0.402 0.088 
Denmark, all 2704655 1978 -2007  (30) -0.930 0.000  -0.766 0.000 
Switzerland, Vaud 323759 1988 -2007  (20) -0.402 0.079  -0.370 0.119 
France, Bas-Rhin 534515 1975 -2007  (33) -0.536 0.001  -0.458 0.049 
Canada, Sascatchhevan 495639 1968 -2007  (40) -0.724 0.000  -0.083 0.734 
France, Isere 585746 1979 -2007  (29) 0.045 0.816  0.129 0.599 
USA, Calif, Los Angel, His 
Whites 
2220592 1973 -2007  (35) 
-0.457 0.006 
 -0.076 0.756 
Spain, Murcia 714667 1983 -2007  (25) -0.394 0.051  -0.382 0.107 
Spain, Granada 438332 1985 -2007  (23) -0.442 0.035  -0.396 0.093 
USA, Michigan, Detroit, Blacks 475552 1973 -2007  (35) -0.271 0.116  0.193 0.428 
Colombia, Cali 1000036 1983 -2007  (25) 0.010 0.964  0.029 0.906 
Israel, Jews 2674800 1963 -2007  (45) -0.637 0.000  -0.173 0.479 
Italy, Torino 435148 1985 -2007  (23) -0.341 0.112  0.048 0.844 
Austria, Tyrol 342794 1988 -2007  (20) -0.530 0.016  -0.475 0.040 
Slovakia, all 2621095 1973 -2007  (35) -0.818 0.000  -0.463 0.046 
USA, SEER (9 Regs), Blacks 1724091 1975 -2007  (33) -0.592 0.000  -0.434 0.063 
Japan, Miyagi 1140676 1978 -2007  (30) -0.383 0.036  -0.574 0.010 
Croatia, all 2137984 1988 -2007  (20) -0.737 0.000  -0.713 0.001 
Costa Rica, all 2227538 1980 -2007  (28) -0.008 0.967  -0.419 0.074 
USA, Calif, Los Angel, Blacks 450132 1973 -2007  (35) -0.357 0.035  -0.155 0.525 
Estonia, all 617828 1968 -2007  (40) -0.420 0.007  -0.471 0.042 
Brazil, Goiania 588132 1988 -2007  (20) 0.048 0.842  0.098 0.690 
Philippines, Manila 2993487 1983 -2007  (25) -0.371 0.068  -0.185 0.448 
Italy, Romagna 577247 1988 -2007  (20) -0.074 0.755  -0.192 0.431 
Japan, Osaka 4366616 1963 -2007  (45) -0.915 0.000  -0.572 0.011 
Singapore, Chinese 1324700 1968 -2007  (40) -0.558 0.000  -0.188 0.441 
Thailand, Chiang Mai 741784 1983 -2007  (25) -0.281 0.173  -0.109 0.658 
India, Mumbai 7479777 1978 -2007  (30) -0.425 0.019  -0.567 0.011 
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Table 4.4: Correlations between incidence (WASR) trends of oesophageal 
adenocarcinoma and total gastric cancer in two time periods of full range and 
1989-2007 in women 
Study Population 
 
Period (yrs) Full Range  1989-2007 
CC P value  CC P value 
Scotland, all 1975 -2007  (33) -0.860 0.000  -0.400 0.090 
England, North West 1979 -2007  (29) -0.778 0.000  -0.452 0.052 
England, South & West 1979 -2007  (29) -0.944 0.000  -0.849 0.000 
Netherlands, all 1989 -2007  (19) -0.853 0.000  -0.860 0.000 
USA, Michigan, Detroit, Whites 1973 -2007  (35) -0.716 0.000  -0.384 0.104 
USA, SEER (9 Regs), Whites 1975 -2007  (33) -0.863 0.000  -0.612 0.005 
Switzerland, St Gall-Appenzell 1983 -2007  (25) -0.270 0.191  -0.130 0.595 
USA, Calif, Los Angel, Non-His 
Whites 
1973 -2007  (35) 
-0.730 0.000 
 -0.408 0.083 
Australia, New South Wales 1983 -2007  (25) -0.680 0.000  -0.573 0.010 
Australia. Victoria 1983 -2007  (25) -0.610 0.001  -0.476 0.040 
Canada, Manitoba 1958 -2007  (50) -0.486 0.000  -0.175 0.474 
Denmark, all 1978 -2007  (30) -0.731 0.000  -0.246 0.309 
Switzerland, Vaud 1988 -2007  (20) -0.104 0.662  0.011 0.966 
France, Bas-Rhin 1975 -2007  (33) -0.523 0.002  -0.234 0.334 
Canada, Sascatchhevan 1968 -2007  (40) -0.270 0.091  0.168 0.492 
France, Isere 1979 -2007  (29) -0.032 0.870  0.118 0.631 
USA, Calif, Los Angel, His Whites 1973 -2007  (35) -0.419 0.012  -0.310 0.196 
Spain, Murcia 1983 -2007  (25) -0.014 0.949  0.122 0.620 
Spain, Granada 1985 -2007  (23) -0.348 0.104  -0.222 0.360 
USA, Michigan, Detroit, Blacks 1973 -2007  (35) -0.295 0.085  -0.283 0.241 
Colombia, Cali 1983 -2007  (25) -0.373 0.066  -0.336 0.160 
Israel, Jews 1963 -2007  (45) -0.477 0.001  0.086 0.726 
Italy, Torino 1985 -2007  (23) -0.451 0.031  -0.251 0.301 
Austria, Tyrol 1988 -2007  (20) -0.159 0.504  -0.251 0.301 
Slovakia, all 1973 -2007  (35) -0.607 0.000  -0.383 0.106 
USA, SEER (9 Regs), Blacks 1975 -2007  (33) -0.429 0.013  -0.353 0.138 
Japan, Miyagi 1978 -2007  (30) -0.171 0.367  0.237 0.328 
Croatia, all 1988 -2007  (20) -0.155 0.514  -0.272 0.260 
Costa Rica, all 1980 -2007  (28) 0.143 0.468  0.244 0.314 
USA, Calif, Los Angel, Blacks 1973 -2007  (35) -0.316 0.064  -0.075 0.761 
Estonia, all 1968 -2007  (40) -0.428 0.006  -0.243 0.316 
Brazil, Goiania 1988 -2007  (20) 0.071 0.767  -0.077 0.755 
Philippines, Manila 1983 -2007  (25) 0.149 0.478  0.019 0.940 
Italy, Romagna 1988 -2007  (20) -0.470 0.037  -0.421 0.073 
Japan, Osaka 1963 -2007  (45) -0.667 0.000  -0.292 0.225 
Singapore, Chinese 1968 -2007  (40) -0.237 0.141  -0.096 0.697 
Thailand, Chiang Mai 1983 -2007  (25) -0.463 0.020  -0.514 0.024 
India, Mumbai 1978 -2007  (30) -0.297 0.111  -0.529 0.020 
 
 
4.4.3 Relationship of longitudinal and cross-sectional data 
We investigated the relationship between the cross-sectional data of most recent incidences 
of the two cancers and the longitudinal incidence trends.  On the cross-sectional scatter 
plot figure showing the correlation between current incidence of OAC and TGC across 
different countries we superimposed a line through the correlation dot plots for the 
available time points over preceding years.  This allowed us to examine the changes in 
incidence of both TGC and OAC cancer over time and how it related to their current 
incidences in different countries.  To facilitate visual inspection we did this separately for 
each of the four categories of countries i.e. groups A, B, C and D based on incidence 
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pattern of the two cancers (Figure 4.6).   For the longitudinal data we selected the 3 
populations from each of groups A, B, C and D with the longest observation periods.  The 
resulting plots indicated that the countries with current low incidence of TGC and high, 
medium or low incidence of OAC had previously resembled countries with a current high 
incidence of gastric cancer and low incidence of OAC; as the former had decreased the 
latter had increased markedly, (group A) moderately (group B) or not at all (group C).   
 
 
Figure 4.6: Longitudinal data superimposed on cross-sectional cancer incidences in men.  
The dots indicate the cross-sectional data of the most recent OAC and TGC incidences for 
the different countries shown in Figure 4.1. The superimposed colour lines represent 
longitudinal data for selected populations.  The populations were selected by having the 
longest available longitudinal data.  The time line of the longitudinal data is always from 
right to left. Note: Incidence of OAC and TGC plotted are per 100,000py. 
 
 
 
4.5 Discussion 
Our study has demonstrated an inverse association between the incidence of OAC and gastric 
cancer.  This is apparent with respect to both the current incidences of these two cancers 
across different countries and with respect to changing incidence of the two cancers within 
the same populations over time.  The inverse association is intriguing in view of the apparent 
similarities between these two cancers.  Both OAC and TGC arise from epithelia of closely 
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adjacent, indeed abutting regions of the upper gastrointestinal tract, both are the result of 
chronic damage and inflammation exerted by their luminal environment and both usually 
show very similar and often indistinguishable histological appearance.   
Our cross-sectional study showed that both cancers were similar in having a wide range in 
current incidence rates (20-30 fold in males) across the different countries but different in 
having contrasting geographical patterns. The longitudinal studies showed that the 
incidences of both TGC and OAC had changed markedly over recent decades, but these 
changes were in opposite directions and there was a statistically significant inverse 
association between the changing incidence rates of the two cancers in 74% of the registries. 
Combining the cross-sectional and longitudinal data provided an overall picture of what has 
been happening to these two cancers over time and in different regions of the world.  
Previously, most countries had a high incidence of gastric cancer and a low incidence of 
OAC.  Since then, the incidence of gastric cancer has fallen in all countries and as it has 
reached low levels it has been accompanied by varying degrees of increase in OAC. 
What is the explanation for the opposing incidences and time trends of these two cancers?  
Could differences between countries in classification of junctional cancers into oesophageal 
versus gastric locations and/or changes in classification of these cancers over time explain 
some of the observations?  In the cross-sectional study, we found that the inverse association 
remained strong and indeed became slightly stronger by excluding cancers occurring at the 
gastric cardia and thus more likely to be misclassified.  The longitudinal data only provided 
information on TGC. Spurious inverse association between incidence trends of the two 
cancers due to changing classification of cardia junctional cancers would only be likely to 
be a significant issue in countries with a very high incidence of gastric cancer and low 
incidence of OAC as misclassification of a small proportion of the former could substantially 
increase the latter.(147)  Such misclassification, however, could not explain the strong 
inverse incidence trends as they were most apparent in countries with lower gastric cancer 
incidence.(148) 
The marked changes in incidence of TGC and OAC over a short time scale indicate the 
influence of a changing environmental factor. In addition, the inverse association between 
the changing incidences indicates that the environment factor is exerting opposite effects on 
these two cancers. The environmental factors that are thought to explain the falling incidence 
of TGC include a falling incidence of H. pylori atrophic gastritis, dietary changes and 
reduced smoking.(149)  Could the falling incidence of any of these be associated with an 
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increase in OAC and thus explain the inverse association in the incidence trends of the two 
cancers? Smoking is not a candidate as it is a similar risk factor for both cancers.(138, 150) 
Dietary changes might be important. There is some evidence that increased intake of 
vitamins and reduced salt consumption may have contributed to the falling incidence of 
gastric cancer.(151, 152) These specific dietary factors would not in themselves explain the 
increase in OAC and indeed increased vitamin consumption may protect from OAC.(153) 
However, increased caloric intake and associated obesity is a well-established risk factor for 
OAC.(153) It is therefore possible that changes in the diet comprising both a fall in salt 
content and increased caloric content could produce a fall in total TGC and rise in OAC. 
However, a recent analysis indicated that increasing obesity may only account for 6.5% of 
the increase in incidence of OAC and suggesting the role of additional environmental 
factors.(136)  Another environmental factor that might exert opposite effects on the 
incidence of the two cancers is H. pylori atrophic gastritis which is the most important 
etiological factor for non-cardia gastric cancer.(154)  In countries with a high incidence of 
gastric cancer there is also a high incidence of atrophic gastritis and associated impaired 
gastric acid secretion.(155)  In contrast, in subjects without H. pylori, gastric acid is 
maintained and shows no decline with increasing age.(88)  In countries with a high incidence 
of gastric cancer the high prevalence of H. pylori atrophic gastritis will protect from OAC 
as any gastro-oesophageal refluxate will have reduced ability to damage the oesophagus due 
to its reduced acidity. Epidemiological studies have shown consistent associations between 
H. pylori and both TGC and OAC being positive with respect to the former and negative 
with respect to the latter.(141)  As the prevalence of H. pylori atrophic gastritis falls, it will 
be accompanied by a fall in gastric cancer but potentially also a rise in OAC due to increasing 
gastric acidity. The prevalence of H. pylori infection has fallen over recent decades in 
association with improved living conditions.(49) 
Interactions between H. pylori and dietary factors might also be important. There is some 
evidence that a high-vitamin, low salt diet may protect from the development of atrophic 
gastritis in H. pylori-infected subjects.(156)  Improved living conditions, with 
accompanying fall in H. pylori prevalence as well as increased vitamin and reduced salt 
intake could together markedly reduce atrophic gastritis with resultant fall in TGC and 
increase in OAC.  In the previous study by Anderson et al. showing a strong negative 
association between H. pylori and oesophageal adenocarcinoma, the association persisted 
even after correcting for atrophic gastritis detected by serum pepsinogens.(71)  However, it 
is recognized that serum pepsinogens are insensitive markers of atrophy.(157)  In addition,  
H. pylori body-predominant gastritis is associated with reduced gastric acid secretion 
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independent of atrophy.(158)  Furthermore, body-predominant gastritis is an important risk 
factor for gastric cancer,(159) so even without significant atrophy it might both promote 
gastric cancer and protect from oesophageal adenocarcinoma. 
  Though there were strong inverse associations between the two cancers with respect to both 
current incidences and time trends, there was a group of countries with a low incidence of 
both cancers. This was a heterogeneous group consisting of Thailand, Philippines, 
Singapore, India, Egypt, Israel, Bulgaria, Croatia, Italy, Spain, Poland, Serbia, and Slovenia. 
Due to the limited availability of longitudinal data for many of these populations, it was 
difficult to determine whether their low incidence of both cancers was due to the absence of 
a rise in OAC as their incidence of TGC fell, or whether they had never had a high incidence 
of TGC and were somehow protected from both cancers. It is possible that genetic and/or 
environmental factors present in some of these populations might inhibit the progression 
from inflammation to neoplasia which is a common final step in the pathways leading to 
both TGC and OAC.  A lack of increase in OAC despite TGC falling to a low level might 
be due to the genetic and/or environmental factors protecting from gastro-oesophageal 
reflux, which is an essential early step in the pathway to OAC. Comparative studies of 
countries with low vs. high incidence of OAC despite low incidence of TGC may shed new 
light on the aetiology and pathogenesis of OAC.    
An important question is whether countries where gastric cancer incidence is still high but 
falling such as Japan and South East Asia will encounter a rise in OAC like that recently 
experienced in Western countries.  The current incidence of gastric cancer in these countries 
is still at a level which when present in Western countries was not yet associated with any 
rise in OAC.  However, the current incidence of gastric cancer in Japan and South East Asia 
is still at a level which when present in Western countries was not yet associated with any 
rise in OAC and it will be interesting to observe what happens when this point is reached. 
Strengths of our study include the use of high quality global surveillance data. Limitations 
also need however to be recognised.  Incidence rates used in the cross-sectional analysis 
were based on country-, age- and sex-specific proportions of OAC from CI5X, which were 
then applied to GLOBOCAN 2012 data.  Hence, they represent estimates of the true 
incidence rates within each country and should be interpreted with caution.  Our inclusion 
criteria for the cross-sectional study furthermore resulted in a selection of 51 mostly high-
income countries, which may not be fully representative on the global level.  As pathological 
practices and classifications of histological subtypes will have changed over time, this should 
also be kept in mind when interpreting the results, especially from the longitudinal analyses.  
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Also, registries covering different time periods (19 to 50 years) were included in some of the 
longitudinal analysis, making them not directly comparable. 
In conclusion, this study demonstrates a strong inverse association between gastric cancer 
and OAC with respect to both their current incidences and time trends and which is 
consistent with H. pylori gastritis predisposing to the former and protecting from the latter.  
Our study also points to marked differences between populations with respect to the degree 
of increase in incidence of OAC observed as gastric cancer falls to a low level and 
understanding the factors responsible for these differences will be key to developing 
preventative strategies for OAC in the future. 
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CHAPTER 5 
 
Study of the effect of 
Helicobacter pylori infection on 
intragastric acidity 
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5.1 Introduction 
Helicobacter pylori (H. pylori) is a common bacterial infection of the stomach present in the 
majority of the world’s human population and resulting in varying degrees of inflammation 
of the underlying gastric mucosa.  The infection is acquired in early childhood and usually 
persists indefinitely unless specifically eradicated.(46) 
One of the major medical advances of the past 25 years has been the discovery that this 
common infection plays an important role in the aetiology of duodenal and gastric ulcers 
and also of gastric cancer.(160)  Eradicating the infection produces a long-term cure for the 
majority of patients with peptic ulcers unrelated to NSAID therapy. There is also increasing 
evidence that eradication of the infection reduces the risk of gastric cancer.(64) 
An unexplained observation regarding the infection is its negative association with gastro-
oesophageal reflux disease (GORD) and its complications of Barrett’s oesophagus and 
oesophageal adenocarcinoma, with these disorders being less than half as common in 
infected subjects.(142, 161)  It has been postulated that this negative association may 
represent the gastric infection protecting against these oesophageal disorders.  If so, the 
falling incidence of the infection in the general population might explain the rising incidence 
of these oesophageal diseases.  
One mechanism by which the infection might protect against oesophageal disease is by 
reducing the ability of the gastric mucosa to secrete acid and pepsin which are the 
constituents of gastric juice which can induce oesophageal damage.  The infection is known 
to exert varying effects on gastric secretory function.  In subjects with duodenal ulcers, the 
infection produces a non-atrophic gastritis with well-maintained gastric secretory cell mass 
which secretes increased amounts of acid due to the infection inhibiting the gastrin-mediated 
negative feedback control of acid secretion.(162) In patients who develop gastric cancer, the 
infection induces an atrophic gastritis with loss of gastric secretory cells and thus reduced 
acid secretion.  Only approximately 1 in 10 H.pylori infected subjects develop complicating 
ulcer disease or gastric cancer and relatively little is known about the effects of the chronic 
infection on gastric secretory function in the 90% of infected subjects without these 
complications.(60)  If the degree of reduction in oesophageal disease in the H.pylori infected 
population is due to the infection reducing gastric acid secretion, then this suppression of 
acid secretion would need to be apparent in the majority of infected subjects. 
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Recent evidence indicates that it is the acidity of the gastric contents close to the gastro-
oesophageal junction (GOJ), referred to as the acid pocket, which refluxes and causes 
oesophageal damage.(163) It is also known that loss of gastric secretory cells due to 
H.pylori-induced atrophic gastritis does not occur uniformly throughout the stomach but 
may be more marked at the periphery of the acid secreting mucosa.(97)   In assessing any 
potential protective effect of the infection against oesophageal damage, it is important to 
examine the structure and secretory function of different anatomical regions of the stomach 
as well as its overall secretory capacity. 
 
5.2 Aims 
The aim of this study was to assess gastric acid secretory status in different anatomical 
regions of the stomach and in subjects representative of the majority of the H. pylori infected 
population.  
 
5.3 Methods and Materials 
5.3.1 Subjects 
Study participants were volunteers from the general population of the West of Scotland.   
Subjects who were currently taking, or had recently taken, proton pump inhibitors, were 
currently using H2 receptor antagonists or had ever received H. pylori eradication therapy 
were excluded.  Recruitment was by general advertisement and from the NHS Scotland 
SHARE database.    
 
5.3.2 Study Design 
5.3.2.1 Study Day 1: Clinical measurements and Urea breath test 
The presence and severity of any gastrointestinal symptoms was assessed using the Short-
Form Leeds Dyspepsia Questionnaire(164) and a medication history was recorded.  
Measurements of height, weight, waist and hip circumference were taken.  Volunteers 
were tested for H. pylori infection by C14 urea breath test.  Fasting serum and plasma 
samples were stored at -20˚C and later tested for H. pylori CagA IgG using ELISA 
(Genesis Diagnostics Ltd, Littleport, UK).  
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5.3.2.2 Study day 2: Upper gastrointestinal endoscopy 
Volunteers attended after an overnight fast for upper gastrointestinal endoscopy.   They 
were offered topical lidocaine throat spray or conscious sedation with midazolam 1-3mg.  
Biopsies were taken using large capacity biopsy forceps (Radial Jaw™ 4; Boston 
Scientific, Hemel Hempstead, UK) with a jaw span of 8mm.  Two junctional biopsies were 
taken perpendicular to the squamocolumnar junction (SCJ), one from lesser and one from 
greater curve, and targeted to include squamous mucosa at the proximal end.  Three further 
junctional biopsies were taken longitudinally below the SCJ, aiming for end-to-end 
biopsies starting at 6, 12 and 18mm distal to the SCJ down the lesser curve.  In addition, 
six further gastric biopsies were taken from gastric fundus, mid-body on greater curve, 
mid-body on lesser curve, distal body on greater curve, incisura angularis and antrum.  
Finally, two small metal radio-opaque clips were attached to the SCJ using a single use 
rotatable clip fixing device (QuickClip 2™; Olympus, Southend-on-Sea, UK). 
Biopsies were immediately placed onto non-adherent dental wax and oriented flat.  More 
detailed information concerning the two-stage orientation method has been described 
elsewhere.(165)  The specimens were later embedded in agar on the filter paper without 
further manipulation.  Staining was performed with conventional H&E, as well as 
monoclonal antibodies to H+/K+ATPase, pepsinogen I and gastrin. 
 
5.3.2.3 Study Day 3: Combined manometry and pH study 
The volunteers attended after an overnight fast for combined high-resolution manometry 
and pH studies.  The combined probe was passed pernasally and positioned so that the 
most proximal pH sensor was 5cm above the lower oesophageal sphincter (LOS), with the 
remaining eleven sensors lying across the sphincter and within the proximal stomach.  The 
relative positions of the 12-sensor pH catheter, 36 sensor manometer and SCJ are shown in 
Figure 5.1.  Manometry and pH data were recorded concurrently for a 20-minute fasting 
period.  Subjects then consumed a standardised meal over ten minutes [400g Waitrose 
spaghetti bolognese ready meal and 100ml water (500kcal; 55.2g carbohydrate, 27.8g 
protein, 17.6g fat)].  Following this, manometry and pH recordings were continued for a 
further 90 minutes.  An X-ray was taken before and after the meal to visualise the metal 
clips at the SCJ. 
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Figure 5.1: Schematic diagram of the relative positions of the 12-sensor pH catheter, 36 
sensor manometer and squamocolumnar junction (SCJ) (identified by attached metal clip). 
 
 
5.3.3 Equipment 
5.3.3.1 High-resolution pHmetry    
pH recordings were taken using a high-resolution pH catheter (Synectics Medical Ltd, 
Enfield, UK).  This was a custom-made pH probe composed of 12 antimony pH electrodes 
with the most distal electrode situated 5mm from the tip of the catheter, with the other 
eleven electrodes 35, 46, 57, 68, 79, 90, 101, 112, 123, 134 and 169mm proximal to the tip.  
The probe was calibrated prior to each study using pH buffer solution (Synmed Ltd, 
Enfield, UK) at pH 7.01 and pH 1.07.  Recordings were captured using Polygram Net 
software (Synectics Medical Ltd, Enfield, UK). 
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5.3.3.2 High-resolution manometry  
Manometry was performed using a high resolution solid-state catheter with 7.5mm spacing 
between 36 circumferential sensors (Given Imaging, Hamburg, Germany).   Calibration 
was performed prior to each study and In vivo calibration was carried out on a weekly 
basis and applied to each study to compensate for thermal drift.  Recordings were captured 
with ManoScan 360 high-resolution Manometry System and analysed with ManoView 
ESO v3.0.1 software (Given Imaging, Hamburg, Germany).   
 
5.3.3.3 Combined probe  
The manometry and pH catheters were combined using two thin strips of Leukoplast Sleek 
waterproof tape (BSN Medical, Pinetown, SA) such that manometry sensor 25 was 
immediately adjacent to pH sensor 3.   
 
5.3.4 Data analysis 
5.3.4.1 Intragastric acid 
The 90-minute postprandial period was split into three 30-minute periods for analysis.  The 
median pH for each of the 12 pH sensors was calculated for the twenty-minute fasting 
period and the three 30-minute postprandial periods.  Acid exposure at the GEJ was also 
examined by calculating the % of time pH <4.    
 
5.3.4.2 Manometry  
Manometric characteristics were analysed in detail during fasting and the same three 
postprandial periods.  For each two-minute period, one inspiratory point and one expiratory 
point was chosen from the longest period without interference from swallowing, coughing 
or transient lower oesophageal sphincter relaxations (TLOSRs).  The mean pressure in 
inspiration and expiration was calculated for each of the 36 sensors over the twenty-minute 
fasting period and thirty-minute postprandial periods.  The peak LOS pressure was taken as 
the sensor showing the highest mean pressure.  The position of the SCJ was derived from 
the position of the metal clips relative to the combined manometry and pH sensors seen on 
X-ray. 
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5.3.4.3 Histopathological Assessment 
Glandular height:  The vertical height of epithelium starting from lamina propria to tip of 
gland were measured in 3 well-oriented and representative fields and expressed as “Total 
Thickness of Epithelium”.  To measure the “Glandular Height”, the same method was 
limited to areas of gland containing secretory cells, but not superficial foveolar epithelial 
cells.  All results were expressed as median (IQR) in mm. 
Inflammatory scoring:  The intensity of inflammatory infiltrate by polymorphonuclear 
(PMN) and mononuclear (MN) cells was scored semi-quantitively (0=none; 1=mild; 
2=moderate; 3=severe) as recommended in the Updated Sydney Classification of 
Gastritis.(54)    A combined inflammatory score was calculated as the sum of these two 
scores.   Intestinal metaplasia (IM) was scored by estimating the proportion of epithelial 
surface covered by goblet cells. 
Immunohistochemistry: The oriented biopsies, double embedded in agar and paraffin, were 
cut in standard 4-micron thickness and immunostained individually for parietal cell, chief 
cell and G cells.  For parietal cells, we used a commercial mouse monoclonal anti-H+/K+ 
ATPase (Ab 2866, Abcam, Cambridge, UK) diluted at 1:20,000.  For Chief cells, a mouse 
monoclonal anti-pepsinogen 1 antibody (Ab 50123, Abcam, Cambridge, UK) was used at 
dilution of 1:4000.  The G cells were stained with anti-gastrin (Ab-16035, Abcam, 
Cambridge, UK) diluted at 1:200.  A Thermo Quanto Detection Kit (TL-125-OHD, 
Thermo Fisher, UK) was used as secondary antibody. 
To calculate the density of parietal cells, chief cells and G cells, absolute number of stained 
cells were counted at a magnification of 125X in 3 well-oriented and representative fields 
(1 mm2 each) and expressed as mean cell number per 1 mm2 area in each patient.  All 
selected areas must have had complete glands located in sagittal plane, in which the lamina 
propria was in bottom and luminal side of epithelium was in top. 
 
5.3.5 Statistical analysis 
All continuous data are expressed as medians and interquartile ranges unless otherwise 
stated.  Comparison of variables between groups was made using the Mann-Whitney U 
test.  Biopsy inflammatory scores are presented as crosstabulations and compared using 
Fisher’s exact test.  Significance for all statistical tests was set as p value <0.05. 
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5.3.6 Ethics 
The study protocol was approved by the West of Scotland Ethics Committee and all 
volunteers provided informed written consent. 
 
5.4 Results 
5.4.1 Subjects 
Of the 137 subjects assessed for eligibility for the study, 49 were excluded due to current 
or recent use of PPI therapy (n=9) or history of previous H. pylori eradication therapy 
(n=8) or declining to participate following full explanation of the study protocol (n=32). 
Eighty-eight subjects proceeded to the urea breath test, of which 31 were H. pylori 
positive, and all of these went on to complete the full study protocol. Of the 57 testing H. 
pylori negative, 28 went on to complete the study due to 1 withdrawing consent after the 
endoscopy and 28 not being selected to proceed in order to maintain matching of the 
positive and negative groups with respect to age, gender and BMI. 
The 31 H. pylori positive and 28 H. pylori negative subjects who completed the study were 
well matched with respect to age (55 vs 56 years; p=0.95), gender (18/31 vs 18/28 males; 
p=0.84) and BMI (26.3 vs 26.8 kg/m2; p=0.72). There were seven current smokers in the 
H. pylori positive group compared with one current smoker in the H. pylori negative group 
(p=0.035). 
The median dyspepsia score for H. pylori positives was 2.0 (range 0–9) compared with 0 
(range 0–3) for the H. pylori negative subjects (p=0.002). Out of 31 H. pylori positives, 17 
(54.8%) of them were taking no medication compared with 10/29 (35.7%) of the H. pylori 
negative subjects. The most frequent medications were antihypertensives, statins, 
antidepressants and inhalers for asthma. No subject was taking medications known to 
affect gastric secretion. 
At endoscopy, four H. pylori positive subjects had a hiatus hernia (2–4 cm in length), one 
subject had Los Angeles (LA) grade A reflux oesophagitis and one subject had Barrett's 
mucosa of 3 cm. None of the H. pylori negatives had a hiatus hernia, although two subjects 
had reflux oesophagitis (LA grades A and B). 
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5.4.2 Gastro-oesophageal acidity  
5.4.2.1 Fasting period 
Under fasting conditions, the H. pylori positive subjects had less intragastric acidity 
compared to the H. pylori negatives at all sensors more than 1.1cm distal to the peak LOS 
pressure.  The fall from neutral oesophageal pH to highly acidic intragastric pH also 
occurred more abruptly in the H. pylori negatives.  At the sensor 3.3cm distal to the peak 
LOS pressure, the median pH in the H. pylori negatives had fallen to 2.27 compared to 
6.13 in the positives (p<0.001).  The radio-opaque clips indicated that this pH sensor was 
1.8cm distal to the SC junction.  At the most distal pH sensor, 6.6cm below the peak LOS 
pressure, the median pH in the H. pylori negatives was 1.62 compared to 2.39 in the 
positives (p=0.003), indicating that even this far into the stomach the acidity is 
significantly less in H. pylori infected subjects.  Table 5.1 shows the fasting median pH 
values and interquartile ranges for all sensors in both groups.   
 
Table 5.1. Median (IQR) pH values at sensors relative to peak LOS pressure comparing 
H. pylori negative (n=28) and positive (n=31) groups during 20-minute fasting period. 
Sensor location H. pylori negative H. pylori positive P value 
5cm proximal 7.20 (0.70) 7.19 (0.74) 0.933 
1.1cm proximal 7.33 (0.78) 7.37 (0.62) 0.525 
Peak LOS pressure 7.34 (0.79) 7.28 (0.51) 0.499 
1.1cm distal 7.06 (1.63) 7.13 (0.51) 0.213 
2.2cm distal  5.79 (4.26) 6.94 (1.38) 0.004 
3.3cm distal 2.27 (2.58) 6.13 (5.06) <0.001 
4.4cm distal 1.70 (1.16) 4.11 (4.95) <0.001 
5.5cm distal 1.68 (0.66) 2.88 (3.66) <0.001 
6.6cm distal 1.62 (3.66) 2.39 (3.06) 0.003 
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Figure 5.2 shows the median pH of both groups at each sensor below peak LOS pressure 
and illustrates both the sudden decrease in pH in H pylori negatives and the increased 
acidity in H pylori negatives compared to positives at all sensors more than 1.1cm distal to 
peak LOS pressure.  The mean distance of the SCJ and distal border of the LOS from the 
peak LOS pressure is also shown on the graph.  This shows the difference between the two 
groups begins at the first sensor below the SCJ, and this sensor is located within the distal 
end of the LOS. 
 
 
Figure 5.2: Median pH for 20-minute fasting period relative to lower oesophageal 
sphincter (LOS) and squamocolumnar junction (SCJ) in H. pylori positive (HP+) and 
negative (HP-) subjects. 
 
pH values represent the negative logarithm of the hydrogen ion activity, which relates 
closely to the hydrogen ion (H+) concentration.  We transformed our pH data into 
hydrogen ion activity to show the actual differences in acidity between the two groups.   In 
the H. pylori positives, the H+ activity at 4.4 cm distal to peak LOS pressure (the first 
sensor with pH <5) is 0.1 mmol/l and this increases to 4.1 mmol/l at 6.6cm distal.  In H. 
pylori negatives the H+ activity is 20.2 mmol/l at 4.4cm and 24.3 mmol/l at 6.6cm.  The 
data for all intragastric sensors is given in table 5.2. 
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Table 5.2. Median (IQR) hydrogen ion activity (mmol/l) at sensors relative to peak LOS 
pressure comparing H. pylori negative (n=28) and positive (n=31) groups during 20-
minute fasting period. 
Sensor location H. pylori negative H. pylori positive P value 
1.1cm distal 1.0x10-4 (3.4x10-3) 7.4x10-5 (9.1x10-5) 0.15 
2.2cm distal 2.9x10-3 (6.3) 1.1x10-3 (1.3x10-3) 0.003 
3.3cm distal  5.6 (19.6) 7.4x10-4 (6.3) <0.001 
4.4cm distal 20.2 (26.2) 0.1 (16.2) <0.001 
5.5cm distal 21.1 (26.3) 1.3 (16.2) <0.001 
6.6cm distal 24.3 (28.7) 4.1 (25.1) 0.003 
 
 
5.4.2.2 Postprandial periods 
Throughout the three postprandial periods, intragastric acidity was significantly less in the 
H. pylori positives at the pH sensors placed 2.2, 3.3 and 4.4cm distal to the peak pressure 
of the LOS but no significant difference was detected by the more distal sensors placed at 
5.5 and 6.6cm distal to this reference point (Table 5.3).  In the first postprandial period, 
which starts immediately after meal has been consumed up until 30 minutes later, the 
lowest median pH value is 2.46 at 3.3cm distal to the peak LOS pressure in the H. pylori 
negative group.  In the H. pylori positives, the lowest median pH is 4.26, also at 3.3cm 
distal to peak LOS pressure.  In the second postprandial period (30-60 minutes after the 
meal) in the H. pylori negative group the median pH has fallen further to 1.59 at 3.3cm 
distal to peak LOS pressure.  In the H. pylori positives, the pH has fallen to 2.07, but there 
is still a significant difference between the two groups (p=0.009).  In the third and final 
postprandial period (60-90 minutes after the meal) the results are similar, with the lowest 
median pH being 1.61 at 3.3cm distal to peak LOS pressure in H. pylori negatives and 2.01 
for H. pylori positives at 4.4cm distal to peak LOS pressure.  These three sensors detecting 
a significant difference in gastric acidity between the two groups were those closest to the 
GOJ with the most proximal of them being only 0.6cm distal to the SCJ.  Figure 5.3 shows 
the median pH values in the first postprandial period (0-30 minutes) for the two groups at 
each sensor below the peak LOS pressure.  It also shows the mean distance of the SCJ and 
distal border of the LOS from the peak LOS pressure.  This illustrates that the first sensor 
showing significant differences between the two groups is the sensor immediately below 
the SCJ, and this is within the distal end of the lower oesophageal sphincter.  The graph 
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also reveals the formation of an acid pocket which has developed in the H. pylori negative 
subjects and is attenuated in the H. pylori positives. 
   
Table 5.3 Median (IQR) pH values at sensors relative to peak LOS pressure comparing H. 
pylori negative (n=28) and positive (n=31) groups during the three 30-minute postprandial 
periods. 
 0-30 minutes  30-60 minutes  60-90 minutes 
Sensor 
location 
HP- HP+ p 
value 
 HP- HP+ p 
value 
 HP- HP+ p 
value 
5cm 
proximal 
7.28 
(0.79) 
7.03 
(0.72) 
0.274  
7.18 
(0.81) 
6.98 
(0.77) 
0.499  
7.13 
(0.85) 
7.04 
(0.67) 
0.861 
1.1cm 
proximal 
7.20 
(0.96) 
7.29 
(0.68) 
0.443  
7.06 
(1.42) 
7.00 
(0.75) 
0.705  
7.13 
(1.77) 
6.96 
(1.27) 
0.786 
Peak 
LOS 
pressure 
6.83 
(0.62) 
6.94 
(0.66) 
0.339  
6.76 
(1.02) 
6.88 
(0.48) 
0.391  
6.56 
(1.27) 
6.77 
(0.58) 
0.245 
1.1cm 
distal 
5.90 
(1.88) 
6.74 
(1.18) 
0.063  
5.25 
(4.19) 
6.40 
(1.72) 
0.053  
6.43 
(4.80) 
6.38 
(2.21) 
0.306 
2.2cm 
distal 
3.17 
(3.07) 
5.55 
(2.84) 
0.005  
1.95 
(1.00) 
3.21 
(4.46) 
0.005  
2.20 
(2.82) 
3.82 
(4.40) 
0.024 
3.3cm 
distal 
2.46 
(2.75) 
4.26 
(2.84) 
0.006  
1.59 
(1.08) 
2.07 
(2.29) 
0.009  
1.61 
(0.82) 
2.30 
(3.08) 
0.010 
4.4cm 
distal 
4.09 
(3.17) 
4.87 
(1.60) 
0.025  
1.81 
(2.09) 
2.93 
(3.25) 
0.032  
1.67 
(0.94) 
2.01 
(2.10) 
0.031 
5.5cm 
distal 
4.62 
(1.21) 
4.79 
(1.36) 
0.309  
2.13 
(2.02) 
3.48 
(2.89) 
0.062  
1.74 
(1.45) 
2.36 
(2.74) 
0.078 
6.6cm 
distal 
4.60 
(1.17) 
4.68 
(0.96) 
0.313  
3.39 
(2.19) 
4.10 
(2.23) 
0.158  
2.08 
(1.58) 
3.87 
(2.35) 
0.184 
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Figure 5.3: Median pH for 0-30 minute period after meal relative to lower oesophageal 
sphincter (LOS) and squamocolumnar junction (SCJ) in H. pylori positive (HP+) and 
negative (HP-) subjects. 
 
The % of time pH<4 for each of the three postprandial periods was significantly greater in 
the H. pylori negatives versus positive subjects for the electrodes extending 4.4cm distal to 
the peak LOS pressure in the first postprandial period (0-30 minutes).  In addition, the % 
time pH<4 was also significantly greater at the sensor immediately at peak LOS pressure 
and extending 1.1cm above the peak LOS pressure, indicating increased intrasphincteric 
reflux in this group.  This was also evident in the second postprandial period, with the H. 
pylori negatives having a median %time pH<4 of 3.7% at the peak LOS pressure and 2.1% 
1.1cm proximally.  In H. pylori positives this was 0.9% at peak LOS pressure and 0.3% 
1.1cm proximal.  In the third postprandial period the differences between the two groups at 
the intrasphincteric sensors did not reach statistical significance.  There was little evidence 
of trans-sphincteric acid reflux at the sensor placed 5cm proximal in either group at any 
stage (Table 5.4). 
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5.4.2.3 CagA 
Seventeen of the H. pylori positives were CagA seropositive and fourteen CagA 
seronegative.  In the fasting period, there were significant differences between H. pylori 
negatives and CagA seronegative H. pylori positives at the sensors 4.4, 5.5 and 6.6cm 
distal to peak LOS pressure.  For CagA seropositives there were significant differences at 
sensors 2.2, 3.3, 4.4, 5.5 and 6.6cm distal to peak LOS pressure.  Between CagA 
seronegatives and seropositives, there were significant differences at two sensors, at 2.2cm 
and 6.6cm distal to peak LOS pressure.   
 
Table 5.4: Median (IQR) percentage time pH<4 at sensors relative to peak LOS pressure 
comparing H. pylori negative (n=28) and positive (n=31) groups during the three 30-minute 
postprandial periods. 
 0-30 minutes  30-60 minutes  60-90 minutes 
Sensor 
location 
HP- HP+ 
p 
value 
 HP- HP+ 
p 
value 
 HP- HP+ 
p 
value 
5cm 
proximal 
0.2 
(0.4) 
0.0 
(0.7) 
0.384  
0.0 
(0.7) 
0.0 
(0.5) 
0.354  
0.0 
(1.2) 
0.0 
(0.5) 
0.280 
1.1cm 
proximal 
3.0 
(2.8) 
0.0 
(1.3) 
0.005  
2.1 
(14.3) 
0.3 
(2.8) 
0.046  
2.0 
(6.4) 
0.6 
(0.7) 
0.088 
Peak LOS 
pressure 
4.2 
(6.5) 
0.6 
(2.0) 
<0.001  
3.7 
(15.3) 
0.9 
(4.4) 
0.017  
2.7 
(8.7) 
1.2 
(7.4) 
0.162 
1.1cm 
distal 
15.4 
(30.8) 
1.8 
(19.3) 
0.003  
33.9 
(67.0) 
5.2 
(33.0) 
0.021  
7.6 
(77.1) 
10.1 
(25.5) 
0.264 
2.2cm 
distal 
62.9 
(49.7) 
22.6 
(51.8) 
0.001  
90.8 
(28.7) 
63.2 
(81.1) 
0.002  
81.1 
(51.7) 
55.1 
(84.7) 
0.026 
3.3cm 
distal 
64.9 
(45.7) 
46.4 
(66.1) 
0.004  
99.7 
(9.3) 
91.5 
(49.0) 
0.017  
99.2 
(3.2) 
91.0 
(59.1) 
0.009 
4.4cm 
distal 
44.2 
(69.2) 
15.1 
(53.0) 
0.032  
99.0 
(18.7) 
88.9 
(77.9) 
0.111  
100.0 
(3.0) 
99.4 
(20.7) 
0.043 
5.5cm 
distal 
24.3 
(47.4) 
12.9 
(48.5) 
0.375  
96.2 
(37.3) 
86.1 
(88.2) 
0.083  
100.0 
(1.2) 
99.8 
(80.1) 
0.105 
6.6cm 
distal 
13.7 
(46.4) 
9.9 
(21.7) 
0.355  
82.8 
(72.6) 
38.5 
(99.3) 
0.104  
99.8 
(9.0) 
96.8 
(61.0) 
0.099 
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In the first postprandial period (0-30 minutes after meal) there were significant differences 
between CagA seropositives and H. pylori negatives at the sensors 1.1 to 4.4 cm distal to 
peak LOS pressure.  Similarly, in the second postprandial period (30-60 minutes), CagA 
seropositives were significantly different to H. pylori negatives at sensors 2.2 to 5.5cm 
distal to peak LOS pressure.  At the sensor 3.3cm distal to peak LOS pressure there was a 
significant difference in median pH between CagA seronegatives and seropositives.  In the 
final postprandial period (60-90 minutes) significant differences existed between H. pylori 
negatives and CagA seropositives at sensors 2.2 to 5.5cm distal to peak LOS pressure.   
There were no significant differences between CagA seropositives and negatives, or CagA 
seronegatives and H. pylori negatives. (Table 5.5) 
 
5.4.3 Conventional H&E Staining 
5.4.3.1 Inflammation 
The H. pylori positives had a greater combined inflammatory cell infiltrate at each of the 11 
biopsy sites compared to the H. pylori negatives (Table 5.6).  The increased combined 
inflammatory cell infiltrate in the H. pylori positives consisted of a mixture of PMN cells 
and MN cells and tended to be more intense close to the SCJ, lesser curve, distal stomach, 
incisura and antrum compared to the gastric fundus and mid-body (p<0.05 for each).  The 
H. pylori negatives had a MN cell infiltrate limited to the SCJ and to a lesser extent at the 
antrum and angularis incisura, but its intensity was less than that of the H. pylori positives 
at these sites. (Table 5.7) There was minimal evidence of PMN cell infiltrate at any location 
in the H. pylori negatives. (Table 5.8) 
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Table 5.5: Median (IQR) pH in H. pylori negatives (n=28), H. pylori positive CagA negatives (n=14) and H. pylori positive CagA 
positives (n=17) during 20-minute fasting and three 30-minute postprandial periods.   Note: *Indicates statistically different from H. 
pylori negatives. ‡Indicates statistically different from H. pylori positive CagA negatives (p<0.05). 
 Fasting  0-30 minutes  30-60 minutes  60-90 minutes 
Sensor location HP- HP+ 
CagA- 
HP+ 
CagA+ 
 HP- HP+ 
CagA- 
HP+ 
CagA+ 
 HP- HP+ 
CagA- 
HP+ 
CagA+ 
 HP- HP+ 
CagA- 
HP+ 
CagA+ 
5cm proximal 7.20 
(0.70) 
7.22 
(0.68) 
7.06 
(0.64) 
 7.28 
(0.79) 
7.11 
(0.80) 
6.97 
(0.64) 
 7.18 
(0.81) 
7.01 
(0.83) 
6.93 
(0.61) 
 7.13 
(0.85) 
7.09 
(0.90) 
7.00 
(0.85) 
1.1cm proximal 7.33 
(0.78) 
7.65 
(0.75) 
7.32 
(0.53) 
 7.20 
(0.96) 
7.55 
(0.67) 
7.20 
(0.59) 
 7.06 
(1.42) 
6.97 
(1.46) 
7.00 
(0.60) 
 7.13 
(1.77) 
6.96 
(0.79) 
6.95 
(0.83) 
Peak LOS pressure 7.34 
(0.79) 
7.52 
(0.51) 
7.18 
(0.31) 
 6.83 
(0.62) 
7.02 
(0.77) 
6.89 
(0.63) 
 6.76 
(1.02) 
6.93 
(1.02) 
6.80 
(0.39) 
 6.56 
(1.27) 
6.79 
(0.70) 
6.77 
(0.56) 
1.1cm distal 7.06 
(1.63) 
7.13 
(1.65) 
7.13 
(0.40) 
 5.90 
(1.88) 
6.66 
(4.46) 
6.74* 
(1.10) 
 5.25 
(4.19) 
6.36 
(2.52) 
6.55 
(1.79) 
 6.43 
(4.80) 
5.96 
(2.60) 
6.48 
(1.21) 
2.2cm distal 5.79 
(4.26) 
6.19 
(4.53) 
7.13*‡ 
(0.70) 
 3.17 
(3.07) 
4.38 
(3.76) 
6.25* 
(1.84) 
 1.95 
(1.00) 
2.19 
(3.02) 
5.72* 
(4.69) 
 2.20 
(2.82) 
3.37 
(4.28) 
5.86* 
(4.65) 
3.3cm distal 2.27 
(2.58) 
3.16 
(4.94) 
6.76* 
(3.22) 
 2.46 
(2.75) 
3.58 
(2.67) 
5.16* 
(1.92) 
 1.59 
(1.08) 
1.86 
(1.85) 
2.61*‡ 
(3.73) 
 1.61 
(0.82) 
2.08 
(1.32) 
2.86* 
(4.06) 
4.4cm distal 1.70 
(1.16) 
3.60* 
(4.99) 
4.11* 
(4.09) 
 4.09 
(3.17) 
4.48 
(1.51) 
5.28* 
(1.78) 
 1.81 
(2.01) 
2.54 
(1.70) 
3.85* 
(3.67) 
 1.67 
(0.94) 
1.89 
(1.75) 
2.19* 
(3.39) 
5.5cm distal 1.68 
(0.66) 
2.18* 
(2.26) 
4.17* 
(4.17) 
 4.62 
(1.21) 
4.70 
(1.31) 
4.97 
(1.61) 
 2.13 
(2.02) 
2.99 
(2.64) 
4.36* 
(3.16) 
 1.74 
(1.45) 
1.84 
(1.94) 
2.56* 
(2.78) 
6.6cm distal 1.62 
(3.66) 
1.80 
(1.46) 
4.11*‡ 
(4.72) 
 4.60 
(1.17) 
4.66 
(0.77) 
4.68 
(1.13) 
 3.39 
(2.19) 
3.76 
(2.10) 
4.35 
(2.23) 
 2.08 
(1.58) 
2.15 
(2.09) 
3.18 
(3.56) 
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Table 5.6: Cross-tabulation table showing the number of subjects within the H. pylori 
negative (HP-) and positive (HP+) groups with each combined inflammatory score (0-6) 
at the 11 different gastric biopsy locations. 
Combined 
Inflammat
ory score 
Across 
SCJ 
(greater 
curve) 
 Across 
SCJ 
(lesser 
curve) 
  
6mm 
distal 
SCJ 
  
12mm 
distal 
SCJ 
  
18mm 
distal 
SCJ 
  
HP
- 
HP
+  
 HP
-  
HP
+  
 HP
- 
HP
+  
 HP
- 
HP
+  
 HP
-  
HP
+ 
   
0 8 0  1 0  15 0  25 0  26 0    
1 10 0  16 0  8 1  2 1  1 4    
2 9 0  6 0  1 3  0 6  0 7    
3 1 7  0 7  0 10  0 8  1 9    
4 0 11  0 11  0 11  0 11  0 5    
5 0 11  0 9  0 5  0 4  0 4    
6 0 1  0 0  0 0  0 0  0 1    
Fisher’s 
Exact test 
p<0.001  p<0.001  p<0.001  p<0.001  p<0.001   
            
Combined 
Inflammat
ory score 
 
Fundus 
 Mid-
body, 
 lesser 
curve 
 Mid-
body, 
 greater 
curve 
 Distal 
body, 
greater 
curve 
  
Incisura 
angulari
s 
  
Antrum 
HP
- 
HP
+  
 HP
- 
HP
+  
 HP
- 
HP
+  
 HP
- 
HP
+  
 HP
- 
HP
+  
 HP- H
P
+  
0 25 0  25 0  27 0  24 0  17 0  14 0 
1 1 5  2 0  0 2  2 0  9 0  9 0 
2 0 6  0 6  0 8  0 7  1 0  0 0 
3 1 12  0 11  0 8  0 5  0 6  1 1 
4 0 5  0 6  1 5  1 7  0 3  0 6 
5 0 1  0 4  0 4  1 8  0 13  0 1
1 
6 0 2  0 4  0 4  0 4  0 9  0 8 
Fisher’s 
Exact test 
p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001 
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Table 5.7: Cross-tabulation table showing the number of subjects within the H. pylori 
negative (HP-) and positive (HP+) groups with each chronic inflammatory score (0-3) at 
the 11 different gastric biopsy locations. 
 
 
MN 
score 
Across 
SCJ 
(above 
greater 
curve) 
 Across 
SCJ 
(above 
lesser 
curve) 
  
6mm 
distal SCJ 
  
12mm 
distal SCJ 
  
18mm 
distal SCJ 
  
HP- HP+   HP-  HP+   HP- HP+   HP- HP+   HP-  HP+    
0 4 0  1 0  15 0  25 0  26 0    
1 10 0  16 0  8 3  2 7  1 9    
2 10 15  6 15  1 19  0 17  1 15    
3 0 15  0 12  0 7  0 6  0 6    
Fisher’s 
Exact 
test 
p<0.001  p<0.001  p<0.001  p<0.001  p<0.001   
            
 
 
MN 
score 
 
Fundus 
 Mid-body 
lesser 
curve 
 Mid-body 
greater 
curve 
 Distal 
body 
greater 
curve 
  
Incisura 
angularis 
  
Antrum 
HP- HP+   HP- HP+   HP- HP+   HP- HP+   HP- HP+   HP- HP+  
0 25 0  25 0  27 0  24 0  17 0  14 0 
1 1 11  2 6  0 10  2 7  9 0  9 0 
2 1 17  0 17  1 13  1 11  1 9  1 6 
3 0 3  0 8  0 8  1 13  0 22  0 20 
Fisher’s 
Exact 
test 
p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001 
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Table 5.8: Cross-tabulation table showing the number of subjects within the H. pylori 
negative (HP-) and positive (HP+) groups with each acute inflammatory score (0-6) at 
the 11 different gastric biopsy locations. 
 
 
PMN 
score 
Across 
SCJ 
(above 
greater 
curve) 
 Across 
SCJ 
(above 
lesser 
curve) 
  
6mm 
distal SCJ 
  
12mm 
distal SCJ 
  
18mm 
distal SCJ 
  
HP- HP+   HP-  HP+   HP- HP+   HP- HP+   HP-  HP+    
0 16 0  23 0  23 0  27 1  27 6    
1 1 9  0 11  0 14  0 16  1 15    
2 0 20  0 15  0 15  0 13  0 8    
3 0 1  0 1  0 0  0 0  0 1    
Fisher’s 
Exact 
test 
p<0.001  p<0.001  p<0.001  p<0.001  p<0.001   
            
 
 
PMN 
score 
 
Fundus 
 Mid-body 
lesser 
curve 
 Mid-body 
greater 
curve 
 Distal 
body 
greater 
curve 
  
Incisura 
angularis 
  
Antrum 
HP- HP+   HP- HP+   HP- HP+   HP- HP+   HP- HP+   HP- HP+  
0 26 5  27 0  27 2  26 0  27 0  23 0 
1 1 18  0 17  0 16  0 13  0 6  1 2 
2 0 6  0 10  1 9  2 14  0 16  0 16 
3 0 2  0 4  0 4  0 4  0 9  0 8 
Fisher’s 
Exact 
test 
p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001 
 
 
5.4.3.2 Intestinal Metaplasia 
Intestinal metaplasia was identified in 14 of the 31 H. pylori positive subjects.  In 7 of these 
it was limited to one or more of the biopsies from mid-body lesser curve, distal body greater 
curve, incisura angularis and antrum.  In 3 of the subjects it was present in at least one of the 
above sites and in the biopsies close to the SCJ.  In a further 3 it was limited to the region 
close to the SCJ.  In 1 subject it was present in each biopsy except for one of the biopsies 
from the SCJ.  
Intestinal metaplasia was identified in only four of the 28 H. pylori negative subjects.  In 
three of these it was only seen in the biopsies across the SCJ and in the fourth subject it was 
only seen in the biopsy from the fundus. 
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5.4.3.3 Gastric Gland Thickness 
The thickness of the gastric secretory glands was significantly reduced in the H. pylori 
positive versus negative subjects throughout the gastric mucosa except for the biopsies taken 
across the SCJ.  Median glandular thickness was greatest in H. pylori negatives from biopsies 
at the mid-body of the greater curve and from 18mm distal to SCJ, which was more proximal 
along the greater curvature.  The degree of reduction in median glandular thickness was 
similar throughout the oxyntic gastric mucosa (Table 5.9). 
 
 
 
 
 
 
 
 
 
Table 5.9: Median glandular thickness in millimetres (IQR) at each biopsy location comparing H. 
pylori negatives (n=28) and positives (n=31). 
Biopsy location H. pylori negatives H. pylori positives P value 
Across SCJ, Greater curve 
0.30 
(0.20–0.30) 
0.25 
(0.20–0.30) 
0.515 
Across SCJ, Lesser curve 
0.28 
(0.0–0.30) 
0.20 
(0.10–0.30) 
0.461 
6mm distal SCJ 
0.35 
(0.30–0.40) 
0.30 
(0.20–0.30) 
0.006 
12mm distal SCJ 
0.40 
(0.40–0.45) 
0.30 
(0.30–0.35) 
<0.001 
18mm distal SCJ 
0.45 
(0.40–0.50) 
0.35 
(0.30–0.40) 
<0.001 
Fundus 
0.43 
(0.40–0.45) 
0.40 
(0.35–0.40) 
0.008 
Mid-body, Lesser curve 
0.40 
(0.40–0.45) 
0.35 
(0.30–0.40) 
<0.001 
Mid-body, Greater curve 
0.45 
(0.40–0.45) 
0.35 
(0.30–0.40) 
<0.001 
Distal body, Greater curve 
0.40 
(0.35–0.49) 
0.30 
(0.25–0.35) 
<0.001 
Incisura Angularis 
0.33 
(0.30–0.40) 
0.25 
(0.20–0.30) 
<0.001 
Antrum 
0.20 
(0.13–0.30) 
0.20 
(0.0–0.20) 
0.041 
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5.4.4 Immunohistochemistry   
5.4.4.1 Parietal and Chief Cell Density 
The median parietal and chief cell density in H. pylori negatives was greater in biopsies 
taken from the gastric body (i.e. fundus, mid-body lesser cure and greater curve) compared 
to biopsies taken from the gastro-oesophageal junction (i.e. across SCJ and distal to SCJ).  
The H. pylori positives had a significant reduction in density of both parietal and chief cells 
compared to H. pylori negatives, and this was seen at each of the 11 intragastric locations 
assessed except for the SCJ greater curve where the difference did not achieve statistical 
significance (Table 5.10).  The degree of reduction was similar for the two cell types.  
Representative biopsies stained for parietal cells from an H. pylori negative and positive 
subject are shown in figure 5.4. 
  
 
  
 
 
 
 
Table 5.10: Median densities (IQR) of parietal and chief cells at each biopsy location 
comparing H. pylori negatives (n=28) and positives (n=31). 
 Parietal cell density 
(cells/mm2) 
 Chief cell density (cells/mm2) 
Biopsy location H.pylori - H.pylori + P value  H.pylori - H.pylori + P value 
Across SCJ, Greater curve 
67 
(0-162) 
17 
(10-39) 
0.185  
94 
(0-156) 
22 
(3-52) 
0.150 
Across SCJ, Lesser curve 
50 
(14-127) 
9 
(0-51) 
0.012  
89 
(17-139) 
22 
(0-62) 
0.017 
6mm distal SCJ 
231 
(175-286) 
144 
(59-190) 
<0.001  
245 
(203-272) 
129 
(52-190) 
<0.001 
12mm distal SCJ 
317 
(300-362) 
193 
(137-250) 
<0.001  
379 
(312-404) 
206 
(125-299) 
<0.001 
18mm distal SCJ 
357 
(334-383) 
241 
(201-283) 
<0.001  
404 
(374-421) 
273 
(194-353) 
<0.001 
Fundus 
347 
(285-401) 
258 
(220-292) 
<0.001  
421 
(384-451) 
310 
(255-389) 
<0.001 
Mid-body, Lesser curve 
361 
(316-381) 
235 
(166-290) 
<0.001  
401 
(367-419) 
285 
(206-367) 
<0.001 
Mid-body, Greater curve 
356 
(318-398) 
250 
(201-297) 
<0.001  
420 
(372-441) 
305 
(243-354) 
<0.001 
Distal body, Greater curve 
322 
(293-349) 
107 
(25-263) 
<0.001  
365 
(296-398) 
136 
(17-292) 
<0.001 
Incisura Angularis 
203 
(124-250) 
12 
(0-87) 
<0.001  
215 
(98-296) 
7 
(0-99) 
<0.001 
Antrum 
40 
(6-67) 
7 
(0-18) 
0.002  
22 
(1-85) 
0 
(0-5) 
<0.001 
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Figure 5.4 Biopsies from gastric body stained with monoclonal antibody to H
+
/K
+
ATPase  
   
 
 
 
 
 
The depletion of both cells in the H. pylori positives versus negatives was more marked in 
the biopsies taken from the distal gastric mucosa (i.e. antrum, incisura angularis, and distal 
body greater curve) being reduced by 67-100% compared to that observed in the more 
central region of the oxyntic mucosa (fundus and mid-body) at 26-35% (Fig. 5.5).   
In addition, the length of mucosa extending distal to the SCJ which contained no detectable 
parietal cells was greater in the H. pylori positives versus negatives (1.5mm vs 1.0mm; 
p=0.013). However, the degree of reduction in specialised cell density in the biopsies taken 
6mm and 12mm distal to the SCJ (38-47%) was not dissimilar from that observed in the 
more central oxyntic mucosa (i.e. fundus and mid-body) (26-35%) (Fig. 5.5).   
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Fig 5.5: Relative reduction in parietal and chief cell densities at different gastric locations in H. 
pylori infected versus non-infected 
 
     Note: At the GE junction and distal stomach these cells are reduced by 80% whereas in the 
mid-body reduction was about 30%.  Biopsy locations:  JG: across SCJ above greater curve; JL1:  
across SCJ above lesser curve; JL2:  6mm distal SCJ; JL3:  12mm distal SCJ; JL4:  18mm distal SCJ; 
BG3:  Fundus; BL:  mid-body lesser curve; BG2:  mid-body greater curve; BG1:  distal body greater 
curve; IA:  incisura angularis; Ant:  antrum.   
 
5.4.4.2 G Cell Density 
The density of G cells was reduced in the antrum of the H. pylori positive versus negative 
subjects [48 (IQR: 31-86) vs. 91 (64-129), p<0.001], but the converse was seen with 
respect to the biopsies taken from the distal body region [0 (IQR: 0-32) vs 0 (0-0), 
p=0.007]. 
 
5.4.4.3 CagA 
Seventeen of the H. pylori positives were CagA seropositive and fourteen CagA 
seronegative.   The CagA seropositives had a greater combined inflammatory cell infiltrate 
at 3 of the 11 biopsy sites compared to CagA seronegatives. These sites were 6mm distal to 
SCJ, 18mm distal to SCJ and distal body on greater curvature.  At the other 8 sites there was 
no statistical difference found between CagA seropositives and seronegatives. (Table 5.11) 
CagA seropositives had a significantly reduced parietal cell density compared to CagA 
seronegatives at only one of the biopsy sites and this was across the SCJ (above greater 
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curve).  Similarly, only one biopsy site showed reduced chief cell density in the CagA 
seropositive site compared to the seronegatives, this time 18mm distal to SCJ. (Table 5.12)  
 
Table 5.11: Cross-tabulation table comparing the number of H. pylori positive CagA 
negative (HP+ CagA-) and H. pylori positive CagA positive (HP+ CagA+) subjects with 
each combined inflammatory score (0-6) at all gastric biopsy locations. 
 
Combi
ned 
Inflam
matory 
score 
Across 
SCJ 
(above 
greater 
curve) 
 Across 
SCJ 
(above 
lesser 
curve) 
  
6mm 
distal 
SCJ 
  
12mm 
distal 
SCJ 
  
18mm 
distal 
SCJ 
  
HP
+ 
Ca
gA- 
HP
+ 
Ca
gA
+ 
 HP
+ 
Ca
gA- 
HP
+ 
Ca
gA
+ 
 HP
+ 
Ca
gA- 
HP
+ 
Ca
gA
+ 
 HP
+ 
Ca
gA- 
HP
+ 
Ca
gA
+ 
 HP
+ 
Ca
gA- 
HP
+ 
Ca
gA
+ 
   
0 0 0  0 0  0 0  0 0  0 0    
1 0 0  0 0  1 0  0 1  2 2    
2 0 0  0 0  3 0  5 1  5 2    
3 3 4  2 5  1 9  4 4  5 4    
4 5 6  5 6  6 5  4 7  0 5    
5 5 6  4 5  2 3  0 4  0 4    
6 0 1  0 0  0 0  0 0  1 0    
Fisher’
s Exact 
test 
p=1.000  p=0.449  p=0.009  p=0.084  p=0.034   
 
 
Combi
ned 
Inflam
matory 
score 
           
 
Fundus 
 Mid-body 
lesser 
curve 
 Mid-body 
greater 
curve 
 Distal 
body 
greater 
curve 
 Incisura 
angularis 
  
Antrum 
HP
+ 
Ca
gA- 
HP
+ 
Ca
gA
+ 
 HP
+ 
Ca
gA- 
HP
+ 
Ca
gA
+ 
 HP
+ 
Ca
gA- 
HP
+ 
Ca
gA
+ 
 HP
+ 
Ca
gA- 
HP
+ 
Ca
gA
+ 
 HP
+ 
Ca
gA- 
HP
+ 
Ca
gA
+ 
 HP+ 
CagA
- 
H
P
+ 
C
a
g
A
+ 
0 0 0  0 0  0 0  0 0  0 0  0 0 
1 2 3  0 0  1 1  0 0  0 0  0 0 
2 3 3  4 2  5 3  7 0  0 0  0 0 
3 7 5  6 5  1 7  1 4  2 4  1 0 
4 1 4  2 4  4 1  3 4  3 0  4 2 
5 0 1  1 3  2 2  2 6  7 6  6 5 
6 1 1  1 3  1 3  1 3  2 7  2 6 
Fisher’
s Exact 
test 
p=0.803  p=0.579  p=0.158  p=0.012  p=0.120  p=0.343 
 
 
 
75 
 
 
 
Table 5.12: Median densities (IQR) of parietal and chief cells at each biopsy location 
comparing H. pylori negatives (n=28), H. pylori positive CagA negatives (n=14) and H. 
pylori positive CagA positives (n=17)  
Note: *Indicates statistically different from H. pylori negatives. ‡Indicates statistically 
different from H. pylori positive CagA negatives (p<0.05). 
 Parietal cell density  Chief cell density 
Biopsy location HP- HP+ 
CagA- 
HP+ 
CagA+ 
 HP- HP+ 
CagA- 
HP+ 
CagA+ 
Across SCJ (above 
greater curve) 
67 
(162) 
30 (59)  12 (19)‡  94 
(156)  
39 (109)  17 (35)  
Across SCJ (above 
lesser curve) 
50 
(113)  
8 (50)* 9 (56)*   89 
(122)  
5 (45)* 26 (66)* 
6mm distal SCJ 231 
(111)  
146 
(142)* 
141 
(129)* 
 245 
(69)  
104 
(155)*  
139 
(152)* 
12mm distal SCJ 317 
(62)  
193 
(135)*  
188 
(124)* 
 379 
(92)  
201 
(190)*  
211 
(170)* 
18mm distal SCJ 357 
(49)  
253 (65)*  233 
(127)* 
 404 
(47)  
310 
(107)*  
253 
(163)*‡ 
Fundus 347 
(116)  
226 (88)*  263 
(63)* 
 421 
(67)  
327 
(140)*  
397 
(124)* 
Mid-body lesser 
curve 
361 
(65)  
223 
(123)*  
247 
(150)* 
 401 
(52) 
354 
(204)*  
245 
(190)* 
Mid-body greater 
curve 
356 
(80)  
255 
(116)*  
250 
(89)* 
 420 
(69) 
333 
(164)*  
287 
(118)* 
Distal body greater 
curve 
322 
(56) 
165 
(255)*  
84 
(190)* 
 366 
(102)  
266 
(336)*  
59 (221)* 
Incisura angularis 203 
(126)  
39 (155)*  10 (34)*  215 
(198)  
68 (172)*  0 (28)* 
Antrum 40 (61)  12 (24)*  5 (17)*  22 (84) 0 (7)*  0 (0)* 
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5.5 Discussion 
In our volunteers recruited from the general population of the West of Scotland, those with 
H. pylori infection had less intragastric acidity both under fasting conditions and following 
a meal compared to uninfected volunteers matched for age, gender and BMI.  In addition, 
those with the infection had a reduced density of both acid secreting parietal cells and pepsin 
producing chief cells compared to those uninfected.  These findings indicate that H. pylori 
infection within our Western population is associated with a less acidic and proteolytic 
intragastric environment. 
The reduced intragastric acidity in the H. pylori positive subjects was apparent throughout 
the stomach under fasting conditions.  After the meal, however, the reduced acidity in the H. 
pylori positives was evident within the first few centimetres distal to the GEJ but no 
significant difference in acidity was apparent in the main body of the stomach.  There was 
also evidence of increased acidity after the meal in the H. pylori negatives right at the SCJ 
junction and extending 2cm above it indicating increased intrasphincteric acid reflux.  We 
and others have previously reported that the proximal region of the stomach close to the GEJ 
largely escapes the buffering effect of ingested food and may remain highly acidic after a 
meal.(13, 166)  This phenomenon has been called the acid pocket and is thought to be 
important in GORD induced oesophageal damage after a meal when reflux is most common.  
It is therefore interesting that it is at this region close to the GEJ where the reduced acidity 
was most apparent in the H. pylori infected subjects. 
What is the reason for the reduced acidity in the H. pylori positives after a meal, being most 
marked close to the GEJ?  There was no evidence that the depletion in parietal cell density 
in the H. pylori positives was more pronounced over the few centimetres close to the GEJ 
compared to other regions in the stomach.  Inflammation may also inhibit gastric secretory 
function(158) and this was slightly increased close to the GEJ and in the distal stomach 
compared to the mid-body gastric mucosa.   The elevation of intragastric pH following the 
meal in the H. pylori positives being most marked close to the GEJ may simply reflect the 
relative intragastric distribution of gastric juice and ingested food.  Following a meal, the 
food occupies the centre of the stomach and the secreted gastric juice, the region close to the 
stomach wall which secretes it.  Impaired acid secretion will elevate the pH of the gastric 
juice and this will be most apparent close to the stomach wall.  In contrast, the central region 
of the stomach will reflect the pH of the food and thus will be relatively unaffected by 
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changes in the acidity of secreted juice.  The effect of H. pylori on intragastric pH after the 
meal being most evident close to the GEJ may be due to this region being close to the wall 
of the stomach.  
Whatever the explanation for the changes in acidity between H. pylori positives and 
negatives being most marked close to the GEJ, after the meal, the observation is likely to be 
important with respect to the propensity of gastro-oesophageal reflux producing oesophageal 
damage.  It is well recognised that gastric juice which refluxes into the oesophagus is that 
present close to the GEJ and also that reflux most commonly occurs during the postprandial 
period when TLOSRs are most frequent.(167) 
The reduction in parietal cell density observed in the H. pylori positive subjects was 
associated with a similar reduction in chief cell density.  This is consistent with the infection 
and inflammation causing a loss in gastric glands and also with the previous literature 
showing that the development of parietal and chief cells is intimately linked.(168)  We did 
not measure the secretion of pepsin and other digestive enzymes produced by the chief cells 
but their reduced density is likely to be associated with reduced secretory capacity after the 
meal.  Reduction in gastric juice peptic activity has previously been reported in H.pylori 
infected subjects.(169)  The peptic activity of the gastric juice is as important, and arguably 
more important than its acidity, with respect to the ability to damage oesophageal mucosa 
and therefore the reduction in both specialised cells is likely to represent a substantial 
reduction in the damaging capacity of reflux gastric juice in H.pylori infected subjects.(170)  
There was a reduction in the density of G cells in the antrum of the H. pylori positives 
indicating a depletion of antral as well as oxyntic glands.  In contrast, G cell density in the 
distal body mucosa of the H. pylori positives was higher than in the H. pylori negative 
subjects.  This can be explained by the distal acid secreting body mucosa, which does not 
have G cells, being replaced by an antral-like mucosa that contains G cells (a process that 
has been called “antralization”).  This process can be associated with the development of 
pseudo-pyloric metaplasia, also called spasmolytic polypeptide expressing metaplasia 
(SPEM).(171, 172)  This is consistent with our observation that the reduction in parietal and 
chief cell densities in H. pylori positives was most pronounced in the distal body mucosa.  
Together these findings are likely to represent the previously reported proximal progression 
of the junction between the antrum and body type mucosa leading to shrinkage in the surface 
area of the stomach covered by oxyntic mucosa in H. pylori atrophic gastritis.(173)     
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There are few previous studies assessing gastric secretory function in H. pylori infected 
healthy volunteers in the Western world.  In a retrospective analysis of 95 healthy, young 
male volunteers (age 19-26 years) Smith et al reported that the 8 seropositive for H.pylori 
had similar intragastric acidity to the other 87.(82)   In a retrospective analysis of 136 healthy 
volunteers, Peterson et al reported reduced basal acid output but no significant difference in 
gastrin stimulated peak acid output or meal stimulated acid output assessed by intragastric 
titration in H.pylori seropositives.(79)  In a prospective study of 206 healthy volunteers, 
Feldman et al in 1996 reported reduced gastrin stimulated peak acid output and reduced 
basal pepsin output in those with H.pylori detected histologically in gastric biopsies.(88)   In 
1998, our own group reported a reduced acid secretory response to gastrin stimulation in 20 
H.pylori positive versus 24 H.pylori negative healthy volunteers.(83)   Several studies in the 
Japanese population have reported reduced gastric secretory function in H.pylori positive 
healthy volunteers.(80, 174)  
Our current study differs from previously published studies in several important respects.  
Firstly, we aimed to study subjects representative of the general population infected with H. 
pylori rather than asymptomatic healthy volunteers.  Secondly, by using intragastric pH 
sensors, we avoided the use of non-physiological gastric stimuli, gastric aspiration or 
intragastric titration which may not be representative of the subjects usual gastric 
functioning.   Thirdly, we focused on the middle-aged population rather than young students 
as the former is the population in whom reflux disease manifests itself.  Finally, and probably 
most critically, we employed a technique which allowed us to assess the acidity in different 
regions of the stomach and in particular close to the GEJ.  
Our observation that gastric acidity was reduced most markedly close to the GEJ is 
interesting in the light of the previously reported but unexplained observations by Feldman 
et al in 1999.  They observed that in healthy volunteers, eradication of H.pylori did not alter 
basal or meal-stimulated gastric acid secretion assessed by intragastric titration but did result 
in a 2-3 fold increase in gastro-oesophageal acid reflux.(84)   In the light of our current study, 
the observed increase in gastro-oesophageal acid reflux may have been explained by the 
H.pylori infection reducing intragastric acidity close to the GEJ.  
Is our finding of reduced gastric secretory function in the H. pylori infected population a 
peculiar feature of our West of Scotland population or relevant to the wider Western 
community?  H.pylori induced atrophic gastritis and reduced acid secretory function is 
associated with gastric cancer and the prevalence of the two correlates at a population 
level.(175)  The incidence of gastric cancer in Scotland is 9.7 /100,00py and similar to that 
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of Western European and North American countries and substantially lower than that of 
Eastern European and Far Eastern countries.(176)  This would suggest that our findings of 
reduced acid secretory function is representative of what is happening in Western countries.  
Though our study demonstrates that the H. pylori infected general adult population has less 
intragastric acidity than the uninfected population, this association does not necessarily 
indicate that the reduced intragastric acidity is caused by the infection.  However, causal 
association seems highly likely as H. pylori gastritis is recognised to cause loss of gastric 
glands and impaired secretory function.  In addition, the more marked changes in gastric 
secretory function in those with the more virulent CagA strain supports it being caused by 
the infection.  Confirming causality by an intervention study has potential problems as H. 
pylori-induced loss of gastric glands is generally regarded as being irreversible. 
In summary, our current study indicates that H. pylori infected population volunteers have 
reduced intragastric acidity compared to uninfected controls and that this is most marked 
close to the GEJ.  This observation may explain the negative association between the 
infection and GEJ disease and its complications.      
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CHAPTER 6 
 
Study of the effect of increasing  
intra-abdominal pressure by 
waist compression on  
gastro-oesophageal reflux 
disease 
 
 
 
 
6.1 Introduction and Aims 
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Central obesity is strongly associated with gastro-oesophageal reflux and its complications 
of Barrett’s oesophagus and oesophageal adenocarcinoma.(106, 177)  The nature of this 
association is incompletely understood and both mechanical and humoral effects of central 
obesity may be important.   
Both BMI and waist circumference (WC) show a strong positive correlation with intra-
gastric pressure (IGP) and the gastro-oesophageal pressure gradient (GOPG).(10, 178)  
Abdominal compression by a waist belt also increases these pressures and thus reproduces 
the manometric characteristics associated with central obesity.(7, 179)  Previous 
investigators have examined the effect of waist belt compression on the manometric 
characteristics of the lower oesophageal sphincter (LOS) in both healthy volunteers and 
patients with reflux disease.  The rise in IGP caused by the waist belt is accompanied by a 
rise in LOS pressure though sometimes of a lesser magnitude.(180, 181)  Waist belt 
compression in short term studies does not result in the development of, or aggravation of, 
hiatus hernia or an increased separation of the intrinsic and extrinsic components of the 
LOS.(23, 182)  
Surprisingly, there is a paucity of information on the effects of waist belt compression on 
gastro-oesophageal acid reflux itself despite this being the main mediator of oesophageal 
damage.  Lee et al recently examined the effect of waist belt compression on gastro-
oesophageal pH in healthy volunteers without reflux disease.(183)  The belt caused the 
location of the pH transition point where the pH changes from gastric to oesophageal pH to 
migrate 2cm more proximally within the LOS and this was most apparent after a meal. The 
belt did not cause the pH transition point to extend above the squamocolumnar junction 
(SCJ) onto oesophageal mucosa. There was an increase in short segment reflux detected 
1.3cm above the SCJ but none detected at any of the 7 pH sensors spaced at 1 cm 
increments proximal to this.  In these subjects with a normal LOS there was, therefore, 
little evidence that the waist belt significantly increased oesophageal acid exposure.   
The aim of this study is to investigate the effects of waist belt compression in patients 
known to have reflux disease.   
 
 
 
6.2 METHODS & MATERIALS 
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6.2.1 Subjects 
Study subjects were patients with typical symptoms of gastro-oesophageal reflux disease 
(GORD) and at least Los Angeles (LA) Grade B reflux oesophagitis or Barrett’s 
oesophagus on upper GI endoscopy.  Proton pump inhibitors (PPIs) were stopped at least 7 
days prior to the study and H2 receptor antagonists were stopped for at least 24 hours.   
 
6.2.2 Study design 
6.2.2.1 Study Day 1: Clinical measurements  
The severity of upper gastrointestinal symptoms was assessed using the Short-Form Leeds 
Dyspepsia Questionnaire.(164)  Medication history was recorded.  Measurements of 
height, weight, waist and hip circumference were taken. 
 
 6.2.2.2 Study day 2: Upper gastrointestinal endoscopy 
Volunteers attended after an overnight fast for upper gastrointestinal endoscopy.   They 
were offered topical lidocaine throat spray or conscious sedation with midazolam 1-3mg.  
The upper gastrointestinal tract was inspected.  The distance from incisors to SCJ was 
measured.  If a hiatus hernia was present, the distance to the diaphragmatic impression was 
also noted.  Two small metal radio-opaque clips were attached to the SCJ using a single 
use rotatable clip fixing device (QuickClip 2™; Olympus, Southend-on-Sea, UK).  In 
subjects with Barrett’s oesophagus the clips were attached to the most proximal margin of 
the gastric folds. 
 
6.2.2.3 Study Days 3 and 4: Combined manometry and pH study with and 
without waist belt      
The volunteers attended fasted for a further two study days.  On days, a combined high-
resolution manometer and pH probe was passed pernasally and positioned so that the pH 
sensors were lying across the LOS and extending at least 5.5 cm above the LOS.  The 
relative positions of the 12-sensor pH catheter, 36-sensor manometer and SCJ is shown in 
Figure 6.1. 
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Figure 6.1: Diagrammatic representation of relative positions of the pH probe, manometer 
probe, squamocolumnar junction marked by radio-opaque clip and crural diaphragm. The 
marks on the probes indicate the sensor numbering of each probe. 
 
      
 
One of the study days was performed without the application of the waist belt.  Manometry 
and pH data were recorded concurrently for a 20-minute fasting period with the subjects 
sitting upright at a 60-degree angle.  They then consumed a standardised meal over ten 
minutes [400g Waitrose spaghetti bolognese ready meal and 100ml water (500kcal; 55.2g 
carbohydrate, 27.8g protein, 17.6g fat)].  Following this, manometry and pH recordings 
were continued for a further 90 minutes.  An X-ray was taken before and after the meal to 
visualise the metal clips at the SCJ. 
 On the other study day, the above procedure was repeated but with the application of a 
waist belt throughout the whole recording period.  A weight-lifter belt (Nike, USA) was 
applied tightly with a blood pressure cuff placed under the belt.  This was inflated to a 
constant cuff pressure of 50mmHg.  The order of the study days with and without the waist 
belt was alternated in random fashion.  Any upper GI symptoms experienced during the 
tests were recorded with respect to time, location, duration and character. 
 
6.2.3 Equipment 
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6.2.3.1 High-resolution pHmetry    
pH recordings were taken using a high-resolution pH catheter (Synectics Medical Ltd, 
Enfield, UK).  This was a custom-made pH probe composed of 12 antimony pH electrodes 
with the most distal electrode situated 5mm from the tip of the catheter, with the other 
eleven electrodes 35, 46, 57, 68, 79, 90, 101, 112, 123, 134 and 169mm proximal to the tip.  
The probe was calibrated prior to each study using pH buffer solution (Synmed Ltd, 
Enfield, UK) at pH 7.01 and pH 1.07.  Recordings were captured using Polygram Net 
software (Synectics Medical Ltd, Enfield, UK). 
 
6.2.3.2 High-resolution manometry  
Manometry was performed using a high resolution solid-state catheter with 7.5mm spacing 
between 36 circumferential sensors (Given Imaging, Hamburg, Germany).   Calibration 
was performed prior to each study and In vivo calibration was carried out weekly and 
applied to each study to compensate for thermal drift.  Recordings were captured with 
ManoScan 360 high-resolution Manometry System and analysed with ManoView ESO 
v3.0.1 software (Given Imaging, Hamburg, Germany).   
 
6.2.3.3 Combined probe  
The manometry and pH catheters were combined using two thin strips of Leukoplast Sleek 
waterproof tape (BSN Medical, Pinetown, SA) such that manometry sensor 21 was 
immediately adjacent to pH sensor 7.   
 
6.2.4 Data analysis 
6.2.4.1 Acid exposure  
Acid exposure was examined by calculating the percentage of time pH was less than 4 for 
each sensor across the LOS and up to 5.5cm proximal to LOS in the 20-minute fasting 
period and the 90-minute postprandial period.  Location of the pH transition point was 
defined by the position of the pH sensor recording a drop in median pH of at least one unit 
from proximal to distal and correcting for 1.1 cm spacing as previously described.(184)  
Reflux events were defined as a drop in pH to below 4 and lasting at least 1 second.  The 
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total number of reflux events were counted within the 20-minute fasting period and 90-
minute postprandial period.     
 
6.2.4.2 Manometric parameters 
Manometric characteristics were analysed in detail during fasting and after the meal.  For 
each two-minute period, one inspiratory point and one expiratory point was chosen from 
the longest period without interference from swallowing, coughing or transient lower 
oesophageal sphincter relaxations (TLOSRs).  The mean pressure in inspiration and 
expiration was calculated for each of the 36 sensors in the fasting period and postprandial 
period.  The peak LOS pressure was taken as the sensor showing the highest mean 
pressure. IGP was also calculated on inspiration and expiration and was defined as the 
mean pressure of the first three sensors immediately distal to the LOS.  Intra-oesophageal 
pressure (IOP) was defined as the mean pressure of three consecutive sensors located 6, 
6.75 and 7.5 cm proximal to the peak LOS pressure.   
 
6.2.4.3 Measurement of manometric locations 
All measurements were made using data collected in the expiratory phase of respiration.  
The upper border of the LOS was defined as the most proximal sensor where the pressure 
was at least 2mmHg above IGP.  The lower border of the LOS was defined as the most 
distal sensor where the pressure was at least 2mm Hg above IGP.  The pressure inversion 
point (PIP) was defined as the transition point from the abdominal pressure compartment 
(positive wave deflection) into the thoracic pressure compartment (negative wave 
deflection).  The position of the SCJ was derived from the position of the metal clips 
relative to the combined manometry and pH sensors seen on X-ray.  In the event of clips 
being visible at different levels, the mid-point between the two clips was used as the 
position of the SCJ.  All measurements (in cm) were determined from the nares. 
 
6.2.5 Statistical analysis 
     All continuous data are expressed as medians and interquartile ranges unless otherwise 
stated.  Comparison of variables between related groups was made using the Wilcoxon 
Signed Rank test.  For all correlations between two continuous variables, the Spearman 
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Rho bivariate correlations were used. Significance for all statistical tests was set as p value 
<0.05. 
 
6.2.6 Ethics 
The study protocol was approved by the West of Scotland Ethics Committee and all 
volunteers provided informed written consent. 
 
6.3 Results 
Fifteen subjects completed the study protocol, but one had to be excluded due to a 
technical issue resulting in loss of the manometry data for one study day. Thus 14 subjects 
were included in the final analysis.  The median age of the group was 56 years (range 24-
76) and all subjects were male.  The median BMI was 26.8 (range 22-42) and the median 
WC was 101cm (range 79-142cm).  At endoscopy, 11/14 had evidence of a hiatus hernia 
(length 2-4cm).  8/14 had reflux oesophagitis (either LA grade B or C) and 6/14 had 
Barrett’s 0esophagus (median length 3.5cm, range 1-9cm). 
 
6.3.1 Effect of belt on Intragastric Pressure and GOPG 
During fasting the belt increased IGP and GOPG during both inspiration and expiration 
(Table 6.1). On inspiration, the median IGP was 13.5mmHg without the belt versus 
19.9mmHg with the belt (p=0.005) and the GOPG was 13.7mmHg versus 18.6 mmHg 
(p=0.041).  On expiration, the median IGP was 9.8mmHg without the belt compared to 
16.7mmHg with the belt (p=0.002) and the GOPG was 5.0mmHg versus 9.1mmHg 
(p=0.035). 
 Following the meal, the belt also increased IGP on both inspiration and expiration (Table 
6.1). On inspiration, the IGP without the belt was 13.5mmHg versus 23.3mmHg with the 
belt (p=0.001) and the GOPG was 16.2 versus 22.5mmHg (p=0.008).  On expiration, the 
IGP was 10.8mmHg without the belt compared to 19.8mmHg with the belt on (p=0.001) 
and the GOPG was 8.0mmHg versus 11.9mmHg (p=0.016).  The greater increase in the 
IGP than GOPG was due to the belt also causing an increase in intra-oesophageal pressure. 
 Without the belt there was no difference in IGP fasting versus after the meal [9.8mmHg 
(IQR 8.9) versus 10.8mmHg (IQR 7.2); p=0.084). With the belt the IGP was greater after 
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the meal compared with under fasting conditions [19.8mmHg (IQR 7.6) versus 16.7mmHg 
(IQR 9.5); p=0.002]. 
 
6.3.2 Effect of belt on LOS 
 During the fasting period the belt increased median peak LOS pressure on expiration 
relative to atmospheric pressure, being 23.9mmHg with the belt off versus 27.5mmHg with 
the belt on (p=0.030) (Table 6.1). However, there was a fall in the median peak LOS 
pressure relative to the IGP on inspiration apparent after the meal, being 27.1mmHg with 
the belt off and 17.8mmHg with the belt on (p=0.041).  
The belt did not cause any significant changes in the LOS with respect to the distance 
between its upper border and nares, its length, or the position of the PIP, peak LOS 
pressure or SCJ relative to upper border of the LOS (Table 6.2). In addition, the belt did 
not influence the number of subjects with a double peak manometric pattern.  When fasted, 
5 subjects had a double peak pattern without the belt and 7 with the belt and after the meal, 
6 without the belt and 7 with it.   
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LOS = Lower oesophageal sphincter, LOSP = Lower oesophageal sphincter pressure, IGP = Intragastric pressure, IOP = Intra-oesophageal pressure, GOPG = Gastro-
oesophageal sphincter pressure, IQR = Interquartile range. 
Table 6.1: Effect of waist belt on manometric parameters in fasting and postprandial states in expiration and inspiration 
 Fasting  Postprandial 
     Expiration Belt Off Belt On p value  Belt Off Belt On p value 
Median Peak LOS pressure (IQR) 23.9 (8.4) 27.5 (11.9) 0.030  25.3 (9.6) 30.9 (12.8) 0.177 
Median LOSP vs IGP (IQR), mm Hg 12.6 (7.2) 11.3 (9.4) 0.826  14.2 (12.7) 10.7 (13.7) 0.158 
Median IOP (IQR), mm Hg 5.2 (5.0) 6.3 (4.9) 0.124  4.3 (4.7) 6.8 (5.5) 0.004 
Median IGP (IQR), mm Hg 9.8 (8.9) 16.7 (9.5) 0.002  10.8 (7.2) 19.8 (7.6) 0.001 
Median GOPG (IQR) 5.0 (4.8) 9.1 (5.9) 0.035  8.0 (3.2) 11.9 (7.4) 0.016 
     Inspiration        
Median Peak LOS pressure (IQR) 33.2 (12.9) 39.5 (17.6) 0.433  41.3 (21.5) 41.2 (4.5) 0.778 
Median LOSP vs IGP (IQR), mm Hg 20.2 (17.5) 20.0 (15.4) 0.124  27.1 (18.8) 17.8 (16.2) 0.041 
Median IOP (IQR), mm Hg -0.9 (3.7) 0.5 (2.0) 0.158  -0.2 (4.8) 0.9 (4.0) 0.022 
Median IGP (IQR), mm Hg 13.5 (7.6) 19.9 (11.5) 0.005  13.5 (5.8) 23.3 (8.1) 0.001 
Median GOPG (IQR) 13.7 (7.7) 18.6 (11.5) 0.041  16.2 (6.6) 22.5 (4.9) 0.008 
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Table 6.2: Effect of waist belt on relative locations of anatomical structures of the gastro-oesophageal junction. 
 Fasting  Postprandial 
 
Belt Off Belt On p value  Belt Off Belt On p value 
Upper border LOS (cm from nares) 43.38(4.81) 43.38 (4.00) 0.271  41.75 (3.63) 42.21 (2.40) 0.330 
LOS length, cm 3.75 (1.50) 3.38 (1.88) 0.218  3.00 (2.06) 2.88 (1.38) 0.636 
PIP (cm from upper border LOS) 0.43 (0.93) 0.43 (1.80) 0.801  0.60 (2.01) 0.54 (0.88) 0.245 
Peak LOSP (cm from upper border 
LOS) 
1.13 (0.75) 1.13 (0.75) 0.809  1.25 (0.69) 1.13 (0.56) 0.598 
SCJ (cm from upper border LOS) 1.12 (1.80) 1.10 (1.90) 0.241  0.88 (1.40) 0.48 (1.79) 0.124 
pH transition point (cm from upper 
border LOS) 
2.18 (1.55) 1.53 (2.80) 0.220  0.78 (1.51) -0.64 (3.37) 0.003 
pH transition point (cm from SCJ) 0.83 (2.61) 1.05 (2.51) 0.444  0.00 (1.02) -1.17 (2.89) 0.016 
 
LOS = Lower oesophageal sphincter, PIP = Pressure inversion point, LOSP = Lower oesophageal sphincter pressure, SCJ = Squamocolumnar junction. 
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6.3.3 Effect of belt on gastro-oesophageal reflux 
The waist belt caused a marked increase in gastro-oesophageal reflux during the 90 
minutes following the meal (Table 6.3). Acid exposure at each of the 5 pH sensors 
extending 5.5cm proximal to the peak LOS pressure point was significantly increased with 
versus without the belt with the percentage time pH <4 being increased by approximately 8 
times at each position.  Both with and without the belt acid exposure progressively 
increased with proximity to the peak LOS pressure point so that with the belt the pH was 
less than 4 at 1.1cm above the peak LOS pressure point for 49.7% of the time following 
the meal compared to 7.3% without the belt (p=0.03).  The waist belt also increased the 
acid exposure at the peak LOS pressure point (66.1% versus 18.4%, p=0.056) and 1.1 cm 
distal to it (89.6% versus 59.4%, p=0.026). 
The waist belt also increased acid reflux after the meal relative to the clip marking the SCJ 
or in the case of the 6 patients with Barrett’s, the proximal extent of the gastric folds.  At 
1.1cm proximal to the clip, the percentage time pH<4 was 41.4% (IQR 61.1) with the belt 
versus 7.0% (IQR 18.9) without it (p<0.05); at 2.2cm proximal 12.5% (IQR 44.0) versus 
1.3% (IQR 8.4; p=0.01); at 3.3cm proximal 11.3% (IQR 21.2) versus 0.7% (IQR 6.5; 
p<0.02) and at 4.4cm proximal 4.5% (IQR 9.9) versus 0.3% (IQR 2.8; p<0.01). 
Following the meal, the median number of reflux events with the belt was twice that 
without the belt [2 (IQR 2) vs 4 (IQR 6); p=0.008] (Table 6.4). The median number of 
TLOSRs was not different but the number accompanied by acid reflux was increased with 
the belt [2 (IQR 2) vs 3.5 (IQR 5); p=0.041].  The median time from onset of TLOSR until 
return of the LOS to stable tone and original position was not different with the belt off 
versus on [46.0s (IQR 10.4) vs 44.8s (IQR 14.4); p=0.279].  The most marked effect of the 
belt was to reduce the rate of oesophageal clearance of refluxed acid with the median time 
being 23.0 seconds without the belt versus 81.1 seconds with the waist belt (p=0.008).  
Examining the pH plots of the long reflux events occurring after the meal with the belt 
revealed evidence of attempted clearance of acid followed by immediate re-reflux of acid 
(Figure 6.2). There was no difference in the median amplitude of distal oesophageal 
contractions with or without the waist belt [85.8mmHg (IQR 32.8) vs 79.5mmHg (IQR 
48.1); p=0.387] (Table 6.4)  
During the fasting period there was no difference in oesophageal acid exposure with versus 
without the belt. However, the acidity at the peak LOS pressure point and at the 
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intragastric sensors located 1.1cm, 2.2cm, and 3.3cm distal to it was greater with versus 
without belt. (p< 0.02 for each). (Table 6.3)       
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Table 6.3: Median (IQR) percentage time pH<4 at sensors relative to peak LOS pressure comparing subjects with and 
without waist belt.  
: Effect of waist belt on manometry parameters in fasting and postprandial states in expiration and inspiration 
 Fasting  Postprandial 
     Sensor Location Belt Off Belt On p value  Belt Off Belt On p value 
5.5cm proximal  0 (0) 0 (0) 0.285  0.2 (1.4) 2.5 (9.6) 0.038 
4.4cm proximal  0 (0.1) 0 (0) 1.000  0.5 (2.6) 4.7 (14.3) 0.002 
3.3cm proximal  0 (0.1) 0 (0.6) 0.341  1.0 (5.0) 8.0 (31.4) 0.013 
2.2cm proximal  0.1 (1.5) 0.1 (1.3) 0.415  3.5 (10.1) 12.4 (41.3) 0.009 
1.1cm proximal  0.3 (3.8) 0.4 (9.0) 0.286  7.3 (15.0) 49.7 (52.0) 0.030 
Peak LOS pressure  2.6 (6.9) 5.2 (41.5) 0.016  18.4 (38.6) 66.1 (42.3) 0.056 
1.1cm distal 18.3 (48.2) 55.6 (79.3) 0.019  59.4 (48.5) 89.6 (14.2) 0.026 
2.2cm distal 53.4 (57.4) 95.1 (15.8) 0.005  86.7 (19.9) 85.3 (26.2) 0.701 
3.3cm distal 88.6 (66.4) 99.8 (5.0) 0.016  88.3 (36.2) 89.8 (31.9) 0.722 
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Table 6.4: Effect of waist belt on mechanism of acid exposure across the LOS during 90-minute 
postprandial period 
      Belt Off Belt On p value 
Median no. of reflux events (IQR) 2 (2) 4 (6) 0.008 
Median no. TLOSRs (IQR) 7 (3.3) 6 (5.3) 0.279 
Median no. TLOSRs associated with reflux (IQR) 2 (2) 3.5 (5) 0.041 
Average clearance time (IQR), seconds 23.0 (63.4) 81.1 (110.6) 0.008 
Median no. peristalsis to clear acid (IQR) 1.0 (1) 
 
 
 
 
1.5 (2) 0.074 
Median peristaltic distal oesophageal pressure 
(IQR), mmHg  
79.5 (48.1) 85.8 (32.8) 0.387 
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Figure 6.2: An example of an oesophageal pH recording at sensor 5.5cm above 
peak LOS pressure from one of the study subjects wearing a belt during the 
postprandial period. Following the initial reflux event (marked by arrow) there is 
clearance of acid by a peristaltic wave but this is followed immediately by re-reflux. 
 
 
 
 
 
6.3.4 Effect of Belt on Gastro-oesophageal pH Step-Up Point 
The belt caused the location of the point where acidity changes from gastric pH to 
oesophageal pH (pH transition point) to move proximally after the meal with respect to the 
LOS upper border and peak pressure as well as the SCJ (Table 6.2).  Without the belt the 
pH transition point was 0.78cm distal to the upper border LOS but with the belt it was 
0.64cm proximal to it (p=0.003). Likewise, without the belt the pH transition point was 
precisely at the level of the clip marking the squamocolumnar junction (or in the 6 subjects 
with circumferential Barrett’s the proximal extent of the gastric folds) but with the belt it 
was 1.17cm proximal to it (p=0.016). This meant that with the belt on the distal 
oesophagus was constantly exposed to the level of acidity normally only seen in the 
stomach. 
There was no significant difference in the position of the pH step up with and without the 
belt during the 20-minute fasting period (Table 6.2). 
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6.3.5 Correlation of WC with both the intragastric pressure and GOPG 
Without the belt, there was a strong correlation between the WC of the 14 patients included 
in the study and their fasting IGP both on expiration (r=0.682, p=0.008) and inspiration 
(r=0.581, p=0.029).  There was also a positive correlation with fasting GOPG on 
inspiration (r=0.640, p=0.014) but this was not seen on expiration.  No significant 
correlations were apparent in the 90-minute period following the meal.  
 
6.4 Discussion 
Our study indicates that in reflux patients, waist belt constriction causes a marked increase 
in gastro-oesophageal reflux most evident after a meal. The effect of the belt was most 
marked close to the gastro-oesophageal junction where the pH of the distal oesophagus 
lined, or normally lined, by squamous mucosa became like that of the proximal stomach. 
As previously reported the belt caused a rise in the IGP, which in the empty stomach is 
equivalent to intra-abdominal pressure, and also an increase in GOPG.(179, 183)  The rise 
in GOPG was less than in IGP and this can be explained by the fact that the belt also 
caused an increase in intra-oesophageal pressure.   
The belt also raised peak LOS pressure which has previously been observed both in 
healthy volunteers and reflux patients.(185)  Mittal et al observed that the rise in LOS 
pressure with abdominal compression was associated with tonic contraction of crural 
diaphragm EMG activity.(181)  In our current study after the meal the belt caused a greater 
rise in the IGP than in LOS pressure causing a significant fall in LOS pressure relative to 
the IGP which is the pressure gradient preventing reflux. This fall in LOS pressure relative 
to the IGP has been reported by some but not all investigators.(23, 183)  The fall in LOS 
pressure relative to the IGP in our current study was only apparent after the meal and 
involved patients with reflux disease and in these respects differed from previous studies. 
Consistent with previous reports we found no evidence that the belt, at least in the short 
term of our study, caused any increased separation of the two components of the LOS 
which would be indicative of promoting hiatus hernia formation.(182) 
We extended previous work by monitoring the effect of the belt on actual acid reflux.     
We found that the belt markedly increased acid exposure following the meal at each of the 
pH sensors placed at 1.1cm increments and extending 5.5cm proximal to the peak LOS 
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pressure point. At each of these locations the belt increased oesophageal acid exposure by 
approximately 8-fold relative to that without the belt. Without the belt the amount of acid 
increased with proximity to the LOS and the 8-fold increase with the belt caused the pH of 
the most distal oesophagus to be < 4 for 49.7% of the time following the meal.   The belt 
also caused a marked increase in acid exposure after the meal when measured relative to 
the clip marking the SCJ or proximal extent of gastric folds. 
Our combined high-resolution pH and manometry system allowed us to examine the 
mechanism of the increased oesophageal acid exposure induced by the belt. After the meal 
the belt doubled the number of reflux episodes. There was no increase in the number of 
TLOSRs but there was an increase in those associated with reflux.  The most marked effect 
of the belt was impairment of oesophageal acid clearance which was approximately 4 
times longer than without the belt. This impaired clearance was often related to re-reflux of 
acid occurring immediately after an oesophageal peristaltic clearance wave.  
The pH pattern of the impaired oesophageal clearance with the belt in our study is similar 
to that previously reported in patients with hiatus hernia.  Mittal et al in 1987 observed that 
in hiatus hernia patients oesophageal acid clearance by a swallow was often followed by 
rapid re-reflux due to retrograde flow of contents from the hiatal sac during the swallow 
induced relaxation of the LOS.(20)  Jones et al also found that impaired oesophageal 
clearance was strongly correlated with oesophagitis and hiatus hernia.(16)  In hiatus hernia 
patients reflux of barium trapped in the hiatal sac following a swallow has also been 
observed and shown to be most marked in non-reducing hernias.(18, 21)  The vast majority 
of the reflux patients in our study had hiatus hernias and the belt is thus aggravating the 
impaired oesophageal clearance associated with hiatus hernia. 
The waist belt also caused the pH step up point (where the pH changes from gastric to 
oesophageal) to move proximally by 1-2cm within and even above the LOS and again this 
was most marked following the meal. We were also able to see the effect of the belt on the 
location of the pH step-up point relative to the location of the SCJ or in the case of the 6 
patients with circumferential Barrett’s the proximal extent of the gastric folds. Without the 
belt the pH step-up was at the level of the SCJ (or proximal gastric folds in Barrett’s 
patients) but with the belt was displaced 1-2cm above it. The cause of this proximal 
displacement of the pH step-up point is unclear but might be due to marked impaired distal 
oesophageal acid clearance. In hiatus hernia patients, the impaired clearance is most 
marked near to the gastro-oesophageal junction.(20) 
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We considered the possibility that the belt might cause some artefactual evidence of distal 
oesophageal acid reflux by increasing the duration and/or magnitude of proximal migration 
of the gastro-oesophageal junction during TLOSRs.  This could increase acid detected by 
the distal oesophageal sensors due to their contact with the acidic gastric mucosa.  
However, our analysis indicated that the time for restitution of normal tone and position of 
the LOS following TLOSRs was the same with versus without the belt.  This excludes the 
prolonged acid clearance, which was the main effect of the belt, from being attributed to 
prolonged proximal migration of the gastro-oesophageal junction during TLOSRs.  
Although we could not measure the amplitude of migration of the gastro-oesophageal 
junction during TLOSRs, a previous study by Kahrilas et al showed that abdominal 
compression did not influence the proximal movement of the gastro-oesophageal junction 
during peristalsis in healthy volunteers or subjects with hiatus hernia.(182)   
The increase in oesophageal acid exposure produced by the belt in our current study is 
substantially more than observed in the earlier study in healthy volunteers without reflux 
disease or hiatus hernia.(183)    This indicates that the reflux promoting effect of the belt is 
much more significant in patients with impaired LOS function.  
The increase in oesophageal acid exposure induced by the belt was confined to the 90-
minute period after the meal and several factors may explain this.  The actual IGP with the 
belt on was higher after the meal than fasted despite these pressures being similar without 
the belt.  In addition, most of the increase in reflux occurred during TLOSRs and its 
subsequent impaired clearance and TLOSRs mainly occur after meals. Though there was 
no increased oesophageal acid exposure with the belt during the fasting period the acidity 
of the most proximal stomach close to the gastro-oesophageal junction was increased and 
the reason for this is not clear.   
The acid exposure of the distal oesophagus in our reflux subjects with the belt was 
equivalent to that of the proximal stomach. The proximal region of the stomach escapes the 
buffering effect of food and remains highly acidic after a meal. If this degree of acid 
exposure of the distal oesophagus were prolonged it would be likely to result in columnar 
metaplasia as the squamous mucosa transforms to a type more suited to a gastric rather 
than oesophageal luminal environment.  Six of our patients did have Barrett’s oesophagus. 
Our findings are likely to be relevant to the mechanism of the association between central 
obesity and reflux disease. Increasing WC is accompanied by an increase in intra-
abdominal and intra-gastric pressure.(178)  Even with the relatively small number of 
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subjects in our current study there was a strong and highly significant correlation between 
WC and IGP. The range in IGP between the smallest and largest WC was 17mmHg and 
this is greater than the average rise in intragastric pressure produced by the waist belt of 
6.5mmHg fasted and 9.5mmHg after the meal.  It would appear, therefore, that much of the 
association between WC and reflux could be explained by the effects on intra-abdominal 
pressure.  
Our findings are also relevant to potential adverse effects of tight waist bands or clothing 
in subjects with impaired LOS function. As both central obesity and tight waist band 
increase intra-abdominal pressure it would seem appropriate to advise reflux patients to 
both lose weight and avoid such clothing. Our findings suggest that it will be particularly 
important to avoid tight waist belts after meals when their reflux promoting effects are 
most pronounced. However, caution needs to be taken in extrapolating the findings of our 
short-term study to long-term use of waist constricting clothing.  
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7.1 Discussion 
The studies included within this thesis all add to the current understanding of the 
environmental factors contributing to the rising incidence of gastro-oesophageal reflux 
disease and its malignant complications of Barrett’s oesophagus and oesophageal 
adenocarcinoma.     
Gastro-oesophageal reflux disease is one of the commonest chronic conditions and 
evidence suggests that the incidence has been increasing over the past few decades.(1)  
Chronic GORD can lead to Barrett’s metaplasia of the distal oesophagus which can 
progress to oesophageal adenocarcinoma, and the incidence of these conditions appears to 
be rising also.  There has been a marked 3-4 fold rise in the incidence of oesophageal 
adenocarcinoma in the West over the past 30 years(41, 43).  Our epidemiological study of 
national cancer registries suggests that Scotland has the highest recorded incidence of 
oesophageal adenocarcinoma in the world.  The rapid rise in incidence of oesophageal 
cancer indicates that it is the result of environmental changes and identifying these will be 
an essential step in the development of preventative measures. 
We showed the incidence of oesophageal adenocarcinoma varies considerably across 
different countries.  A similar variation exists in the incidence of gastric adenocarcinoma.  
We observed a very strong negative association between these two cancers, with 
oesophageal adenocarcinoma only rising above 2 per 100,000-person years in populations 
where non-cardia gastric cancer is below 10 per 100,000-person years. In addition, we 
found a very strong negative correlation in the time trends of the two cancers in the West.  
In Scotland, gastric cancer showed a 3-fold fall in incidence over the same time period as a 
3-4 fold rise in oesophageal adenocarcinoma.  This trend was apparent in many 
populations.  Oesophageal cancer has risen significantly in the majority of the populations 
over an 18-year period, whilst gastric adenocarcinoma rates have fallen in the majority of 
populations. 
The inverse association between the changing incidences of the two cancers may indicate 
that a single environmental factor is responsible and is exerting opposite effects on the two 
cancers.  The environmental factors that are thought to explain the falling incidence of gastric 
adenocarcinoma include a falling incidence of H. pylori atrophic gastritis, dietary changes 
and reduced smoking.(149)  Smoking is a similar risk factor for both cancers and as smoking 
rates have generally been decreasing this could not explain the rising incidence of 
oesophageal cancer.(138, 150) There is some evidence that increased intake of vitamins and 
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reduced salt consumption may have contributed to the falling incidence of gastric 
cancer.(151, 152) These specific dietary factors would not in themselves explain the increase 
in oesophageal adenocarcinoma and indeed increased vitamin consumption may protect 
against oesophageal adenocarcinoma.(153) However, increased caloric intake and 
associated obesity is a well-established risk factor for OAC.(153) It is therefore possible that 
changes in the diet comprising both a fall in salt content and increased caloric content could 
produce a fall in gastric cancer and rise in oesophageal adenocarcinoma. However, a recent 
analysis indicated that increasing obesity may only account for 6.5% of the increase in 
incidence of oesophageal adenocarcinoma.(136)  Another environmental factor that might 
exert opposite effects on the incidence of the two cancers is H. pylori atrophic gastritis which 
is the most important etiological factor for non-cardia gastric cancer.(154)  In countries with 
a high incidence of gastric cancer there is also a high incidence of atrophic gastritis and 
associated impaired gastric acid secretion.(155)  This will protect from oesophageal 
adenocarcinoma as any gastro-oesophageal refluxate will have reduced ability to damage the 
oesophagus due to its reduced acidity.   
H. pylori infection of the stomach, discovered in 1984, is estimated to infect more than half 
of the world’s population.(47) Numerous epidemiological studies have found decreasing 
H. pylori incidence rates in many parts of the world.(47-51)  The infection causes a chronic 
gastritis which can progress to atrophic gastritis with intestinal metaplasia.  This can lead 
to the development of complications such as gastric and duodenal ulcer disease, gastric 
adenocarcinoma and MALT lymphoma.  H. pylori strains which are cagA-PAI positive  
cause peptic ulceration and gastric cancer more frequently that cagA-PAI negative 
strains.(59)  The well documented inverse association between H. pylori infection and 
presence of GORD, Barrett’s oesophagus and oesophageal adenocarcinoma could be 
explained by the gastric infection protecting against these oesophageal diseases. If so, the 
falling incidence of the infection in the general population might explain the rising 
incidence of the oesophageal disorders.  One mechanism by which the infection might 
protect against oesophageal disease is by reducing the ability of the gastric mucosa to 
secrete acid and pepsin which are the constituents of gastric juice which can induce 
oesophageal damage.   
 
We studied the effect of H. pylori infection on intragastric acidity in the West of Scotland 
population as if the infection is conferring protection against oesophageal adenocarcinoma, 
it must be protecting against oesophageal disease in the vast majority of the population 
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rather than just the 10% who develop complications such as peptic ulcer disease.  If the 
protection is due to the infection reducing gastric acid secretion, then this suppression of 
acid secretion would need to be apparent in the majority of infected subjects.   
 
Our study of subjects from the general population of the West of Scotland found that those 
with H. pylori infection had less intragastric acidity both under fasting conditions and 
following a meal compared to uninfected subjects matched for age, gender and body 
weight.  This adds to our understanding of why there is an inverse association between the 
infection and gastro-oesophageal reflux disease.  Following a meal, the reduced acidity 
was found close to the GOJ, compared to fasting when the reduced acidity was throughout 
the stomach.  Parietal cell density was reduced throughout the gastric mucosa and not just 
in the area close to the GOJ, so could not explain this finding.  Inflammation was found to 
be slightly increased close to the GOJ, as well as in the distal stomach compared to the 
mid-body gastric mucosa.  This is a potential reason for the reduced acidity in this area as 
inflammation can inhibit gastric secretory function.(158) However this would not explain 
why this reduced acidity is only seen in the postprandial period and not in the fasting 
period.  
The acid pocket, described as a local pocket of acid close to the gastro-oesophageal 
junction which escaped the buffering effect of the meal, may explain these postprandial 
findings.  The phenomenon likely represents the relative intragastric distribution of gastric 
juice and ingested food.  Following a meal, the food occupies the centre of the stomach 
whilst newly secreted gastric juice will be close to the stomach wall.  Impaired acid 
secretion will elevate the pH of the gastric juice which will therefore be most apparent 
close to the stomach wall.  In contrast, the central region of the stomach will reflect the pH 
of the food and thus will be relatively unaffected by changes in the acidity of secreted 
juice.  At the GOJ the stomach wall is closer together therefore the pH probe will more 
likely to be close to the wall where the pH is lower. Therefore, the effect of H. pylori on 
gastric secretion is likely to be greatest here.  It is plausible that this effect offers the main 
protection against acid refluxing from this acid pocket 
At present, H. pylori is being treated in virtually all subjects with the infection despite the 
great majority not having any clinical disease arising from it.  The growing evidence that 
the infection may be exerting a protective effect on acid reflux and oesophageal 
adenocarcinoma suggests this approach may not be correct.  This is particularly important 
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now that the risk of oesophageal adenocarcinoma has exceeded that of gastric cancer in the 
UK.   
The findings of this study do not necessarily indicate that the reduced intragastric acidity is 
caused by the infection.  However, causal association seems highly likely as H. pylori 
gastritis is recognised to cause loss of gastric glands and impaired secretory function.  In 
addition, the more marked changes in gastric secretory function in those with the more 
virulent CagA strain supports it being caused by the infection.  Confirming causality by an 
intervention study has potential problems as H. pylori-induced loss of gastric glands is 
generally regarded as being irreversible. 
The third and final study described within this thesis adds to our understanding of the 
association between obesity and GORD.  The incidence of obesity is rising around the 
world, and is especially well documented in the United States and the UK.(100-103)  
Obesity is clearly associated with GORD and oesophageal adenocarcinoma.(106, 115) 
The nature of this association is incompletely understood and both mechanical and 
humoral effects of central obesity may be important.   
We looked at the effect of waist belt compression on intra-abdominal pressure.  Consistent 
with previous studies, we found a strong correlation between waist circumference and IGP, 
suggesting this is an important mechanism in explaining the association.  The waist belt 
increased IGP and the GOPG as documented in previous studies.  However, we extended 
previous work by monitoring the effect of the belt on actual acid reflux and found that the 
belt markedly increased acid exposure following the meal up to 5.5cm proximal to the peak 
LOS pressure point by approximately 8-fold relative to that without the belt.  The mechanism 
causing this appeared to be an increase in the number of TLOSRs associated with acid reflux 
in addition to impairment of oesophageal acid clearance, which was approximately 4 times 
longer with the waist belt applied.   
Our study indicates that in reflux patients, waist belt constriction causes a marked increase 
in gastro-oesophageal reflux most evident after a meal. The effect of the belt was most 
marked close to the gastro-oesophageal junction where the pH of the distal oesophagus 
lined, or normally lined, by squamous mucosa became like that of the proximal stomach. 
Our combined high-resolution pH and manometry system allowed us to examine the 
mechanism of the increased oesophageal acid exposure induced by the belt. After the meal 
the belt doubled the number of reflux episodes. There was no increase in the number of 
TLOSRs but there was an increase in those associated with reflux.  The most marked effect 
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of the belt was impairment of oesophageal acid clearance which was approximately 4 
times longer than without the belt. This impaired clearance was often related to re-reflux of 
acid occurring immediately after an oesophageal peristaltic clearance wave.  
The pH pattern of the impaired oesophageal clearance with the belt in our study is similar 
to that previously reported in patients with hiatus hernia.  Mittal et al in 1987 observed that 
in hiatus hernia patients oesophageal acid clearance by a swallow was often followed by 
rapid re-reflux due to retrograde flow of contents from the hiatal sac during the swallow 
induced relaxation of the LOS.(20)  Jones et al also found that impaired oesophageal 
clearance was strongly correlated with oesophagitis and hiatus hernia.(16)  In hiatus hernia 
patients reflux of barium trapped in the hiatal sac following a swallow has also been 
observed and shown to be most marked in non-reducing hernias.(18, 21)  The vast majority 
of the reflux patients in our study had hiatus hernias and the belt is thus aggravating the 
impaired oesophageal clearance associated with hiatus hernia. 
The waist belt also caused the pH step up point (where the pH changes from gastric to 
oesophageal) to move proximally by 1-2cm within and even above the LOS and again this 
was most marked following the meal. We were also able to see the effect of the belt on the 
location of the pH step-up point relative to the location of the SCJ or in the case of the 6 
patients with circumferential Barrett’s the proximal extent of the gastric folds. Without the 
belt the pH step-up was at the level of the SCJ (or proximal gastric folds in Barrett’s 
patients) but with the belt was displaced 1-2cm above it. The cause of this proximal 
displacement of the pH step-up point is unclear but might be due to marked impaired distal 
oesophageal acid clearance. In hiatus hernia patients, the impaired clearance is most 
marked near to the gastro-oesophageal junction.(20) 
The increase in oesophageal acid exposure produced by the belt in our current study is 
substantially more than observed in the earlier study in healthy volunteers without reflux 
disease or hiatus hernia.(183)    This indicates that the reflux promoting effect of the belt is 
much more significant in patients with impaired LOS function.  
Our findings are likely to be relevant to the mechanism of the association between central 
obesity and reflux disease. Increasing WC is accompanied by an increase in intra-
abdominal and intra-gastric pressure.(178)  Even with the relatively small number of 
subjects in our current study there was a strong and highly significant correlation between 
WC and IGP. The range in IGP between the smallest and largest WC was 17mmHg and 
this is greater than the average rise in intragastric pressure produced by the waist belt of 
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6.5mmHg fasted and 9.5mmHg after the meal.  It would appear, therefore, that much of the 
association between WC and reflux could be explained by the effects on intra-abdominal 
pressure.  
Our findings are also relevant to potential adverse effects of tight waist bands or clothing 
in subjects with impaired LOS function. As both central obesity and tight waist band 
increase intra-abdominal pressure it would seem appropriate to advise reflux patients to 
both lose weight and avoid such clothing. Our findings suggest that it will be particularly 
important to avoid tight waist belts after meals when their reflux promoting effects are 
most pronounced. However, caution needs to be taken in extrapolating the findings of our 
short-term study to long-term use of waist constricting clothing.  
 
7.2 Suggestions for future work 
Several questions arise from our epidemiological study.  Future work in countries with a 
high incidence of gastric adenocarcinoma should assess if the changing epidemiology of 
gastric and oesophageal adenocarcinoma mirrors the changes seen in the Western World.  
Predicting and highlighting this change early will be important in preparing health services 
for a rise in reflux disease and oesophageal adenocarcinoma.  
The study highlighted a heterogeneous group of countries with low levels of both 
oesophageal and gastric adenocarcinoma.   It is unclear whether these countries have 
always had low levels of these cancers, or whether they have seen gastric adenocarcinoma 
levels fall similar to other countries throughout the world, without the rise in oesophageal 
adenocarcinoma levels seen elsewhere. Studies comparing patients from countries with 
low incidence of both cancers e.g. Italy and Spain with patients from countries with high 
level of oesophageal adenocarcinoma and low levels of gastric adenocarcinoma could shed 
new light on the aetiology and pathogenesis of oesophageal adenocarcinoma. 
Understanding how H. pylori infection protects against acid reflux and oesophageal 
adenocarcinoma by modifying the acid secreting capacity of the gastric mucosa closest to 
the oesophagus may allow more targeted approaches to the treatment of these conditions to 
be developed.  At present, treatments suppress the secretion of acid by the entire stomach 
and are consequently associated with adverse effects including increased risks of infection, 
impaired absorption of calcium and iron and rebound acid hypersecretion due to reflux 
hypergastrinaemia induced oxyntic mucosal hyperplasia.  The real panacea for gastro-
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oesophageal reflux disease treatment would be the development of a drug or technique 
which prevents acid reflux with no side-effects. Targeting the acid in the proximal stomach 
in the postprandial period without affecting overall gastric acidity would be an attractive 
prospect. 
H. pylori testing and eradication is currently indicated for patients presenting to primary 
care with dyspeptic symptoms.  In this setting dyspepsia is defined broadly to include 
people with heartburn, acid regurgitation, nausea, and bloating in addition to those with 
recurrent epigastric pain.  The general population who have had previous H. pylori 
eradication would be an interesting group to assess in terms of gastric mucosa 
histopathology, as well as a physiological assessment of their GOJ function and presence 
of acid reflux.  Determining the number of years of infection, as well as the length of time 
post-eradication could be correlated with the findings of gastric mucosal status and acid 
reflux.  This could give us more evidence of the effect of H. pylori eradication in a 
population with low levels of gastric cancer and increasing incidence of oesophageal 
adenocarcinoma.   
The dynamic nature of the GOJ and the SCJ within it means this is a difficult area to study.  
Advancement in technology should be used to gain greater understanding of the 
pathophysiology of GORD.  As the technology available for oesophageal manometry and 
pH measurement advances our understanding of the pathophysiology of GORD will 
improve.  Impedance is becoming more commonly used in research and clinical care.  This 
would give further information of the types of reflux which occur in the groups of patients 
we studied 
In our study using a tight waist belt applied for 2 hours, the manometric changes across the 
GOJ are similar to those seen in obese patients, however on removal of the waist belt the 
changes are reversed.  IT would be interesting to assess whether the physiological and 
manometric changes which occur in obese patients are reversed by weight loss.  It may be 
that the changes at the GOJ which lead to hiatus hernia development are permanent and 
therefore medical and surgical treatments are required for severe GORD even if weight 
loss is achieved.   
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